<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Aerobic exercise training for adults with fibromyalgia - Bidonde, J - 2017 | Cochrane Library</title> <meta content="Aerobic exercise training for adults with fibromyalgia - Bidonde, J - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012700/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Aerobic exercise training for adults with fibromyalgia - Bidonde, J - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012700/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012700" name="dc.identifier" scheme="DOI"/> <meta content="Aerobic exercise training for adults with fibromyalgia" name="citation_title"/> <meta content="Julia Bidonde" name="citation_author"/> <meta content="Norwegian Institute of Public Health" name="citation_author_institution"/> <meta content="julia.bidonde@usask.ca" name="citation_author_email"/> <meta content="Angela J Busch" name="citation_author"/> <meta content="University of Saskatchewan" name="citation_author_institution"/> <meta content="Candice L Schachter" name="citation_author"/> <meta content="Retired Professor" name="citation_author_institution"/> <meta content="Tom J Overend" name="citation_author"/> <meta content="University of Western Ontario" name="citation_author_institution"/> <meta content="Soo Y Kim" name="citation_author"/> <meta content="University of Saskatchewan" name="citation_author_institution"/> <meta content="Suelen M. Góes" name="citation_author"/> <meta content="University of Saskatchewan" name="citation_author_institution"/> <meta content="Catherine Boden" name="citation_author"/> <meta content="University of Saskatchewan" name="citation_author_institution"/> <meta content="Heather JA Foulds" name="citation_author"/> <meta content="University of Saskatchewan" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD012700" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/06/21" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012700/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012700/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012700/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Exercise; *Muscle Tonus; *Quality of Life; Fatigue [therapy]; Fibromyalgia [physiopathology, *therapy]; Pain Measurement; Patient Dropouts [statistics &amp; numerical data]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012700&amp;doi=10.1002/14651858.CD012700&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012700&amp;doi=10.1002/14651858.CD012700&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012700&amp;doi=10.1002/14651858.CD012700&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012700&amp;doi=10.1002/14651858.CD012700&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012700&amp;doi=10.1002/14651858.CD012700&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012700&amp;doi=10.1002/14651858.CD012700&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012700&amp;doi=10.1002/14651858.CD012700&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012700&amp;doi=10.1002/14651858.CD012700&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012700&amp;doi=10.1002/14651858.CD012700&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012700&amp;doi=10.1002/14651858.CD012700&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012700&amp;doi=10.1002/14651858.CD012700&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012700&amp;doi=10.1002/14651858.CD012700&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012700&amp;doi=10.1002/14651858.CD012700&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012700&amp;doi=10.1002/14651858.CD012700&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012700&amp;doi=10.1002/14651858.CD012700&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012700&amp;doi=10.1002/14651858.CD012700&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012700&amp;doi=10.1002/14651858.CD012700&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012700&amp;doi=10.1002/14651858.CD012700&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012700&amp;doi=10.1002/14651858.CD012700&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012700&amp;doi=10.1002/14651858.CD012700&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012700&amp;doi=10.1002/14651858.CD012700&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012700&amp;doi=10.1002/14651858.CD012700&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012700&amp;doi=10.1002/14651858.CD012700&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="uQyIsxpV";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012700\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012700\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012700\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012700\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","pl","de","fa","pt"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012700",title:"Aerobic exercise training for adults with fibromyalgia",firstPublishedDate:"Jun 21, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Musculoskeletal Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uQyIsxpV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012700&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012700';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012700/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012700/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012700%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012700/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012700/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012700/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012700/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012700" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012700/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012700" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012700/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012700/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>22176 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012700" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012700/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012700/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012700/full#CD012700-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012700/full#CD012700-sec-0106"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012700/full#CD012700-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012700/full#CD012700-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012700/full#CD012700-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012700/full#CD012700-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012700/full#CD012700-sec-0054"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012700/full#CD012700-sec-0100"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012700/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012700/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012700/appendices#CD012700-sec-0117"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012700/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012700/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/table_n/CD012700StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/table_n/CD012700StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012700/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012700/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012700/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012700/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012700/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012700/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012700/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Aerobic exercise training for adults with fibromyalgia</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012700/information#CD012700-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Julia Bidonde</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012700/information#CD012700-cr-0003">Angela J Busch</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012700/information#CD012700-cr-0004">Candice L Schachter</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012700/information#CD012700-cr-0005">Tom J Overend</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012700/information#CD012700-cr-0006">Soo Y Kim</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012700/information#CD012700-cr-0007">Suelen M. Góes</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012700/information#CD012700-cr-0008">Catherine Boden</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012700/information#CD012700-cr-0009">Heather JA Foulds</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012700/information/en#CD012700-sec-0133">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 21 June 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012700/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012700">https://doi.org/10.1002/14651858.CD012700</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012700-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012700-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012700-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012700-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/pt#CD012700-abs-0010">Português</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012700-abs-0001" lang="en"> <section id="CD012700-sec-0001"> <h3 class="title" id="CD012700-sec-0001">Background</h3> <p>Exercise training is commonly recommended for individuals with fibromyalgia. This review is one of a series of reviews about exercise training for people with fibromyalgia that will replace the "Exercise for treating fibromyalgia syndrome" review first published in 2002. </p> </section> <section id="CD012700-sec-0002"> <h3 class="title" id="CD012700-sec-0002">Objectives</h3> <p>• To evaluate the benefits and harms of aerobic exercise training for adults with fibromyalgia </p> <p>• To assess the following specific comparisons<br/> ० Aerobic versus control conditions (eg, treatment as usual, wait list control, physical activity as usual)<br/> ० Aerobic versus aerobic interventions (eg, running vs brisk walking)<br/> ० Aerobic versus non‐exercise interventions (eg, medications, education)<br/> <br/> We did not assess specific comparisons involving aerobic exercise versus other exercise interventions (eg, resistance exercise, aquatic exercise, flexibility exercise, mixed exercise). Other systematic reviews have examined or will examine these comparisons (Bidonde 2014; Busch 2013). </p> </section> <section id="CD012700-sec-0003"> <h3 class="title" id="CD012700-sec-0003">Search methods</h3> <p>We searched the Cochrane Library, MEDLINE, Embase, the Cumulative Index to Nursing and Allied Health Literature (CINAHL), the Physiotherapy Evidence Database (PEDro), Thesis and Dissertation Abstracts, the Allied and Complementary Medicine Database (AMED), the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP), and the ClinicalTrials.gov registry up to June 2016, unrestricted by language, and we reviewed the reference lists of retrieved trials to identify potentially relevant trials. </p> </section> <section id="CD012700-sec-0004"> <h3 class="title" id="CD012700-sec-0004">Selection criteria</h3> <p>We included randomized controlled trials (RCTs) in adults with a diagnosis of fibromyalgia that compared aerobic training interventions (dynamic physical activity that increases breathing and heart rate to submaximal levels for a prolonged period) versus no exercise or another intervention. Major outcomes were health‐related quality of life (HRQL), pain intensity, stiffness, fatigue, physical function, withdrawals, and adverse events. </p> </section> <section id="CD012700-sec-0005"> <h3 class="title" id="CD012700-sec-0005">Data collection and analysis</h3> <p>Two review authors independently selected trials for inclusion, extracted data, performed a risk of bias assessment, and assessed the quality of the body of evidence for major outcomes using the GRADE approach. We used a 15% threshold for calculation of clinically relevant differences between groups. </p> </section> <section id="CD012700-sec-0006"> <h3 class="title" id="CD012700-sec-0006">Main results</h3> <p>We included 13 RCTs (839 people). Studies were at risk of selection, performance, and detection bias (owing to lack of blinding for self‐reported outcomes) and had low risk of attrition and reporting bias. We prioritized the findings when aerobic exercise was compared with no exercise control and present them fully here. </p> <p>Eight trials (with 456 participants) provided low‐quality evidence for pain intensity, fatigue, stiffness, and physical function; and moderate‐quality evidence for withdrawals and HRQL at completion of the intervention (6 to 24 weeks). With the exception of withdrawals and adverse events, major outcome measures were self‐reported and were expressed on a 0 to 100 scale (lower values are best, negative mean differences (MDs)/standardized mean differences (SMDs) indicate improvement). Effects for aerobic exercise versus control were as follows: HRQL: mean 56.08; five studies; N = 372; MD ‐7.89, 95% CI ‐13.23 to ‐2.55; absolute improvement of 8% (3% to 13%) and relative improvement of 15% (5% to 24%); pain intensity: mean 65.31; six studies; N = 351; MD ‐11.06, 95% CI ‐18.34 to ‐3.77; absolute improvement of 11% (95% CI 4% to 18%) and relative improvement of 18% (7% to 30%); stiffness: mean 69; one study; N = 143; MD ‐7.96, 95% CI ‐14.95 to ‐0.97; absolute difference in improvement of 8% (1% to 15%) and relative change in improvement of 11.4% (21.4% to 1.4%); physical function: mean 38.32; three studies; N = 246; MD ‐10.16, 95% CI ‐15.39 to ‐4.94; absolute change in improvement of 10% (15% to 5%) and relative change in improvement of 21.9% (33% to 11%); and fatigue: mean 68; three studies; N = 286; MD ‐6.48, 95% CI ‐14.33 to 1.38; absolute change in improvement of 6% (12% improvement to 0.3% worse) and relative change in improvement of 8% (16% improvement to 0.4% worse). Pooled analysis resulted in a risk ratio (RR) of moderate quality for withdrawals (17 per 100 and 20 per 100 in control and intervention groups, respectively; eight studies; N = 456; RR 1.25, 95%CI 0.89 to 1.77; absolute change of 5% more withdrawals with exercise (3% fewer to 12% more). </p> <p>Three trials provided low‐quality evidence on long‐term effects (24 to 208 weeks post intervention) and reported that benefits for pain and function persisted but did not for HRQL or fatigue. Withdrawals were similar, and investigators did not assess stiffness and adverse events. </p> <p>We are uncertain about the effects of one aerobic intervention versus another, as the evidence was of low to very low quality and was derived from single trials only, precluding meta‐analyses. Similarly, we are uncertain of the effects of aerobic exercise over active controls (ie, education, three studies; stress management training, one study; medication, one study) owing to evidence of low to very low quality provided by single trials. Most studies did not measure adverse events; thus we are uncertain about the risk of adverse events associated with aerobic exercise. </p> </section> <section id="CD012700-sec-0007"> <h3 class="title" id="CD012700-sec-0007">Authors' conclusions</h3> <p>When compared with control, moderate‐quality evidence indicates that aerobic exercise probably improves HRQL and all‐cause withdrawal, and low‐quality evidence suggests that aerobic exercise may slightly decrease pain intensity, may slightly improve physical function, and may lead to little difference in fatigue and stiffness. Three of the reported outcomes reached clinical significance (HRQL, physical function, and pain). Long‐term effects of aerobic exercise may include little or no difference in pain, physical function, and all‐cause withdrawal, and we are uncertain about long‐term effects on remaining outcomes. We downgraded the evidence owing to the small number of included trials and participants across trials, and because of issues related to unclear and high risks of bias (performance, selection, and detection biases). Aerobic exercise appears to be well tolerated (similar withdrawal rates across groups), although evidence on adverse events is scarce, so we are uncertain about its safety. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012700-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012700-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD012700-abs-0007">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD012700-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012700-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/pl#CD012700-abs-0005">Polski</a> </li> <li class="section-language"> <a class="" href="full/pt#CD012700-abs-0011">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#CD012700-abs-0004">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012700-abs-0003" lang="en"> <h3>Aerobic exercise for adults with fibromyalgia</h3> <p>This review summarizes the effects of aerobic exercise for adults with fibromyalgia.</p> <p><b>What are aerobic exercises?</b> </p> <p>Aerobic exercises, such as walking and swimming, cause harder breathing and faster heart beating than occur at rest. Benefits of doing aerobic exercise include strengthening the heart and improving circulation, lowering blood pressure, and helping to control blood sugar and weight. </p> <p><b>What problems does fibromyalgia cause?</b> </p> <p>People with fibromyalgia have chronic bodily pain and often have increased fatigue (feeling tired), stiffness, depression, and problems sleeping. </p> <p><b>Study characteristics</b> </p> <p>We searched for studies until June 2016, and found 13 studies (839 individuals). Most studies (61.5%) included only female participants. Average age of participants was 41 years (minimum 32 to maximum 56 years). According to the inclusion/exclusion criteria, most participants were not doing exercises before starting the study. </p> <p>Aerobic interventions were compared with controls (wait list, treatment as usual, daily activities as usual) over six to 24 weeks. On average, exercise sessions were provided two to three times per week for 35 minutes each session. Exercises involved walking, cycling, running, and doing low‐impact aerobics and aquacise. Participants exercised at different intensities, starting light and increasing as the study progressed. All programs were supervised. </p> <p><b>Key results at the end of treatment</b> </p> <p>The findings of aerobic exercise compared with no exercise control were prioritised and are presented fully here. Moderate‐quality evidence revealed that aerobic exercise improved HRQL, and low‐quality evidence showed improvement in physical function and decreased pain, fatigue, and stiffness compared with control. Similar numbers of people dropped out of the aerobic interventions group and the comparison group. Minor adverse events were reported, but reporting was inconsistent in these studies. </p> <p>Four studies explored long‐term effects at 24 to 208 weeks <i>after</i> the intervention ended. They reported benefits for pain and physical function among exercisers and noted no other effects. </p> <p><b>Best estimates of what happened in people with fibromyalgia when they did aerobic exercise compared with when they received control interventions</b> </p> <p>Each outcome below was measured on a scale from 0 to 100, on which lower scores were better. </p> <p><b>HRQL after 12 to 24 weeks:</b> People who exercised were 7% better (or 7 points, ranging from 3 to 13 points) and rated their HRQL as 48 points versus 56 points in the control group. </p> <p><b>Pain after 6 to 24 weeks:</b> People who exercised were 11% better (or 11 points, ranging from 4 to 18 points) and rated their pain as 56 points versus 65 points in the control group. </p> <p><b>Fatigue after 14 to 24 weeks:</b> Those who exercised were 6% better (or 6 points, ranging from 12 better to 0.3 worse) and rated their fatigue as 63 points versus 68 points in the control group. </p> <p><b>Stiffness after 16 weeks:</b> Those who exercised were 8% better (or 8 points, ranging from 1 to 15) and rated their stiffness as 61 points versus 69 points in the control group. </p> <p><b>Physical function after 8 to 24 weeks:</b> The aerobic exercise group was 10% better (or 10 points, ranging from 15 to 5) and participants rated their physical function as 37 points versus 46 points in the control group. </p> <p><b>Other results:</b> </p> <p><b>Withdrawal from treatment</b> </p> <p>A total of 20 out of 100 people dropped out of the aerobic group compared with 17 out of 100 from the control group (3% more, ranging from 3% fewer to 12% more) for any reason. </p> <p><b>Adverse events</b> </p> <p>We do not have precise information about adverse events associated with aerobic exercise. Some reports describe increased pain or fatigue, and one of the 496 participants doing aerobic exercise experienced a foot bone (metatarsal) stress fracture. This may have happened by chance. </p> <p><b>Quality of the evidence</b> </p> <p>Evidence shows that aerobic exercise may improve HRQL, pain, stiffness, and physical function, and probably leads to similar numbers of people dropping out from each group. Aerobic exercise does not seem to improve fatigue. The quality of the evidence was considered to be low or moderate because of the small numbers of people included in the studies, some issues involving study design, and low certainty of results. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012700-sec-0106" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012700-sec-0106"></div> <h3 class="title" id="CD012700-sec-0107">Implications for practice</h3> <section id="CD012700-sec-0107"> <p>During past decades, a growing body of research, including several RCTs, umbrella and systematic reviews, and meta‐analyses, has shown that exercise and physical activity are important in the treatment of individuals with a diagnois of fibromyalgia, as they contribute to the individual's daily life by reducing pain and improving function. Nevertheless, despite growth in the literature, trial sample sizes remain small, and effect sizes are also small, often not reaching clinically meaningful levels. </p> <p>Accordingly, the findings of this review indicate that aerobic exercise interventions probably improve HRQL and all‐cause withdrawal, and may slightly decrease pain intensity and stiffness, while slightly improving physical function and cardiorespiratory function, among adults with fibromyalgia. These findings support our current knowledge and understanding of the role of aerobics‐only exercise training in the management of fibromyalgia. Although only two major outcomes reached the clinically meaningful 15% improvement level, aerobic exercises seem to be well tolerated and may be integrated into the treatment of adults with fibromyalgia. </p> <p>Variation in intervention modes was wide and the number of trials was insufficient for calculating effects of different modes on outcomes. Review authors noted poor reporting about the presence or absence of adverse events; however, similar drop‐out rates in treatment and control groups indicate that the risk of adverse events for people receiving aerobic exercise training was low. This review suggests that individuals with fibromyalgia may perform a simple and accessible activity such as walking without exacerbating pain and other symptoms. </p> <p>Heterogeneity among exercise protocols and inconsistencies in reporting of exercise parameters and outcomes make interpretation of results challenging. Consequently, it is unclear which aerobic exercise protocols (intensity, duration, frequency, mode) will yield optimal results for adults with fibromyalgia. At the same time, the heterogeneity of exercise protocols leads us to speculate that benefits of aerobic exercise training may be achieved through a variety of combinations of intensity, duration, frequency, and mode. In general terms, most interventions in this review were supervised, frequency was three times per week, average duration was 35 minutes, intensity progressed from light to vigorous, and interventions were provided for 15 weeks. </p> <p>Some data suggest that long‐term improvements in pain intensity and physical function outcomes occur at six months and at four years. Information on participant activities during this period was not available, so we cannot be sure whether the "intervention" alone produced positive outcomes. Indeed, individuals may have adopted a physically active lifestyle (ie, walking 30') at completion of the intervention, and this might have allowed them to maintain the benefits gained. </p> <p>Emphasis on simple and easy aerobic training interventions such as walking seems acceptable and is well tolerated in this review. It makes sense to encourage promotion of walking ‐ an activity easily accessible and potentially cost free. </p> <p>Evidence is insufficient to reveal the effectiveness of one aerobic exercise intervention compared with another, or of an aerobic exercise intervention compared with education, stress management training, or medication, for adults with fibromyalgia. </p> </section> <h3 class="title" id="CD012700-sec-0108">Implications for research</h3> <section id="CD012700-sec-0108"> <p>This review presents several implications for further research. We have used the EPICOT approach to describe implications for future researchers (<a href="./references#CD012700-bbs2-0229" title="BrachaniecM , DePaulV , ElliottM , MoorL , SherwinP . Partnership in action: an innovative knowledge translation approach to improve outcomes for persons with fibromyalgia (Editorial). Physiotherapy Canada2009;61(3):123‐7. ">Brachaniec 2009</a>). </p> <section id="CD012700-sec-0109"> <h5 class="title">Evidence</h5> <p>We found evidence of low to moderate quality for outcomes of the main comparison group in this review. Although major outcomes were statistically significant, only three of them reached the minimal clinically important difference of 15 points (HRQL, physical function, and pain). Confidence intervals (or precision of results) were likely affected, but smaller sample sizes were included for some outcomes (ie, stiffness, CR max, and CR submax). The small number of studies, clinical heterogeneity, and few participants limited the potential for meta‐analyses on effects of aerobic exercise training compared with other aerobic interventions or other non‐exercise interventions. To determine recommendations on aerobic exercise training for adults with fibromyalgia, researchers should focus on conducting robust (well‐designed and carefully reported) RCTs. </p> <p>The recent trend toward publication of RCT protocols allowed improved evaluation of selective reporting bias. Accumulation of additional studies with a registered or published RCT protocol will permit better evaluation of publication bias and improved transparency in the overall process. In accordance with the findings of this review, trials should take into account the need to accurately report on randomization procedures and allocation concealment processes. </p> <p>Some methodological issues pertaining to the body of literature played a role in the current grading of evidence. A common limitation of exercise trials involves blinding of participants and personnel; another limitation is the typical use of participant‐reported outcome measures in this body of literature. Methodological robustness of trials and detailed reporting practices at all steps taken to avoid or minimize bias may contribute to our understanding and evaluation of the quality of evidence in the future. </p> </section> <section id="CD012700-sec-0110"> <h5 class="title">Population</h5> <p>As fibromyalgia predominantly affects females, it was not surprising to find that more than half of the studies included middle‐aged female participants only. Although this approach provides great advantage in reducing clinical heterogeneity, it limits the generalization of review findings to males with fibromyalgia. Consideration of gender, socioeconomic status, and ethnicity would provide advantages for generalizing findings across geographical areas. </p> <p>The population should be described and the common binding characteristic of members should be clearly specified in future trials, to avoid misleading readers to believe that this is a sample of the general population rather than a specific subgroup. Little is known about which subgroups benefit more (or less) from aerobic exercise interventions. For instance, we need more specific information on factors such as age, severity of disease, pain level at baseline, and level of physical activity. Furthermore, studies identifying individuals who respond well to exercise (responders) and those who do not respond (non‐responders) are scarce in the current body of literature. Studies show variability in mode of intervention delivery, with some interventions supervised and others performed at home or supervised sporadically. </p> <p>Information on the lifestyle or physical activity of individuals before, during, or after exercise intervention is insufficient. Information on the baseline level of participation in physical activity was scarce. Inclusion and exclusion criteria provided some evidence that these individuals were sedentary (ie, did not participated in a planned exercise program for six months before the start of the trial). The total number of hours the individual is actively moving may contribute to the presence or absence of conditioning and symptoms. This information will help us understand the long‐term benefits of the intervention. Also, as discussed in the topic presented above, "gap area" refers to time spent engaging in sedentary behavior (eg, sitting, watching television). </p> </section> <section id="CD012700-sec-0111"> <h5 class="title">Intervention</h5> <p>In comparing findings from this review with current knowledge presented in other reviews, we found evidence to show that future research must document the FITT‐VP (frequency (F), intensity (I), time or duration (T), type or mode (T), total volume (V), and progression (P), with increased training volume) characteristics of exercise interventions more clearly;,this will help us understand and compare the true effects of particular exercise training protocols. </p> <p>In addition, exercise adherence, another important contributor to the efficacy of exercise, needs further examination. Future studies should document exercise adherence to further our understanding of the dose‐response relationship between exercise and fibromyalgia symptoms. </p> <p>Provided we can identify a sufficient number of RCTs in the future, further reviews should have a narrower focus to ensure that effective elements of the specific components of aerobic exercise training can be identified. </p> <p>To increase the robustness of our conclusions on effects of the intervention, information on blinding of participants to their group assignment and/or study hypothesis is of utmost importance. We encourage researchers to report this information in future trials. </p> <p>Walking was the most popular intervention examined in this review. The effectiveness of this basic form of aerobic exercise training warrants research attention. </p> </section> <section id="CD012700-sec-0112"> <h5 class="title">Comparators</h5> <p>Studies used a combination of treatment as usual, placebo, attention only, different aerobic exercise training programs, or other interventions for comparison. Using or finding a placebo control group for this area of research is unlikely, and only one study in this review (with three arms) used a placebo control (<a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a>). </p> <p>Comparing an aerobic training intervention versus another meaningful alternative or aerobic training intervention is a common scenario. Multiple modes of aerobic exercise training are available for individuals with fibromyalgia. However, differences in aerobic training modes compared in this review prevented us from taking a methodological standpoint to meta‐analyse the evidence. Similarly, varying levels of aerobic training interventions compared with other non‐exercise interventions resulted in inability to pool the interventions. Evidence would be strengthened by more studies examining each category. </p> </section> <section id="CD012700-sec-0113"> <h5 class="title">Outcomes</h5> <p>Few studies have described adverse events experienced by participants. In fact, adverse events often were not identified as outcomes but were described in a side note. This information is critical for evaluating the safety and feasibility of interventions in clinical practice and should be reported in a standardized and systematic way. Studies must directly address adverse events, including the number noted (or absence thereof), and should provide a specific description of each adverse event. </p> <p>Different instruments measuring the same outcome present a methodological challenge for combining them in a meta‐analysis. A wide range of outcome measures reported between trials made the combination and further interpretation of study results challenging. Investigators could facilitate future systematic reviews by paying attention to responsiveness to the instrument selected and its relationship to other outcome measures commonly utilized in this area of research. </p> <p>Although we found evidence of post‐treatment effects of exercise training, few trials have focused on long‐term effects. </p> <p>Trials tended to focus more on fibromyalgia symptoms and less on cardiorespiratory outcomes. This finding is similar to that of our previous review, for which the major interest consisted of helping to relieve symptoms associated with the condition. As our knowledge of the benefits of exercise training for symptoms increases, trials can start to focus on general health or cardiorespiratory responses to this type of activity. </p> <p>In accordance with Cochrane methods and IMMPACT recommendations, we included a 30% reduction in pain intensity for interpreting clinical trial efficacy (<a href="./references#CD012700-bbs2-0243" title="DworkinRH , TurkDC , WyrwichKW , BeatonD , CleelandCS , FarrarJT , et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. Journal of Pain2008;9(2):105‐21. ">Dworkin 2008</a>); no study measured this outcome. As this outcome was incorporated, in keeping with a Cochrane recommendation, researchers may wish to focus on it in the future. </p> </section> <section id="CD012700-sec-0114"> <h5 class="title">Time</h5> <p>This review presents data identified up to June 2016; updates will be required as new evidence emerges. This review should be updated in three to five years. </p> </section> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012700-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012700-sec-0022"></div> <div class="table" id="CD012700-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Aerobic exercise training compared with control for fibromyalgia</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Aerobic exercise training compared with control for fibromyalgia</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> individuals with fibromyalgia<br/> <b>Settings:</b> group and supervised<br/> <b>Intervention:</b> aerobic exercise training<br/> <b>Comparison:</b> control comparison (treatment as usual, wait list control, continuation of daily activities including physical activity) </p> <p><b>Outcome:</b> measured at the end of the intervention </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Aerobic exercise training</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Health‐related quality of life</b> <br/> FIQ Total. Scale from 0 to 100 (0 is best)<br/> Follow‐up: 12‐24 weeks<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean health‐related quality of life ranged across control groups from<br/> <b>54 to 63.7 units</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean health‐related quality of life in the intervention groups was<br/> <b>7.89 lower</b> <br/> (13.23 to 2.55 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>372</p> <p>(5 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute change</p> <p>8% (3% to 13%) better</p> <p>Relative change<sup>c</sup> 15% (5% to 24%) better </p> <p>NNTB 6 (4 to 16)<sup>d</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain intensity</b> <br/> Visual analogue scale </p> <p>Scale from 0 to 100 mm (0 is best)<br/> Follow‐up: 6‐24 weeks<sup>e</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean pain intensity ranged across control groups from<br/> <b>56 to 80.5 mm</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean pain intensity in the intervention groups was<br/> <b>11.06 lower</b> <br/> (18.34 to 3.77 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>351<br/> (6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>b,f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute change</p> <p>11% (4% to 18%) better</p> <p>Relative change<sup>c</sup> 18% (7% to 30%) better </p> <p>NNTB 4 (2 to 15)<sup>d</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Fatigue</b> <br/> Visual analogue scale </p> <p>Scale from 0 to 100 mm (0 is best)<br/> Follow‐up: 14‐24 weeks<sup>g</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean fatigue ranged across control groups from<br/> <b>62.3 to 72 mm</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean fatigue in the intervention groups was</p> <p><b>6.06 lower</b> </p> <p>(‐12.41 lower to 0.30 higher)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>246<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>b,h</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute difference</p> <p>6% improvement (12% improvement to 0.3% worse)</p> <p>Relative change<sup>c</sup> 8% improvement (16% improved to </p> <p>0.4% worse)</p> <p>NNTB n/a</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Stiffness</b> <br/> FIQ Scale from 0 to 100 mm (lower scores mean less stiffness) </p> <p>Follow‐up: 16 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean stiffness in control groups was<br/> <b>69 mm</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean stiffness in the intervention groups was<br/> <b>7.96 lower</b> <br/> (14.95 to 0.97 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>143<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>b,i</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute difference</p> <p>8% (1% to 15%) improvement</p> <p>Relative change<sup>c</sup> 11% improvement (1% to 21% improved) </p> <p>NNTB 6 (3 to 218)<sup>d</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Physical function</b> <br/> FIQ and SF‐36 converted, 0 to 100 scale (0 is best)<br/> Follow‐up: 8‐24 weeks<sup>j</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean physical function ranged across control groups from<br/> <b>6 to 22 units</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean physical function in the intervention groups was <b>10.16 lower</b> </p> <p>(15.39 to 4.94 lower)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>246<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>b,h</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute change</p> <p>10% (95% CI 15 to 5) improvement</p> <p>Relative change<sup>c</sup> 21.9% (95% CI 33.2 to 10.7) </p> <p>improvement</p> <p>NNTB 5 (3 to 13)<sup>d</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Withdrawals</b> <br/> All‐cause attrition<br/> Follow‐up: 6‐24 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>17 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>20 per 100</b> <br/> (14 to 25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.25</b> </p> <p>(0.89 to 1.77)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>456<br/> (8 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute change: 5% more withdrawals with exercise (3% fewer to 12% more)</p> <p>Relative change 25% more (11% fewer to 77% more)</p> <p>NNTH n/a</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> <p>Descriptive information</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>"the present study findings confirm earlier studies that have shown aerobic exercise to reduce tender point tenderness, increase work capacity without adverse side effects..." (<a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>; pages 83‐84). The following statements show some minor adverse events following aerobic exercise training: "...unable to exercise after an injury" (<a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>; pages 1840), but it is unclear whether the injury was related to intervention participation: "One participant assigned to the short bout exercise withdrew after developing a metatarsal stress fracture" (<a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>; page 347) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> CI: confidence interval; NNTB: number needed to treat for an additional beneficial outcome; NNTH: number needed to treat for an additional harmful outcome; RR: risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Study author (intervention length in weeks): <a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a> (12), <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a> and <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a> (16), <a href="./references#CD012700-bbs2-0003" title="GowansSE , deHueckA , VossS , SilajA , AbbeySE . Six‐month and one‐year follow up of 23 weeks of aerobic exercise for individuals with fibromyalgia. Arthritis Care &amp; Research2004;51(6):890‐8. GowansSE , deHueckA , VossS , SilajA , AbbeySE , ReynoldsWJ . Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Care &amp; Research2001;45(6):519‐29. ">Gowans 2001</a> (23), <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a> (24)<br/> <sup>b</sup>Downgraded because of lack of blinding (performance and detection bias)<br/> <sup>c</sup>Relative change calculation as per Cochrane Musculoskeletal Review Group procedures: mean difference (MD)/pooled control group baseline means<br/> <sup>d</sup>Number needed to treat for an additional beneficial outcome (NNTB): NNTB for continuous outcomes calculated using the Wells calculator (from the CMSG Editorial office; http://musculoskeletal.cochrane.org/) for statistically significant outcomes only. Mean and standard deviation (SD) for the control group at baseline taken from <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a> (health‐related quality of life 55 (1.3), pain 61 (1.97), stifness 7 (1.9), and physical function 38 (1.86)<br/> <sup>e</sup>Study author (intervention length in weeks): <a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a> (6), <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a> (14), <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a> and <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a> (16), <a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a> (20), <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a> (24)<br/> <sup>f</sup>Downgraded for imprecision, wide confidence intervals, issues related to selective reporting (ie, <a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a> and/or <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>)<br/> <sup>g</sup>Study author (intervention length in weeks): <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a> (14), <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a> and <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a> (16), <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a> (24)<br/> <sup>h</sup>Downgraded for imprecision<br/> <sup>i</sup>One study </p> <p><sup>j</sup>Study author (intervention length in weeks): <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a> (14), <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a> and <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a> (16), <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a> (24) </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012700-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD012700-sec-0023"></div> <section id="CD012700-sec-0024"> <h3 class="title" id="CD012700-sec-0024">Description of the condition</h3> <p>Fibromyalgia is a chronic condition characterized by widespread muscular pain and soft tissue tenderness (<a href="./references#CD012700-bbs2-0266" title="MeaseP . Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. [erratum appears in J Rheumatol Suppl. 2005 Oct;32(10):2063]. Journal of Rheumatology. Supplement2005;75:6‐21. ">Mease 2005</a>; <a href="./references#CD012700-bbs2-0299" title="WolfeF , ClauwDJ , FitzcharlesMA , GoldenbergDL , KatzRS , MeaseP , et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care &amp; Research2010;62(5):600‐10. ">Wolfe 2010</a>; <a href="./references#CD012700-bbs2-0284" title="Schmidt‐WilckeT , ClauwDJ . Fibromyalgia: from pathophysiology to therapy. Nature Reviews. Rheumatology2011;7(9):518‐27. ">Schmidt‐Wilcke 2011</a>). Fibromyalgia is often associated with other somatic complaints, disability, sleep disturbances, anxiety, cognitive dysfunction, depressive episodes, and physical deconditioning. These symptoms significantly affect quality of life and result in both physical and psychosocial disabilities with important implications for family, employment, and independence (<a href="./references#CD012700-bbs2-0266" title="MeaseP . Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. [erratum appears in J Rheumatol Suppl. 2005 Oct;32(10):2063]. Journal of Rheumatology. Supplement2005;75:6‐21. ">Mease 2005</a>). Several abnormalities in brain and neural function in patients with fibromyalgia appear to have a genetic basis (<a href="./references#CD012700-bbs2-0219" title="ArnoldLM , FanJ , RussellIJ , YunusMB , KhanMA , KushnerI , et al. The fibromyalgia family study: a genome‐wide linkage scan study. Arthritis &amp; Rheumatism2013;65(4):1122‐8. ">Arnold 2013</a>; <a href="./references#CD012700-bbs2-0287" title="StaudR . Evidence of involvement of central neural mechanisms in generating fibromyalgia pain. Current Rheumatology Reports2002;4(4):299‐305. ">Staud 2002</a>). </p> <p>Canadian statistics reflect the self‐reported prevalence of fibromyalgia at 1.1% across all ages, with female diagnoses outnumbering male diagnoses (1.83% female to 0.33% male; <a href="./references#CD012700-bbs2-0265" title="McNalleyJD , MathesonDA , BakowshyVS . The epidemiology of self‐reported fibromyalgia in Canada. Chronic Diseases in Canada2006;27(1):9‐16. ">McNalley 2006</a>). Prevalence rates among European countries (France, Italy, Portugal, Spain) are estimated to range between 1.4% (France) and 3.7% (Italy), and fibromyalgia diagnoses are twice as common among females (<a href="./references#CD012700-bbs2-0230" title="BrancoJC , BannwarthB , FaildeI , Abello CarbonellJ , BlotmanF , SpaethM , et al. Prevalence of FM: a survey in five European countries. Seminars in Arthritis and Rheumatism2010;39(6):448‐53. ">Branco 2010</a>). Nakamura and colleagues found the rate in Japan to be 2.1% (<a href="./references#CD012700-bbs2-0271" title="NakamuraI , NishiokaK , UsuiC , OsadaK , IchibayashiH , IshidaM , et al. An epidemiologic internet survey of fibromyalgia and chronic pain in Japan. Arthritis Care &amp; Research2014;66(7):1093‐101. ">Nakamura 2014</a>); this is higher than the fibromyalgia prevalence in China of about 0.05% (<a href="./references#CD012700-bbs2-0304" title="ZengQY , ChenR , DarmawanJ , XiaoZY , ChenSB , WigleyR , et al. Rheumatic diseases in China. Arthritis Research &amp; Therapy2008;10(1):1478. ">Zeng 2008</a>). The American College of Rheumatology (ACR) has prepared new diagnostic criteria for fibromyalgia (<a href="./references#CD012700-bbs2-0299" title="WolfeF , ClauwDJ , FitzcharlesMA , GoldenbergDL , KatzRS , MeaseP , et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care &amp; Research2010;62(5):600‐10. ">Wolfe 2010</a>; <a href="./references#CD012700-bbs2-0300" title="WolfeF , HassettAL , KatzRS , MichaudK , WalittB . Do we need core sets of fibromyalgia domains? The assessment of fibromyalgia (and other rheumatic disorders) in clinical practice. Journal of Rheumatology2011;38(6):1104‐12. ">Wolfe 2011</a>). Use of these new diagnostic criteria may change prevalence rates in North America. In Olmsted County, Minnesota, in the USA, prevalence with age‐ and sex‐adjusted criteria was estimated at 6.4% (<a href="./references#CD012700-bbs2-0293" title="VincentA , LahrBD , WolfeF , ClauwDJ , WhippleMO , OhTH , et al. Prevalence of fibromyalgia: a population‐based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care &amp; Research2013;65(5):786‐92. ">Vincent 2013</a>). In Germany, use of the new criteria revealed a prevalence rate of 2.1%, with a higher rate among females (2.4%) than males (1.8%; <a href="./references#CD012700-bbs2-0301" title="WolfeF , BrahlerE , HinzA , HauserW . Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care &amp; Research2013;65(5):777‐85. ">Wolfe 2013</a>). </p> <p>Fibromyalgia research reveals high levels of health care utilization and high costs associated with medical visits, drug prescriptions, and diagnostic testing (<a href="./references#CD012700-bbs2-0249" title="HauserW , KloseP , LanghorstJ , MoradiB , SteinbachM , SchiltenwolfM , et al. Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta‐analysis of randomised controlled trials. Arthritis Research &amp; Therapy2010;12(3):R79. ">Hauser 2010</a>; <a href="./references#CD012700-bbs2-0258" title="KelleyGA , KelleyKS , JonesDL . Efficacy and effectiveness of exercise on tender points in adults with fibromyalgia: a meta‐analysis of randomized controlled trials. Arthritis2011;2011:1‐10. [DOI: 10.1155/2011/125485] ">Kelley 2011</a>). Individuals with fibromyalgia are often seen by health care professionals for concomitant medical issues (somatic comorbidity associated with fibromyalgia) and related pharmacological treatment. Several Cochrane systematic reviews and a Cochrane overview on the use of medications for treatment of fibromyalgia have yielded tier‐2 evidence of moderate pain relief with pregabalin (an antiepileptic; <a href="./references#CD012700-bbs2-0296" title="WiffenPJ , DerryS , MooreRA , AldingtonD , ColeP , RiceASC , et al. Antiepileptic drugs for neuropathic pain and fibromyalgia ‐ an overview of Cochrane reviews. Cochrane Database of Systematic Reviews2013, Issue 11. [DOI: 10.1002/14651858.CD010567.pub2] ">Wiffen 2013</a>), amitriptyline (a tricyclic antidepressant; <a href="./references#CD012700-bbs2-0269" title="MooreRA , DerryS , AldingtonD , ColeP , WiffenPJ . Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews2012;Issue 12:Art. No.: CD008242. DOI: 10.1002/14651858.CD008242.pub2. ">Moore 2012</a>), milnacipran (a serotonin–norepinephrine reuptake inhibitor; <a href="./references#CD012700-bbs2-0241" title="DerryS , GillD , PhillipsT , MooreRA . Milnacipran for neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews2012, Issue 3. [DOI: 10.1002/14651858.CD008244.pub2] ">Derry 2012</a>), and monoamine oxidase inhibitors (<a href="./references#CD012700-bbs2-0290" title="TortS , UrrútiaG , NishishinyaMB , WalittB . Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome. Cochrane Database of Systematic Reviews2012, Issue 4. [DOI: 10.1002/14651858.CD009807] ">Tort 2012</a>). These Cochrane reviews have informed recent clinical practice guidelines (<a href="./references#CD012700-bbs2-0262" title="MacfarlaneGJ , KronischC , DeanLE , AtzeniF , HäuserW , FlubE , et al. EULAR revised recommendations for the management of fibromyalgia. Annals of the Rheumatic Diseases2016;0:1‐11. [DOI: doi:10.1136/annrheumdis‐2016‐209724] ">Macfarlane 2016</a>). Systematic reviews of non‐pharmacological treatments have provided low‐quality evidence of the effectiveness of exercise (<a href="./references#CD012700-bbs2-0225" title="BidondeJ , BuschAJ , WebberSC , SchachterCL , DanyliwA , OverendTJ , et al. Aquatic exercise training for fibromyalgia. Cochrane Database of Systematic Reviews2014, Issue 10. [DOI: 10.1002/14651858.CD011336] ">Bidonde 2014</a>; <a href="./references#CD012700-bbs2-0226" title="BidondeJ , BuschAJ , BathB , MilosavljevicS . Exercise for adults with fibromyalgia: an umbrella systematic review with synthesis of best evidence. Current Rheumatology Reviews2014;10(1):45‐79. ">Bidonde 2014a</a>; <a href="./references#CD012700-bbs2-0308" title="BuschAJ , SchachterCL , OverendTJ , PelosoPM , BarberKA . Exercise for fibromyalgia: a systematic review. Journal of Rheumatology2008;35(6):1130‐44. ">Busch 2008</a>), cognitive‐behavioral therapy (<a href="./references#CD012700-bbs2-0224" title="BernardyK , KloseP , BuschAJ , ChoyEH , HäuserW . Cognitive behavioural therapies for fibromyalgia. Cochrane Database of Systematic Reviews2013, Issue 9. [DOI: 10.1002/14651858.CD009796.pub2] ">Bernardy 2013</a>), and acupuncture (<a href="./references#CD012700-bbs2-0239" title="DeareJC , ZhengZ , XueCCL , LiuJP , ShangJ , ScottSW , et al. Acupuncture for treating fibromyalgia. Cochrane Database of Systematic Reviews2013, Issue 5. [DOI: 10.1002/14651858.CD007070.pub2] ">Deare 2013</a>) in the management of fibromyalgia. <a href="./references#CD012700-bbs2-0216" title="AblinJN , BuskilaD , AmitalH , FitzcharlesM , ShirY , HenningsenP . A paradigm change for treatment strategies for fibromyalgia syndrome reflected by recommendations of recent evidence‐based interdisciplinary guidelines developed independently in three countries. Arthritis &amp; Rheumatism2013;65(Suppl 10):839. ">Ablin 2013</a> noted that "recent evidence‐based interdisciplinary guidelines concur on the importance of treatments tailored to the individual patient and further emphasize the necessity of self management strategies which include exercise and psychological techniques." </p> <p>People with fibromyalgia are often intolerant of physical activity and tend to have a sedentary lifestyle that increases risks of additional morbidity (<a href="./references#CD012700-bbs2-0277" title="ParkJ , KnudsonS . Medically unexplained physical symptoms. Health Reports2007;18(1):43‐7. ">Park 2007</a>; <a href="./references#CD012700-bbs2-0280" title="RafteryG , BridgesM , HeslopP , WalkerDJ . Are fibromyalgia patients as inactive as they say they are?. Clinical Rheumatology2009;28(6):711‐4. ">Raftery 2009</a>). Exercise is an important part of fibromyalgia management (<a href="./references#CD012700-bbs2-0248" title="GoldenbergDL , BurckhardtC , CroffordL . Management of fibromyalgia syndrome. JAMA2004;292(19):2388‐95. ">Goldenberg 2004</a>; <a href="./references#CD012700-bbs2-0250" title="HauserW , ThiemeK , TurkDC . Guidelines on the management of fibromyalgia syndrome ‐ a systematic review. European Journal of Pain2010;14(1):5‐10. ">Hauser 2010a</a>; <a href="./references#CD012700-bbs2-0282" title="RooksDS . Talking to patients with fibromyalgia about physical activity and exercise. Current Opinion in Rheumatology2008;20(2):208‐12. ">Rooks 2008</a>) because individuals with fibromyalgia are often deconditioned by low cardiovascular fitness (<a href="./references#CD012700-bbs2-0291" title="TurkDC . Suffering and dysfunction in fibromyalgia syndrome. Journal of Musculoskeletal Pain2002;10(1‐2):85‐96. ">Turk 2002</a>), muscle strength, and muscle endurance (<a href="./references#CD012700-bbs2-0221" title="BennettRM , ClarkSR , GoldbergL , NelsonD , BonafedeRP , PorterJ , et al. Aerobic fitness in patients with fibrositis. A controlled study of respiratory gas exchange and 133xenon clearance from exercising muscle. Arthritis &amp; Rheumatism1989;32(4):454‐60. ">Bennett 1989</a>; <a href="./references#CD012700-bbs2-0222" title="BennettRM , ClarkSC , WalczykJ . A randomized, double‐blind, placebo‐controlled study of growth hormone in the treatment of fibromyalgia. American Journal of Medicine1998;104(3):227‐31. ">Bennett 1998</a>). Whether physical deconditioning plays a role in the causal pathway of fibromyalgia is not clear, but several studies have demonstrated that individuals with fibromyalgia can perform different types of exercise (<a href="./references#CD012700-bbs2-0225" title="BidondeJ , BuschAJ , WebberSC , SchachterCL , DanyliwA , OverendTJ , et al. Aquatic exercise training for fibromyalgia. Cochrane Database of Systematic Reviews2014, Issue 10. [DOI: 10.1002/14651858.CD011336] ">Bidonde 2014</a>; <a href="./references#CD012700-bbs2-0234" title="BuschAJ , WebberSC , RichardsRS , BidondeJ , SchachterCL , SchaferLA , et al. Resistance exercise training for fibromyalgia. Cochrane Database of Systematic Reviews2013, Issue 12. [DOI: 10.1002/14651858.CD010884] ">Busch 2013</a>; <a href="./references#CD012700-bbs2-0236" title="CarvilleSF , Arendt‐NielsenS , BliddalH , BlotmanF , BrancoJC , BuskilaD , et al. EULAR evidence‐based recommendations for the management of fibromyalgia syndrome. Annals of the Rheumatic Diseases2008;67(4):536‐41. ">Carville 2008</a>; <a href="./references#CD012700-bbs2-0249" title="HauserW , KloseP , LanghorstJ , MoradiB , SteinbachM , SchiltenwolfM , et al. Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta‐analysis of randomised controlled trials. Arthritis Research &amp; Therapy2010;12(3):R79. ">Hauser 2010</a>). Regular exercise is an important factor in countering age‐related loss of muscle, bone mass, and functional independence for the general population; therefore, individuals with fibromyalgia may improve their overall health and moderate risks associated with other chronic conditions by following an exercise program (<a href="./references#CD012700-bbs2-0282" title="RooksDS . Talking to patients with fibromyalgia about physical activity and exercise. Current Opinion in Rheumatology2008;20(2):208‐12. ">Rooks 2008</a>). Answers to questions regarding the best type of exercise, appropriate intensity, and delivery options for exercise interventions are still needed. This review on aerobic exercise training provides information that will guide clinicians and patients with fibromyalgia in designing the most effective aerobic exercise training interventions. Definitions for some of the terms utilized in this review can be found in the "Glossary of terms" (<a href="#CD012700-tbl-0002">Table 1</a>). </p> <div class="table" id="CD012700-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Glossary of terms</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Definition</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Agonist‐antagonist muscle contraction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Agonist muscles and antagonist muscles refer to muscles that cause or inhibit movement. Agonist muscles cause movement to occur through their own contraction, and antagonist muscles oppose a specific movement, for example, biceps (agonist) and triceps (antagonist) muscles </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Amitriptyline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A widely use tricyclic antidepressant medication; it is used to treat several mental illnesses/disorders such as major depression, anxiety, psychosis, bipolar disorder, etc. Other uses include prevention of neuropathic pain such as fibromyalgia </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Biomarker</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>In medicine, "biomarker" is a term that is often used to refer to measurable characteristics that reflect the severity or presence of some disease state. It is often an indicator of a particular disease state or some other psychological state of an organism </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiorespiratory fitness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The ability of the circulatory and respiratory systems to supply oxygen to muscles during sustained physical activity </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cognitive‐behavioral therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A form of therapy in which the goal is to diminish symptoms by correcting distorted thinking based on negative self‐perceptions and expectations </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Concomitant</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Existing or concurring with something else</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Detraining</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Losing physical and health effects gained during exercise training by stopping exercise</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Exercise</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physical activity that is planned, structured, and repetitive, and [that] has as a final or intermediate objective of improvement or maintenance of physical fitness (<a href="./references#CD012700-bbs2-0246" title="GarberCE , BlissmerB , DeschenesMR , FranklinBA , LamonteMJ , LeeIM , et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Medicine &amp; Science in Sports Exercise2011;43(7):1334‐59. ">Garber 2011</a>) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Exercise training</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Program that is designed to meet individual health and physical fitness goals; a single exercise session should include warm‐up, stretching, conditioning, and cool‐down components. The rate of progression depends on the individual's health status and exercise tolerance </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Genetic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Considered a field of biology, genetics is the study of genes within living organisms; pertaining or according to genetics </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heart rate reserve (HRR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Difference between resting heart rate (HRrest) and maximum heart rate (HRmax). Heart rate reserve is used to determine exercise heart rates </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hormones</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Any of various internally secreted compounds, such as insulin or thyroxine, formed in endocrine glands that affect the functions of specifically receptive organs or tissues when transported to them by body fluids </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Inflammatory</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathology of or caused by inflammation; biological response of body tissues to harmful stimuli such as irritants, damaged cells, or pathogens </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maximal aerobic performance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maximum rate of oxygen consumption as measured during incremental exercise</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maximum heart rate (HRmax)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The highest number of beats per minute your heart can reach during maximum physical exertion. This rate is individual and depends on hereditary factors and age </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Microtrauma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trauma to muscle cells</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Milnacipran</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A serotonin‐norepinephrine reuptake inhibitor</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Min × d<sup>−1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Minutes per day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Monoamine oxidase inhibitors</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>An oxidoreductase inhibitor of a single amino group neurotransmitter</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Muscle strength</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A physical test of the amount of force a muscle can generate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neurotransmitters</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Any of several chemical substances, such as epinephrine or acetylcholine, that transmit nerve impulses across a synapse to a postsynaptic element, such as another nerve, muscle, or gland </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Non‐pharmacological</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment that does not include medication</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>OMERACT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>OMERACT (Outcome Measures in Rheumatology) is an independent initiative of international health professionals interested in outcome measures in rheumatology. Over the past 20 years, OMERACT has served a critical role in the development and validation of clinical and radiographic outcome measures in rheumatoid arthritis, osteoarthritis, psoriatic arthritis, fibromyalgia, and other rheumatic diseases (www.omeract.org). OMERACT is linked to the Cochrane Collaboration Musculoskeletal Review Group, where outcomes endorsed by OMERACT are recommended for use in Cochrane Systematic Reviews </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathophysiology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The physiology of abnormal or diseased organisms or their parts</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Perceived exertion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Amount of effort that is perceived by someone, usually rated on a scale of 6 to 20 or 1 to 10 </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physical activity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Any bodily movement produced by skeletal muscles that results in energy expenditure above resting (basal) levels. Physical activity broadly encompasses exercise, sports, and physical activities done as part of daily living, occupation, leisure, and active transportation (<a href="./references#CD012700-bbs2-0246" title="GarberCE , BlissmerB , DeschenesMR , FranklinBA , LamonteMJ , LeeIM , et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Medicine &amp; Science in Sports Exercise2011;43(7):1334‐59. ">Garber 2011</a>) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physical fitness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ability to carry out daily tasks with vigor and alertness, without undue fatigue and with ample energy to enjoy (leisure) pursuits and to meet unforeseen emergencies. Physical fitness is operationalized as "[a set of] measurable health and skill‐related attributes" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physical function</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The capacity of an individual to carry out physical activities of daily living. Physical function reflects motor function and control, physical fitness, and habitual physical activity and is an independent predictor of functional independence, disability, and morbidity </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physiology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Branch of biology dealing with the functions and activities of living organisms and their parts, including all physical and chemical processes </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Predicted maximum heart rate (HRmax‐p)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HRmax‐p is a score equivalent to maximum heart rate (HRmax). HRmax‐p may provide a way to define training intensities as percentages of maximum heart rate and to follow maximum heart rate changes due to training without an exhaustive maximal stress test </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pregabalin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>An antiepileptic medication</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prevalence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rate of occurrence of a condition, usually expressed on a per‐year basis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Skewness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not every distribution of data is symmetrical ‐ sets of data that are not symmetrical are said to be "asymmetrical." The measure of how asymmetrical a distribution can be is called "skewness" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sleep disturbance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A score derived from a questionnaire that measures sleep quantity and quality. The Medical Outcomes Survey Sleep Scale measures 6 dimensions of sleep (initiation, staying asleep, quantity, adequacy, drowsiness, shortness of breath, snoring) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Somatic comorbidities</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Conditions of the body related to a disease</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Symptoms</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Patients' perceptions of an "abnormal" physical, emotional, or cognitive state</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tenderness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain evoked by tactile pressure</p> </td> </tr> </tbody> </table> </div> </section> <section id="CD012700-sec-0025"> <h3 class="title" id="CD012700-sec-0025">Description of the intervention</h3> <p>For this review, we focused on studies that examined aerobic exercise training in the management of fibromyalgia. According to the American College of Sports Medicine (ACSM) guidelines for exercise testing and prescription, "aerobic exercise (also called cardiorespiratory or endurance exercise) represents a broad range of physical activities such as walking, jogging, cycling, and dancing performed at submaximal intensities that can be sustained from minutes to hours, depending in part on the fitness level of the individual and the intensity of the exercise. Aerobic exercise training represents organized regimens of physical activity that are repeated over time" (<a href="./references#CD012700-bbs2-0217" title="American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription Ninth Edition. 9th Edition. Baltimore, MD: Lippincott Williams &amp; Wilkins, 2013. ">ACSM 2013</a>). We also included two studies of leisure time physical activity ‐ a less structured intervention, in which participants were advised to perform moderate‐intensity aerobic activity on their own. Moderate and vigorous programs of aerobic exercise training and leisure time physical activity have been shown to improve physical fitness, lower risk of all‐cause and cardiovascular disease mortality and morbidity (<a href="./references#CD012700-bbs2-0246" title="GarberCE , BlissmerB , DeschenesMR , FranklinBA , LamonteMJ , LeeIM , et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Medicine &amp; Science in Sports Exercise2011;43(7):1334‐59. ">Garber 2011</a>), and achieve other health benefits (<a href="./references#CD012700-bbs2-0217" title="American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription Ninth Edition. 9th Edition. Baltimore, MD: Lippincott Williams &amp; Wilkins, 2013. ">ACSM 2013</a>, pages 7‐10). </p> <p>The ACSM position paper on quantity and quality of exercise for developing fitness in apparently healthy adults provides well‐recognized and widely accepted guidelines for aerobic and other types of exercise training (<a href="./references#CD012700-bbs2-0246" title="GarberCE , BlissmerB , DeschenesMR , FranklinBA , LamonteMJ , LeeIM , et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Medicine &amp; Science in Sports Exercise2011;43(7):1334‐59. ">Garber 2011</a>). In its position paper, the ACSM recommends that for aerobic exercise, most adults should engage in moderate‐intensity cardiorespiratory exercise training using large muscle groups and rhythmical activities for 30 minutes or longer per day on five or more days per week for a total of 150 minutes or longer; or vigorous‐intensity cardiorespiratory exercise training for 20 minutes or longer per day on three or more days per week for a total of 75 minutes or longer per week; or a combination of moderate‐ and vigorous‐intensity exercise performed to achieve a total energy expenditure of 500 to 1000 metabolic equivalent (MET) minutes per week. </p> <p>The ACSM position paper (<a href="./references#CD012700-bbs2-0246" title="GarberCE , BlissmerB , DeschenesMR , FranklinBA , LamonteMJ , LeeIM , et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Medicine &amp; Science in Sports Exercise2011;43(7):1334‐59. ">Garber 2011</a>) and subsequent publications (<a href="./references#CD012700-bbs2-0217" title="American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription Ninth Edition. 9th Edition. Baltimore, MD: Lippincott Williams &amp; Wilkins, 2013. ">ACSM 2013</a>) have described aerobic exercise training based on the FITT‐VP principle of exercise prescription: frequency (F), intensity (I), time or duration (T), type or mode (T), total volume (V), and progression (P), with increased training volume, as explained below. </p> <p> <ul id="CD012700-list-0001"> <li> <p>F ‐ Exercise frequency refers to the number of times per week that a person exercises.</p> </li> <li> <p>I ‐ Exercise intensity can be described in terms of heart rate, oxygen consumption (VO<sub>2</sub>), perceived exertion, or METs. No studies have compared all methods of exercise intensity at the same time, and these methods are not necessarily completely equivalent to each other (<a href="./references#CD012700-bbs2-0217" title="American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription Ninth Edition. 9th Edition. Baltimore, MD: Lippincott Williams &amp; Wilkins, 2013. ">ACSM 2013</a>). Exercise intensity is most accurately determined from data measured during tests of maximal aerobic performance. Such tests have not been commonly employed in fibromyalgia and exercise research. Although the calculation is subject to greater error, intensity is more commonly determined from predictive equations (<a href="./references#CD012700-bbs2-0217" title="American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription Ninth Edition. 9th Edition. Baltimore, MD: Lippincott Williams &amp; Wilkins, 2013. ">ACSM 2013</a>). Many studies included in this review used predictive heart rate calculations to determine the intensity of the exercise training intervention and described training intensity as a percentage of participants’ predicted maximal heart rate. The specific range of values used to classify exercise intensity as moderate or vigorous has changed over time, guided by research over the past 40 years (<a href="./references#CD012700-bbs2-0217" title="American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription Ninth Edition. 9th Edition. Baltimore, MD: Lippincott Williams &amp; Wilkins, 2013. ">ACSM 2013</a>). We have included in this review a table that shows the current classification of aerobic exercise intensities as described by <a href="./references#CD012700-bbs2-0246" title="GarberCE , BlissmerB , DeschenesMR , FranklinBA , LamonteMJ , LeeIM , et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Medicine &amp; Science in Sports Exercise2011;43(7):1334‐59. ">Garber 2011</a> (<a href="#CD012700-tbl-0003">Table 2</a>). </p> </li> </ul> </p> <div class="table" id="CD012700-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Classification of exercise intensity (Garber, 2011)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intensity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>%VO<sub>2</sub> reserve/% HR reserve</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>% HRmax</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Perceived exertion scale (RPE) 6 to 20</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very light</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RPE &lt; 9</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Light</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37 to 45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>57 to 63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RPE 9 (very light) to 11 (fairly light)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46 to 63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64 to 76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RPE 12 (fairly light) to 13 (somewhat hard)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vigorous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64 to 90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77 to 95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RRE 14 (somewhat hard to 17 (very hard)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Near maximal to maximal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RPE ≥ 18 (very hard)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>HR: heart rate; RPE: rating of perceived exertion; VO<sub>2</sub>: oxygen consumption </p> </div> </div> <p> <ul id="CD012700-list-0002"> <li> <p>T ‐ Time (duration) of exercise refers to the length of an exercise session.</p> </li> </ul> <ul id="CD012700-list-0003"> <li> <p>T ‐ Exercise type (mode) refers to the actual activity done for aerobic exercise.</p> </li> </ul> <ul id="CD012700-list-0004"> <li> <p>V ‐ Total volume of exercise refers to the product of frequency, intensity, and time (FIT) of aerobic exercise. </p> </li> </ul> <ul id="CD012700-list-0005"> <li> <p>P ‐ The recommended rate of progression depends on the participant’s health status, physical fitness, training responses, and exercise program goals. Progression may consist of raising any of frequency, intensity, time, or type of exercise. The ACSM recommends increasing time of aerobic exercise first, then increasing training volume through changes in frequency, intensity, or time. </p> </li> </ul> </p> </section> <section id="CD012700-sec-0026"> <h3 class="title" id="CD012700-sec-0026">How the intervention might work</h3> <p>The pathophysiology of fibromyalgia includes changes in brain and neural structure and function, muscular physiology, hormonal factors, neurotransmitters, neuroendocrine transmitters, inflammatory markers, and genetic influences, resulting in augmented experiences and lowered inhibition of pain and other sensations (<a href="./references#CD012700-bbs2-0257" title="JahanF , NanjiK , QidwaiW , QasimR . Fibromyalgia syndrome: an overview of pathophysiology, diagnosis and management. Oman Medical Journal2012;27(3):192‐5. ">Jahan 2012</a>; <a href="./references#CD012700-bbs2-0263" title="MarcusDA , DeodharA . Non‐medication treatments. Fibromyalgia. New York, NY: Springer Science + Business Media, 2011:159‐74. ">Marcus 2011</a>;<a href="./references#CD012700-bbs2-0284" title="Schmidt‐WilckeT , ClauwDJ . Fibromyalgia: from pathophysiology to therapy. Nature Reviews. Rheumatology2011;7(9):518‐27. ">Schmidt‐Wilcke 2011</a>). Muscle abnormalities that may result in weakness, fatigue, and muscle pain for individuals with fibromyalgia include reductions in type II fibers, abnormal muscle metabolism, excessive agonist–antagonist co‐contraction, lowered levels of adenosine triphosphate, and damage to nerve fibers (<a href="./references#CD012700-bbs2-0276" title="ParkJH , NiermannKJ , OlsenN . Evidence for metabolic abnormalities in the muscles of patients with fibromyalgia. Current Rheumatology Reports2000;2(2):131‐40. ">Park 2000</a>;<a href="./references#CD012700-bbs2-0284" title="Schmidt‐WilckeT , ClauwDJ . Fibromyalgia: from pathophysiology to therapy. Nature Reviews. Rheumatology2011;7(9):518‐27. ">Schmidt‐Wilcke 2011</a>). Mood disorders and psychiatric comorbidities, which also are associated with fibromyalgia, are linked to disturbed stress adaptation responses due to hypothalamic‐pituitary axis abnormalities and interactions among biological, psychological, and behavioral mechanisms (<a href="./references#CD012700-bbs2-0257" title="JahanF , NanjiK , QidwaiW , QasimR . Fibromyalgia syndrome: an overview of pathophysiology, diagnosis and management. Oman Medical Journal2012;27(3):192‐5. ">Jahan 2012</a>; <a href="./references#CD012700-bbs2-0284" title="Schmidt‐WilckeT , ClauwDJ . Fibromyalgia: from pathophysiology to therapy. Nature Reviews. Rheumatology2011;7(9):518‐27. ">Schmidt‐Wilcke 2011</a>). </p> <p>Effective treatment and management strategies for fibromyalgia consist of non‐pharmacological therapies such as exercise (<a href="./references#CD012700-bbs2-0273" title="NueschE , HauserW , BernardyK , BarthJ , JuniP . Comparative efficacy of pharmacological and non‐pharmacological interventions in fibromyalgia syndrome: network meta‐analysis. Annals of the Rheumatic Disease2013;72(6):955‐62. ">Nuesch 2013</a>; <a href="./references#CD012700-bbs2-0284" title="Schmidt‐WilckeT , ClauwDJ . Fibromyalgia: from pathophysiology to therapy. Nature Reviews. Rheumatology2011;7(9):518‐27. ">Schmidt‐Wilcke 2011</a>). Exercise, primarily aerobic exercise, is known to enhance feelings of “energy” and improve quality of life and cognitive function (<a href="./references#CD012700-bbs2-0246" title="GarberCE , BlissmerB , DeschenesMR , FranklinBA , LamonteMJ , LeeIM , et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Medicine &amp; Science in Sports Exercise2011;43(7):1334‐59. ">Garber 2011</a>). Regular exercise can also improve experiences of anxiety, depression, and pain, and can improve sleep quality (<a href="./references#CD012700-bbs2-0233" title="BuschAJ , WebberSC , BrachaniecM , BidondeJ , Bello‐HaasVD , DanyliwAD , et al. Exercise therapy for fibromyalgia. Current Pain and Headache Reports2011;15(5):358‐67. [DOI: 10.1007/s11916‐011‐0214‐2] ">Busch 2011</a>;<a href="./references#CD012700-bbs2-0259" title="KlaperskiS , vonDawansB , HeinrichsM , FuchsR . Effects of a 12‐week endurance training program on the physiological response to psychosocial stress in men: a randomized controlled trial. Journal of Behavioral Medicine2014;37(6):1118‐33. ">Klaperski 2014</a>; <a href="./references#CD012700-bbs2-0270" title="MoylanS , EyreHA , MaesM , BauneBT , JackaFN , BerkM . Exercising the worry away: how inflammation, oxidative and nitrogen stress mediates the beneficial effect of physical activity on anxiety disorder symptoms and behaviours. Neuroscience &amp; Biobehavioral Reviews2013;37(4):573‐84. ">Moylan 2013</a>; <a href="./references#CD012700-bbs2-0302" title="YangPY , HoKH , ChenHC , ChienMY . Exercise training improves sleep quality in middle‐aged and older adults with sleep problems: a systematic review. Journal of Physiotherapy2012;58(3):157‐63. [DOI: 10.1016/S1836‐9553(12)70106‐6] ">Yang 2012</a>). Aerobic exercise alters neurotransmitters, neuromodulators, brain chemistry, and hypothalamic‐pituitary function (<a href="./references#CD012700-bbs2-0220" title="BarclayT , RichardsS , SchoffstallJ , MagnusonC , McPheeC , PriceJ , et al. A pilot study on the effects of exercise on depression symptoms using levels of neurotransmitters and EEG as markers. European Journal of Psychology and Educational Studies2014;1(1):30‐5. ">Barclay 2014</a>; <a href="./references#CD012700-bbs2-0259" title="KlaperskiS , vonDawansB , HeinrichsM , FuchsR . Effects of a 12‐week endurance training program on the physiological response to psychosocial stress in men: a randomized controlled trial. Journal of Behavioral Medicine2014;37(6):1118‐33. ">Klaperski 2014</a>; <a href="./references#CD012700-bbs2-0261" title="LoprestiAL , HoodSD , DrummondPD . A review of lifestyle factors that contribute to important pathways associated with major depression: diet, sleep and exercise. Journal of Affective Disorders2013;148(1):12‐27. ">Lopresti 2013</a>; <a href="./references#CD012700-bbs2-0270" title="MoylanS , EyreHA , MaesM , BauneBT , JackaFN , BerkM . Exercising the worry away: how inflammation, oxidative and nitrogen stress mediates the beneficial effect of physical activity on anxiety disorder symptoms and behaviours. Neuroscience &amp; Biobehavioral Reviews2013;37(4):573‐84. ">Moylan 2013</a>; <a href="./references#CD012700-bbs2-0279" title="PuetzTW . Physical activity and feelings of energy and fatigue: epidemiological evidence. Sports Medicine2006;36(9):767‐80. ">Puetz 2006</a>). These elements are involved in brain function, and their improvement through exercise can lead to improved feelings of energy, improved mood, and reduced stress, anxiety, and depression (<a href="./references#CD012700-bbs2-0259" title="KlaperskiS , vonDawansB , HeinrichsM , FuchsR . Effects of a 12‐week endurance training program on the physiological response to psychosocial stress in men: a randomized controlled trial. Journal of Behavioral Medicine2014;37(6):1118‐33. ">Klaperski 2014</a>; <a href="./references#CD012700-bbs2-0270" title="MoylanS , EyreHA , MaesM , BauneBT , JackaFN , BerkM . Exercising the worry away: how inflammation, oxidative and nitrogen stress mediates the beneficial effect of physical activity on anxiety disorder symptoms and behaviours. Neuroscience &amp; Biobehavioral Reviews2013;37(4):573‐84. ">Moylan 2013</a>; <a href="./references#CD012700-bbs2-0279" title="PuetzTW . Physical activity and feelings of energy and fatigue: epidemiological evidence. Sports Medicine2006;36(9):767‐80. ">Puetz 2006</a>). With aerobic exercise, the hypothalamus releases increased levels of neurotransmitters including endorphins (<a href="./references#CD012700-bbs2-0220" title="BarclayT , RichardsS , SchoffstallJ , MagnusonC , McPheeC , PriceJ , et al. A pilot study on the effects of exercise on depression symptoms using levels of neurotransmitters and EEG as markers. European Journal of Psychology and Educational Studies2014;1(1):30‐5. ">Barclay 2014</a>; <a href="./references#CD012700-bbs2-0261" title="LoprestiAL , HoodSD , DrummondPD . A review of lifestyle factors that contribute to important pathways associated with major depression: diet, sleep and exercise. Journal of Affective Disorders2013;148(1):12‐27. ">Lopresti 2013</a>; <a href="./references#CD012700-bbs2-0283" title="ScheefL , JankowskiJ , DaamenM , WeyerG , KlingenbergM , RennerJ , et al. An fMRI study on the acute effects of exercise on pain processing in trained athletes. Pain2012;153(8):1702‐14. ">Scheef 2012</a>). This increase in endorphin release results in decreased pain sensation and improved mood states and sleep quality (<a href="./references#CD012700-bbs2-0283" title="ScheefL , JankowskiJ , DaamenM , WeyerG , KlingenbergM , RennerJ , et al. An fMRI study on the acute effects of exercise on pain processing in trained athletes. Pain2012;153(8):1702‐14. ">Scheef 2012</a>; <a href="./references#CD012700-bbs2-0302" title="YangPY , HoKH , ChenHC , ChienMY . Exercise training improves sleep quality in middle‐aged and older adults with sleep problems: a systematic review. Journal of Physiotherapy2012;58(3):157‐63. [DOI: 10.1016/S1836‐9553(12)70106‐6] ">Yang 2012</a>). Exercise may contribute to pain reduction by improving the physiological response to muscle microtrauma through increased resilience, repair, and resultant adaptation (<a href="./references#CD012700-bbs2-0264" title="McLoughlinMJ , StegnerAJ , CookDB . The relationship between physical activity and brain responses to pain in fibromyalgia. Journal of Pain2011;12(6):640‐51. ">McLoughlin 2011</a>). Aerobic exercise also leads to reduced inflammation and oxidative stress in the body, which results in reduced anxiety and stress responses (<a href="./references#CD012700-bbs2-0259" title="KlaperskiS , vonDawansB , HeinrichsM , FuchsR . Effects of a 12‐week endurance training program on the physiological response to psychosocial stress in men: a randomized controlled trial. Journal of Behavioral Medicine2014;37(6):1118‐33. ">Klaperski 2014</a>; <a href="./references#CD012700-bbs2-0270" title="MoylanS , EyreHA , MaesM , BauneBT , JackaFN , BerkM . Exercising the worry away: how inflammation, oxidative and nitrogen stress mediates the beneficial effect of physical activity on anxiety disorder symptoms and behaviours. Neuroscience &amp; Biobehavioral Reviews2013;37(4):573‐84. ">Moylan 2013</a>). Overall, aerobic exercise can contribute to improved physiology, which can attenuate the alterations associated with fibromyalgia. </p> </section> <section id="CD012700-sec-0027"> <h3 class="title" id="CD012700-sec-0027">Why it is important to do this review</h3> <p>This is an update of a previously published Cochrane review on exercise for treating fibromyalgia (<a href="./references#CD012700-bbs2-0306" title="BuschAJ , SchachterCL , PelosoP , BombardierC . Exercise for treating fibromyalgia syndrome. Cochrane Database of Systematic Reviews2002, Issue 3. [DOI: 10.1002/14651858.CD003786.pub2] ">Busch 2002</a>; <a href="./references#CD012700-bbs2-0307" title="BuschAJ , BarberKAR , OverendTJ , PelosoPMJ , SchachterCL . Exercise for treating fibromyalgia syndrome. Cochrane Database of Systematic Reviews2007, Issue 4. [DOI: 10.1002/14651858.CD003786.pub2] ">Busch 2007</a>). Review authors specifically evaluated the benefits of aerobic exercise training. Aerobic exercise has been recognized as beneficial for overall health and prevention/management of chronic conditions for more than 50 years (<a href="./references#CD012700-bbs2-0228" title="BouchardC , BlairS , HaskellW . History and current status of the study of physical activity and health.Why study physical activity and health?. Tocco AN, Zavala MJ, editors. 2nd Edition. Vol. Chapter 1, Windsor, ON: Human Kinetics, 2012. ">Bouchard 2012</a>; <a href="./references#CD012700-bbs2-0246" title="GarberCE , BlissmerB , DeschenesMR , FranklinBA , LamonteMJ , LeeIM , et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Medicine &amp; Science in Sports Exercise2011;43(7):1334‐59. ">Garber 2011</a>). Increasing evidence has shown the benefits of aerobic exercise as a treatment for chronic conditions, including fibromyalgia (<a href="./references#CD012700-bbs2-0274" title="NunanD , MahtaniKR , RobertsN , HeneghanC . Physical activity for the prevention and treatment of major chronic disease: an overview of systematic reviews. Systematic Reviews2013;2(56):doi:10. 1186/2046‐4053‐2‐56. ">Nunan 2013</a>). Aerobic exercise is the most easily accessible and most commonly recognized form of exercise, making it a reasonable recommendation and treatment strategy (<a href="./references#CD012700-bbs2-0244" title="EylerAA , BrownsonRC , BacakSJ , HousemannRA . The epidemiology of walking for physical activity in the United States. Medicine &amp; Science in Sports &amp; Exercise2003;35(9):1529‐36. ">Eyler 2003</a>). However, current evidence showing the benefits of aerobic exercise for individuals with fibromyalgia is limited. A growing body of literature suggests that a review of these benefits is needed to accurately assess aerobic exercise effectiveness for improving the health of individuals with fibromyalgia. To provide indicators of the safety of aerobic exercise among patients with fibromyalgia, this review investigated adverse events and evaluated attrition rates and adherence to training protocols. New trials added to this update have served to strengthen the quality of the evidence. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012700-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012700-sec-0028"></div> <p> <ul id="CD012700-list-0006"> <li> <p>To evaluate the benefits and harms of aerobic exercise training for adults with fibromyalgia</p> </li> </ul> <ul id="CD012700-list-0007"> <li> <p>To assess the following specific comparisons</p> <ul id="CD012700-list-0008"> <li> <p>Aerobic versus control conditions (eg, treatment as usual, wait list control, physical activity as usual) </p> </li> <li> <p>Aerobic versus aerobic interventions (eg, running vs brisk walking)</p> </li> <li> <p>Aerobic versus non‐exercise interventions (eg, medications, education)</p> </li> </ul> </li> </ul> </p> <p>We did not assess specific comparisons involving aerobic exercise versus other exercise interventions (eg, resistance exercise, aquatic exercise, flexibility exercise, mixed exercise). Other systematic reviews have examined or will examine these comparisons (<a href="./references#CD012700-bbs2-0225" title="BidondeJ , BuschAJ , WebberSC , SchachterCL , DanyliwA , OverendTJ , et al. Aquatic exercise training for fibromyalgia. Cochrane Database of Systematic Reviews2014, Issue 10. [DOI: 10.1002/14651858.CD011336] ">Bidonde 2014</a>; <a href="./references#CD012700-bbs2-0234" title="BuschAJ , WebberSC , RichardsRS , BidondeJ , SchachterCL , SchaferLA , et al. Resistance exercise training for fibromyalgia. Cochrane Database of Systematic Reviews2013, Issue 12. [DOI: 10.1002/14651858.CD010884] ">Busch 2013</a>). </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012700-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012700-sec-0029"></div> <section id="CD012700-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012700-sec-0031"> <h4 class="title">Types of studies</h4> <p>We included trials described as randomized, even when methods of generating the random sequence were unclear or were not reported, or when the method of allocating participants was likely to be quasi‐random (ie, by alternation, date of birth, or a similar pseudo‐randomized method). </p> </section> <section id="CD012700-sec-0032"> <h4 class="title">Types of participants</h4> <p>We included in the review studies that examined adults with fibromyalgia (≥ 18 years of age). We selected studies that used published criteria for the diagnosis (or classification) of fibromyalgia. Until recently, American College of Rheumatology (ACR) 1990 criteria have been used as the standard for classifying individuals as having fibromyalgia (<a href="./references#CD012700-bbs2-0297" title="WolfeF , SmytheHA , YunusMB , BennettRM , BombardierC , GoldenbergDL , et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis &amp; Rheumatism1990;33(2):160‐72. ">Wolfe 1990</a>). By this method, individuals are classified as having fibromyalgia when they have experienced widespread pain lasting longer than three months with at least 11 active tender points. Tender points are noted at 18 designated locations on the body and are defined as active if pain can be elicited by applying 4 kilogram tactile pressure. </p> <p>A preliminary diagnostic tool, ACR 2010 (<a href="./references#CD012700-bbs2-0299" title="WolfeF , ClauwDJ , FitzcharlesMA , GoldenbergDL , KatzRS , MeaseP , et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care &amp; Research2010;62(5):600‐10. ">Wolfe 2010</a>), which does not rely upon a physical tender point examination, is now available both as a clinician‐administered questionnaire and as a survey questionnaire (<a href="./references#CD012700-bbs2-0300" title="WolfeF , HassettAL , KatzRS , MichaudK , WalittB . Do we need core sets of fibromyalgia domains? The assessment of fibromyalgia (and other rheumatic disorders) in clinical practice. Journal of Rheumatology2011;38(6):1104‐12. ">Wolfe 2011</a>). This measure includes the Widespread Pain Index (19 areas representing anterior and posterior axis and limbs), in addition to a Symptom Severity Scale that contains items related to secondary symptoms such as fatigue, sleep disturbances, cognition, and somatic complaints. Scores on both measures are used to determine whether a person qualifies for a “case definition” of fibromyalgia. This tool has been found to correctly classify 88% of cases that meet ACR 1990 criteria, and it allows ongoing monitoring of symptom change among people with a current or previous fibromyalgia diagnosis (<a href="./references#CD012700-bbs2-0299" title="WolfeF , ClauwDJ , FitzcharlesMA , GoldenbergDL , KatzRS , MeaseP , et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care &amp; Research2010;62(5):600‐10. ">Wolfe 2010</a>). Although measures focusing on tender point counts have been widely applied in clinical and research settings, the methods described by <a href="./references#CD012700-bbs2-0299" title="WolfeF , ClauwDJ , FitzcharlesMA , GoldenbergDL , KatzRS , MeaseP , et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care &amp; Research2010;62(5):600‐10. ">Wolfe 2010</a> and <a href="./references#CD012700-bbs2-0300" title="WolfeF , HassettAL , KatzRS , MichaudK , WalittB . Do we need core sets of fibromyalgia domains? The assessment of fibromyalgia (and other rheumatic disorders) in clinical practice. Journal of Rheumatology2011;38(6):1104‐12. ">Wolfe 2011</a> promise to classify people with fibromyalgia more efficiently, while allowing improved monitoring of disease status over time. </p> <p>Although some differences between published fibromyalgia diagnostic/classification criteria are known, for the purposes of this review, we considered all criteria to be acceptable and comparable. </p> </section> <section id="CD012700-sec-0033"> <h4 class="title">Types of interventions</h4> <p>We examined trials that studied aerobic exercise training interventions (eg, cycling, walking) regardless of frequency, duration, or intensity. We defined aerobic exercise training as dynamic physical activity performed by using large muscle groups and rhythmical movements that increase heart rate and breathing rate above resting levels to submaximal levels for a prolonged period (<a href="./references#CD012700-bbs2-0242" title="DonatelleRJ , Kolen‐ThompsonAM . Chapter 4. Engaging in physical activity for health, fitness, and performance. Health: The Basics. 6th Edition. Toronto, ON: Pearson Canada Inc, 2015. ">Donatelle 2015</a>). </p> <p>In this review, we present data on interventions using the FITT‐VP method and express exercise intensity using both published percentages of maximum heart rate (HRmax) or heart rate reserve (HRR) and corresponding ACSM literal descriptors. </p> <p>Comparator interventions included control (eg, treatment at usual, placebo, wait list control), other aerobic‐only exercise interventions (eg, low‐intensity walking), and non‐exercise interventions (eg, education, self‐management interventions). </p> </section> <section id="CD012700-sec-0034"> <h4 class="title">Types of outcome measures</h4> <p>We designated seven outcomes as major outcomes ‐ heath‐related quality of life, pain intensity, fatigue, stiffness, physical function, number of participants who withdrew or dropped out, and adverse events ‐ and three as minor outcomes ‐ maximum cardiorespiratory function, submaximal cardiorespiratory function, and greater than 30% improvement in pain. In selecting these outcomes, we considered the consensus statement of Choy and associates (<a href="./references#CD012700-bbs2-0238" title="ChoyEH , MeasePJ . Key symptom domains to be assessed in fibromyalgia (outcome measures in rheumatoid arthritis clinical trials). Rheumatic Disease Clinics of North America2009;35(2):329‐37. ">Choy 2009</a>) regarding a core set of outcome measures for clinical trials in fibromyalgia, as well as anticipated effects of aerobic exercise training on physical fitness. We extracted data for the selected outcomes for any time points measured but included baseline, post‐treatment, and follow‐up data in this review. Review criteria required each included study to report measurement of one or more outcomes for at least one of these time periods. </p> <section id="CD012700-sec-0035"> <h5 class="title">Major outcomes</h5> <p>When an included study used more than one instrument to measure a particular outcome, we applied the following preferred hierarchy in choosing the outcome for analysis. </p> <p> <ul id="CD012700-list-0009"> <li> <p><b>Health‐related quality of life</b> (HRQL) ‐ This outcome consists of multidimensional indices used to measure general health status or health‐related quality of life, or both (<a href="./references#CD012700-bbs2-0238" title="ChoyEH , MeasePJ . Key symptom domains to be assessed in fibromyalgia (outcome measures in rheumatoid arthritis clinical trials). Rheumatic Disease Clinics of North America2009;35(2):329‐37. ">Choy 2009</a>). When included studies used more than one instrument to measure health‐related quality of life, we preferentially extracted data from the Fibromyalgia Impact Questionnaire (FIQ Total; <a href="./references#CD012700-bbs2-0232" title="BurckhardtCS , ClarkSR , BennettRM . The Fibromyalgia Impact Questionnaire: development and validation. Journal of Rheumatology1991;18(5):728‐33. ">Burckhardt 1991</a>), followed by the Short Form Questionnaire (ie, SF‐36 Total or SF‐12 Total; <a href="./references#CD012700-bbs2-0235" title="BusijaL , PausenbergerE , HainesTP , HaymesS , BuchbinderR , OsborneRH . Adult measures of general health and health‐related quality of life: Medical Outcomes Study Short Form 36‐Item (SF‐36) and Short Form 12‐Item (SF‐12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF‐6D), Health Utilities Index Mark 3 (HUI3), Quality of Well‐Being Scale (QWB), and Assessment of Quality of Life (AQoL). Arthritis Care &amp; Research2011;63 Suppl 11:S383‐412. ">Busija 2011</a>; <a href="./references#CD012700-bbs2-0295" title="WareJE , SnowKK , KosinskiM , GandekB , NewE . SF‐36 Health Survey: Manual and Interpretation Guide. New York: The Health Institute, New England Medical Center, 1993. ">Ware 1993</a>), and the EuroQol Group Quality of Life Questionnaire (EQ‐5D) (<a href="./references#CD012700-bbs2-0298" title="WolfeF , AndersonJ , HarknessD , BennettRM , CaroXJ , GoldenbergDL , et al. Work and disability status of persons with fibromyalgia. Journal of Rheumatology1997;24(6):1171‐8. ">Wolfe 1997</a>). </p> </li> </ul> <ul id="CD012700-list-0010"> <li> <p><b>Pain intensity</b> ‐ The International Association for the Study of Pain defined pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage” (<a href="./references#CD012700-bbs2-0267" title="MerskeyH , BogdukN . Classifications of Chronic Pain: Descriptions and Definitions of Chronic Pain Syndromes and Definitions of Pain Terms. Seattle, WA: IASP, 1994. ">Merskey 1994</a>). For the purposes of this review, we focused on a single aspect of the pain experience – pain intensity. When a single study reported more than one measure of pain intensity, we preferentially extracted measures of average pain intensity (as opposed to worst, least, or current pain) assessed by visual analogue scale (VAS), FIQ Pain, FIQ‐Translated, or McGill Pain VAS followed by the Numerical Pain Rating Scale. For studies that did not report unidimensional measures of pain intensity, we extracted composite measures that included pain intensity and interference (SF‐36 or Rand 36 Bodily Pain Scale) or pain intensity and suffering from pain (Mulitdimensional Pain Inventory ‐ Pain Severity Scale). </p> </li> <li> <p><b>Fatigue</b> ‐ Individuals with fibromyalgia and clinicians alike recognize fatigue as an important symptom of fibromyalgia (<a href="./references#CD012700-bbs2-0238" title="ChoyEH , MeasePJ . Key symptom domains to be assessed in fibromyalgia (outcome measures in rheumatoid arthritis clinical trials). Rheumatic Disease Clinics of North America2009;35(2):329‐37. ">Choy 2009</a>). Fatigue can be measured in a global manner, whereby an individual rates fatigue on a single‐item scale or using a multidimensional tool that breaks the experience of fatigue down into two or more dimensions, such as general fatigue, physical fatigue, mental fatigue, reduced motivation, reduced activity, and degree of interference with activities of daily living (<a href="./references#CD012700-bbs2-0227" title="BoomershineCS . A comprehensive evaluation of standardized assessment tools in the diagnosis of fibromyalgia and in the assessment of fibromyalgia severity. Pain Research and Treatment2012;2012:653714. ">Boomershine 2012</a>). We accepted both unidimensional and multidimensional measures for this outcome. When included studies used more than one instrument to measure fatigue, we preferentially extracted data from the fatigue VAS (FIQ/FIQ‐Translated Fatigue, or single‐item fatigue VAS), followed by the SF‐36 or the Rand 36 Vitality Subscale, the Chalder Fatigue Scale (Total), the Fatigue Severity Scale, and the Multidimensional Fatigue Inventory. </p> </li> <li> <p><b>Stiffness</b> ‐ In focus groups conducted by <a href="./references#CD012700-bbs2-0218" title="ArnoldLM , CroffordLJ , MeasePJ , BurgessSM , PalmerSC , AbetzL , et al. Patient perspectives on the impact of fibromyalgia. Patient Education and Counseling2008;73(1):114‐20. ">Arnold 2008</a>, individuals with fibromyalgia "... remarked that their muscles were constantly tense. Participants alternately described feeling as if their muscles were ‘lead jelly’ or ‘lead Jell‐O', and this resulted in a general inability to move with ease and a feeling of stiffness." A measure of stiffness commonly encountered in this literature is the FIQ Stiffness Subscale. </p> </li> <li> <p><b>Physical function</b> ‐ This outcome focuses on the basic actions and complex activities considered “essential for maintaining independence, and those considered discretionary that are not required for independent living, but may have an impact on quality of life” (<a href="./references#CD012700-bbs2-0275" title="PainterP , StewartAL , CareyS . Physical functioning: definitions, measurement, and expectations. Advances in Renal Replacement Therapy1999;6(2):110‐23. ">Painter 1999</a>). Cardiorespiratory fitness, neuromuscular attributes (eg, muscular strength, endurance, power), and muscle and joint flexibility are important determinants of physical function; therefore, this outcome is highly relevant as an outcome of exercise interventions. When more than one measure of physical function was available within a study, we preferentially extracted data from the FIQ Physical Impairment Scale (<a href="./references#CD012700-bbs2-0232" title="BurckhardtCS , ClarkSR , BennettRM . The Fibromyalgia Impact Questionnaire: development and validation. Journal of Rheumatology1991;18(5):728‐33. ">Burckhardt 1991</a>), followed by the Health Assessment Questionnaire (HAQ) Disability Scale, the SF‐36 or the Rand 36 Physical Function Scale,the Sickness Impact Profile – Physical Disability Scale (<a href="./references#CD012700-bbs2-0223" title="BergnerM , BobbittRA , CarterWB , GilsonBS . The Sickness Impact Profile: development and final revision of a health status measure. Medical Care1981;19(8):787‐805. ">Bergner 1981</a>), and the Multidimensional Pain Inventory Household Chores Scale (<a href="./references#CD012700-bbs2-0254" title="HuskissonEC , JonesJ , ScottPJ . Application of visual‐analogue scales to the measurement of functional capacity. Rheumatology and Rehabilitation1976;15(3):185‐7. ">Huskisson 1976</a>; <a href="./references#CD012700-bbs2-0255" title="HuskissonEC , SturrockRD , TugwellP . Measurement of patient outcome. British Journal of Rheumatology1983;22:86‐9. ">Huskisson 1983</a>). </p> </li> <li> <p><b>Adverse events</b> ‐ We extracted the proportion of participants who experienced adverse events during the intervention (ie, injuries, exacerbations of pain, and/or other fibromyalgia symptoms); if this information was not available, we described the nature of the adverse events in a narrative report. </p> </li> <li> <p><b>Withdrawals</b> ‐ We recorded the proportion or number of participants who withdrew or dropped out of the study for any reason. </p> </li> </ul> </p> </section> <section id="CD012700-sec-0036"> <h5 class="title">Minor outcomes</h5> <p>We present here a rationale and preference listing of minor outcomes. Among the three outcomes designated as minor outcomes, we included two fitness variables that potentially could be improved by aerobic exercise training. </p> <p> <ul id="CD012700-list-0011"> <li> <p><b>Maximal cardiorespiratory function</b> (CR max) ‐ Cardiorespiratory function is the ability of the heart, lungs, and circulatory system to efficiently supply oxygen and nutrients to working muscles. Rhythmical, aerobic‐type exercises involving large muscle groups are recommended for improving cardiovascular fitness. Maximal oxygen uptake (VO<sub>2</sub>max) is accepted as the best criterion for measuring cardiorespiratory fitness. Maximal oxygen uptake is the product of maximal cardiac output (L blood × min<sup>‐1</sup>) and the arterial‐venous oxygen difference (mL O<sub>2</sub>/L blood). Disadvantages of maximal tests include that they require the participant to exercise to the point of volitional fatigue and often require medical supervision and access to the emergency equipment. For this reason, maximal exercise testing is not always feasible in research, health, and fitness settings. For this review, we preferentially extracted data from maximal or symptom‐limited treadmill or cycle ergometer tests in units of mL/kg/min, energy expended, peak workload, or test duration. We also accepted data from exercise tests that yielded predicted maximum oxygen uptake. </p> </li> </ul> <ul id="CD012700-list-0012"> <li> <p><b>Submaximal cardiorespiratory function</b> (CR submax) ‐ Two major categories of submaximal tests are available: predictive and performance tests. Predictive tests are submaximal tests that are used to predict maximal aerobic capacity (<a href="./references#CD012700-bbs2-0272" title="NoonanV , DeanE . Submaximal exercise testing: clinical application and interpretation. Physical Therapy2000;80(8):782‐807. ">Noonan 2000</a>). Performance tests involve measuring responses to standardized physical activities that are typically encountered in everyday life. For this review, we preferentially extracted data on work completed at a specified exercise heart rate (eg, PWC170 test ‐ estimates physical work capacity at 170 beats per minute), followed by distance walked in six minutes (meters), the two‐minute walk test (meters), walking time for a set distance (seconds), an anaerobic threshold test, and timed walking distance (eg, Quarter Mile Walk Test). </p> </li> <li> <p><b>Improvement in pain greater than 30%</b> ‐ A 30% reduction is considered a benchmark for a moderately important change in pain intensity and is recommended by an Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) for interpreting clinical trial efficacy (<a href="./references#CD012700-bbs2-0243" title="DworkinRH , TurkDC , WyrwichKW , BeatonD , CleelandCS , FarrarJT , et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. Journal of Pain2008;9(2):105‐21. ">Dworkin 2008</a>). When available, we extracted data on proportions of participants who met this criterion for intervention efficacy. </p> </li> </ul> </p> </section> </section> </section> <section id="CD012700-sec-0037"> <h3 class="title">Search methods for identification of studies</h3> <p>The team Information Specialist conducted a comprehensive search of nine databases for physical activity interventions for adults with fibromyalgia. We screened citations found by electronic and manual searches and classified them by type of exercise training. This comprehensive search revealed physical activity intervention studies that included a subset of aerobic training interventions. </p> <section id="CD012700-sec-0038"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases from database inception to June 2016 using current methods outlined in Chapter 6 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012700-bbs2-0260" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6. Searching for studies. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Lefebvre 2011</a>). We applied no language restrictions. We have provided full search strategies for each database in the appendices, as indicated in the list. </p> <p> <ul id="CD012700-list-0013"> <li> <p>MEDLINE (OVID) 1946 to June 2016 (<a href="./appendices#CD012700-sec-0118">Appendix 1</a>). </p> </li> <li> <p>Embase (OVID), Embase Classic+Embase 1947 to June 2016 (<a href="./appendices#CD012700-sec-0119">Appendix 2</a>). </p> </li> <li> <p>Cochrane Library (Wiley) to the present (<a href="http://www.thecochranelibrary.com/view/0/index.html" target="_blank">http://www.thecochranelibrary.com/view/0/index.html</a>) (<a href="./appendices#CD012700-sec-0120">Appendix 3</a>): </p> <ul id="CD012700-list-0014"> <li> <p>Cochrane Database of Systematic Reviews (Cochrane Reviews);</p> </li> <li> <p>Database of Abstracts of Reviews of Effects (DARE);</p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>Health Technology Assessment Database (HTA); and</p> </li> <li> <p>NHS Economic Evaluation Database (EED).</p> </li> </ul> </li> <li> <p>Cumulative Index to Nursing and Allied Health Literature (CINAHL) (Ebsco) 1982 to June 2016 (<a href="./appendices#CD012700-sec-0121">Appendix 4</a>). </p> </li> <li> <p>Physiotherapy Evidence Database (PEDro) (www.pedro.org.au/) accessed to June 2016 (<a href="./appendices#CD012700-sec-0122">Appendix 5</a>). </p> </li> <li> <p>Dissertation Abstracts (ProQuest) accessed to June 2016 (<a href="./appendices#CD012700-sec-0123">Appendix 6</a>). </p> </li> <li> <p>Current Controlled Trials accessed to October 25, 2013 (discontinued) (<a href="./appendices#CD012700-sec-0124">Appendix 7</a>). </p> </li> <li> <p>Clinicaltrials.gov accessed from June 2014 to June 2016 (<a href="./appendices#CD012700-sec-0124">Appendix 7</a>). </p> </li> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (www.who.int/ictrp/) accessed to June 2016 (<a href="./appendices#CD012700-sec-0125">Appendix 8</a>). </p> </li> <li> <p>Allied and Complementary Medicine (AMED) (OVID) 1985 to June 2016 (<a href="./appendices#CD012700-sec-0126">Appendix 9</a>). </p> </li> </ul> </p> </section> <section id="CD012700-sec-0039"> <h4 class="title">Searching other resources</h4> <p>Two review authors independently reviewed reference lists from key journals, identified articles and reviews of all types of treatment for fibromyalgia, scrutinized all promising or potential references, and added appropriate titles to the search output. </p> </section> </section> <section id="CD012700-sec-0040"> <h3 class="title" id="CD012700-sec-0040">Data collection and analysis</h3> <section id="CD012700-sec-0041"> <h4 class="title">Review authors</h4> <p>Review authors were members of the Cochrane Musculoskeletal Group (CMSG) ‐ Exercise for Fibromyalgia Team (see Acknowledgments). The authors of this review were trained in data extraction using a standardized orientation program. Review authors worked independently and in pairs with at least one physical therapist in each pair to extract data. The team met regularly to discuss progress, to clarify procedures, to make decisions regarding inclusion or exclusion and classification of outcome variables, and to work collaboratively in the production of this review. </p> </section> <section id="CD012700-sec-0042"> <h4 class="title">Selection of studies</h4> <p>Two review authors used a set of predetermined criteria to independently examine the titles and abstracts of studies generated by the searches (see <a href="./appendices#CD012700-sec-0127">Appendix 10</a>). We retrieved full‐text publications for all abstracts of potential interest. We had all non‐English reports translated. Two review authors then independently examined the full‐text reports to determine whether studies met selection criteria (see <a href="./appendices#CD012700-sec-0127">Appendix 10</a>). Review authors resolved disagreements and questions regarding interpretation of inclusion criteria through discussion with partners or by involvement of a third review team member if needed. </p> </section> <section id="CD012700-sec-0043"> <h4 class="title">Data extraction and management</h4> <p>We used electronic data extraction forms developed and refined in our previous reviews to facilitate independent data extraction and consensus (<a href="./references#CD012700-bbs2-0308" title="BuschAJ , SchachterCL , OverendTJ , PelosoPM , BarberKA . Exercise for fibromyalgia: a systematic review. Journal of Rheumatology2008;35(6):1130‐44. ">Busch 2008</a>). Pairs of review authors independently extracted data. We resolved disagreements by involving a third review author (AJB). Two review authors (AJB and JB) transferred data into Review Manager (<a href="./references#CD012700-bbs2-0281" title="TheNCC . Review Manager (RevMan). Version 5.3. Copenhaugen: The Cochrane Collaboration, 2014. ">RevMan 2014</a>) software. We double‐checked that data were entered correctly by comparing data presented in the software against study reports. We noted in the <a href="./references#CD012700-sec-0139" title="">Characteristics of included studies</a> table whether outcome data were obtained directly from randomized controlled trial (RCT) authors or were transformed or estimated from a graph. If both unadjusted and adjusted values were reported for the same outcome, we extracted adjusted values. If data were analysed using an intention‐to‐treat (ITT) sample and another sample (eg, per‐protocol, as‐treated), we extracted ITT data. </p> <p>We extracted the following data from the included studies.</p> <p> <ul id="CD012700-list-0015"> <li> <p>Methods: study design, total duration of study and follow‐up (if applicable), and date of study. </p> </li> <li> <p>Participants: N, mean age, age range, gender ratio, disease duration, diagnostic criteria, and inclusion and exclusion criteria. </p> </li> <li> <p>Interventions, comparisons, concomitant treatments, recording:</p> <ul id="CD012700-list-0016"> <li> <p>for all interventions with an exercise component: intervention duration, frequency, duration of exercise sessions, intensity, progression model, mode, and congruence with ACSM guidelines (<a href="./appendices#CD012700-sec-0128">Appendix 11</a>); and </p> </li> <li> <p>for interventions with a non‐exercise component: frequency, duration, and main characteristics.</p> </li> </ul> </li> <li> <p>Outcomes: major and minor outcomes as indicated above. Additional outcomes assessed (recorded in the <a href="./references#CD012700-sec-0139" title="">Characteristics of included studies</a> section under "Outcomes Other"), means and standard deviations for tests at baseline and post intervention, and follow‐up for continuous outcomes. If post‐test data were not available, we extracted means and standard deviations of change scores. </p> </li> <li> <p>Characteristics of trial design as outlined in the <a href="#CD012700-sec-0044">Assessment of risk of bias in included studies</a> section. </p> </li> <li> <p>Notes: funding for trial, language of the article, records of trial author contacts, and notable declarations of interest. </p> </li> </ul> </p> </section> <section id="CD012700-sec-0044"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently evaluated the risk of bias of each included study using a customized form based on the Cochrane "Risk of bias" tool (<a href="./references#CD012700-bbs2-0251" title="HigginsJPT , AltmanDG , SterneJAC , editors. Chapter 8. Assessing risk of bias in included studies. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 [updated March 2011]. www.cochrane‐handbook.org. The Cochrane Collaboration, 2011. ">Higgins 2011a</a>). The risk of bias tool addresses seven specific domains: sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessors, incomplete outcome data, selective outcome reporting (including publication bias), and other sources of bias. For "other" sources of bias, we considered sources such as baseline inequities despite randomization. We rated each criterion as introducing low, high, or unclear risk of bias according to information provided in the studies and sometimes through study author responses. We classified studies as having low risk of bias if all key domains had low risk of bias and no serious flaws. We assigned unclear risk when absence or ambiguity of information blocked assessors' ability to determine the potential for bias. In such cases, we revised assessments when study authors responded to our requests for more information. We resolved disagreements between review author pairs through consensus meetings or by involvement of a third review team member if needed. </p> </section> <section id="CD012700-sec-0045"> <h4 class="title">Measures of treatment effect</h4> <p>For continuous data, we used group post‐test means and standard deviations to calculate effect sizes with <a href="./references#CD012700-bbs2-0281" title="TheNCC . Review Manager (RevMan). Version 5.3. Copenhaugen: The Cochrane Collaboration, 2014. ">RevMan 2014</a> software. We expressed effect sizes preferentially as mean differences (MDs) and 95% confidence intervals (95% CIs), but when different scales were used to measure the same outcome, we calculated standardized mean differences (SMDs) with corresponding 95% CIs instead. We analyzed dichotomous data as risk ratios (RRs) and 95% confidence intervals<i>.</i> We used <a href="./references#CD012700-bbs2-0281" title="TheNCC . Review Manager (RevMan). Version 5.3. Copenhaugen: The Cochrane Collaboration, 2014. ">RevMan 2014</a> software to generate forest plots to display study results. </p> <p>In the comments column of <a href="./full#CD012700-tbl-0001">summary of findings Table for the main comparison</a>, we provided the absolute percent difference and the number needed to treat for an additional beneficial outcome (NNTB) or for an additional harmful outcome (NNTH). We provided the NNTB or NNTH only when the outcome showed a statistically significant difference. We calculated the NNTB for continuous measures using the Wells calculator (available at the CMSG Editorial Office). For dichotomous outcomes, such as adverse events, we calculated the NNTH from the control group event rate and the relative risk using the <a href="./references#CD012700-bbs2-0294" title="Dr. Christopher Cates EBM website. URL: http://www.nntonline.net. Visual Rx. Version 3. Dr. Christopher Cates EBM website. URL: http://www.nntonline.net, 2008. ">Visual Rx</a> NNT calculator (<a href="./references#CD012700-bbs2-0237" title="CatesC . Visual Rx, Version 3. Dr. Chris Cates' EBM Web Site, 2008. ">Cates 2008</a>). </p> <p>In accordance with the Philadelphia Panel (<a href="./references#CD012700-bbs2-0278" title="Philadelphia Panel2001 . Philadelphia Panel evidence‐based clinical practice guidelines on selected rehabilitation interventions for knee pain. Physical Therapy2001;81(10):1675‐700. ">Philadelphia Panel 2001</a>), we assumed a minimal clinically important difference (MCID) of 15 points on a 100‐point continuous pain scale, and a relative difference of 15% on all functional scales, as clinically relevant. We used the MCID in calculating NNTB for continuous outcomes. For dichotomous outcomes, we calculated the absolute risk difference using the risk difference statistic available in <a href="./references#CD012700-bbs2-0281" title="TheNCC . Review Manager (RevMan). Version 5.3. Copenhaugen: The Cochrane Collaboration, 2014. ">RevMan 2014</a>, and expressed the result as a percentage. For continuous outcomes, we calculated the absolute benefit as improvement in the intervention group minus improvement in the control group, expressed in original units. </p> <p>We calculated the relative per cent change for dichotomous data as the risk ratio ‐ 1, and expressed this as a percentage. For continuous outcomes, we calculated the relative difference in changes from baseline as the absolute benefit divided by the baseline mean of the control group, expressed as a percentage. </p> </section> <section id="CD012700-sec-0046"> <h4 class="title">Unit of analysis issues</h4> <p>Although many randomized controlled trials (RCTs) include only two parallel arms (ie, groups), some consist of three or four parallel arms; thus a single randomized trial can yield several relevant comparisons. This review examined any relevant comparisons that allowed evaluation of effects of aerobic exercise training interventions on people with fibromyalgia. For example, a three‐arm trial comparing aerobic versus drug treatment versus sham could appear in two separate analyses: aerobic versus sham and aerobic versus drug treatment. When a control group was used as a comparator twice in the same analysis, we halved the sample size of the control group (<a href="./references#CD012700-bbs2-0240" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration [updated March 2011]. ">Deeks 2011</a>). </p> </section> <section id="CD012700-sec-0047"> <h4 class="title">Dealing with missing data</h4> <p>When numerical data were missing, we contacted the study author to request additional data required for analysis. We used open‐ended questions to request the information needed to assess risk of bias and/or treatment effects. When numerical data were available only in graphical form, we used Engauge version 5.1 (<a href="./references#CD012700-bbs2-0268" title="MitchellM . Engauge Digitizer ‐ Digitizing Software. Version 5.1. https://markummitchell.github.io/engauge‐digitizer/, 2012. [digitizer.sourceforge.net] ">Mitchell 2012</a>) to extrapolate means and standard deviations by digitalizing data points on the graphs provided. </p> <p>For dichotomous outcomes (eg, number of withdrawals), we calculated the withdrawal rate by using the number of participants randomized in the group as the denominator. For continuous outcomes (eg, post‐test pain score), we calculated the MD or the SMD using the number of individuals analysed at that time point. When the number of individuals analysed was not presented for each time point, we used the number of individuals randomized to each group at baseline. When means were not reported, we accepted medians. When post‐test standard deviations were unavailable, we used standard deviations of pretest scores as estimates. When variance was expressed using statistics other than standard deviation (eg, standard error, confidence interval, P value), we computed standard deviations using the methods recommended in Chapter 7 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012700-bbs2-0252" title="HigginsJPT , DeeksJJ , editors. Chapter 7. Selecting studies and collecting data. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 [updated March 2011]. www.cochrane‐handbook.org. The Cochrane Collaboration, 2011. ">Higgins 2011b</a>). When we could not derive missing standard deviations using the methods described above, we imputed them from other studies included in the meta‐analysis. </p> </section> <section id="CD012700-sec-0048"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed clinical and methodological diversity in terms of participants, interventions, outcomes, and study characteristics for the included studies to determine whether a meta‐analysis was appropriate. We did this by reviewing data obtained from data extraction tables. We assessed statistical heterogeneity through visual inspection of the forest plot to look for obvious differences in results between studies, and through use of I² and Chi² statistical tests. As recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012700-bbs2-0240" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration [updated March 2011]. ">Deeks 2011</a>), we interpreted an I² value from 0% to 40% as might "not be important"; from 30% to 60% as may represent "moderate" heterogeneity; from 50% to 90% as may represent "substantial" heterogeneity; and from 75% to 100% as representing "considerable" heterogeneity. We interpreted the Chi² test with a P value ≤ 0.10 as indicating statistical heterogeneity. </p> <p>When we removed a trial from the analysis, we noted changes in both heterogeneity and effect size. Because I² involves overlapping categories (eg, 0% to 40%, 30% to 60%) or "ambiguous" zones, we explored statistical heterogeneity thoroughly when noted (eg, I² between 50% and 60%). Given that values between 50% and 60% fall into an "ambiguous" zone, if we could find no apparent causes of heterogeneity, we kept the trial in the analysis and documented our decision. </p> </section> <section id="CD012700-sec-0049"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to draw contour‐enhanced funnel plots (<a href="./references#CD012700-bbs2-0288" title="SterneJAC , EggerM , MoherD , editors. Chapter 10. Addressing reporting biases. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 [updated March 2011]. Vol. www.cochrane‐handbook.org, The Cochrane Collaboration, 2011:297‐333. [OTHER] ">Sterne 2011</a>) for each meta‐analysis to assess publication reporting bias if a large enough sample of studies (ie, more than 10 studies) was available/included in the meta‐analysis. As the statistical conditions were not met, we did not perform these analyses. </p> <p>If the RCT protocol was available, we compared outcomes in the RCT protocol versus outcomes in the published report. For studies published after July 1, 2005, we screened the Clinical Trials Register at the International Clinical Trials Registry Platform of the World Health Organisation (http://apps.who.int/trialssearch) and at ClinicalTrials.gov (http://clinicaltrials.gov) to look for the RCT protocol. </p> <p>We compared the fixed‐effect estimate against the random‐effects model to assess the possible presence of small sample bias (ie, by which the intervention effect is more beneficial in smaller studies) in the published literature. In the presence of small sample bias, the random‐effects estimate of the intervention is more beneficial than the fixed‐effect estimate (<a href="./references#CD012700-bbs2-0288" title="SterneJAC , EggerM , MoherD , editors. Chapter 10. Addressing reporting biases. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 [updated March 2011]. Vol. www.cochrane‐handbook.org, The Cochrane Collaboration, 2011:297‐333. [OTHER] ">Sterne 2011</a>). </p> </section> <section id="CD012700-sec-0050"> <h4 class="title">Data synthesis</h4> <p>When two or more studies reported the same outcome and when interventions were deemed homogeneous enough, we pooled the data (meta‐analysis) using <a href="./references#CD012700-bbs2-0281" title="TheNCC . Review Manager (RevMan). Version 5.3. Copenhaugen: The Cochrane Collaboration, 2014. ">RevMan 2014</a>. Before pooling data, we ensured the directionality of the data that permitted pooling; we arithmetically reversed selected scales as needed so higher values consistently had the same meaning. We ensured that scaling factors were consistent to permit calculation of MD (eg, 10‐cm scales expressed in mm to match 100‐mm scales). We presented results grouped by common comparator, for example, aerobics versus control, aerobics versus no exercise, aerobics versus aerobic intervention. We included all studies for adverse events and withdrawals. </p> <section id="CD012700-sec-0051"> <h5 class="title">"Summary of findings" table</h5> <p>We used GradePro (version 3.6; <a href="./references#CD012700-bbs2-0285" title="SchünemannHJ , OxmanAD , HigginsJPT , VistGE , GlasziouP , GuyattGH . Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Schünemann 2011a</a>) to prepare the "Summary of findings" table for major outcomes for aerobic exercise training versus no exercise control, at the end of the intervention. In the "Summary of findings" table, we integrated analysis of quality of evidence and magnitude of effect of the interventions. We downgraded the overall rating of quality of evidence for the study (outcome by outcome) by at least one grade (using GRADE) if the study had high or unclear risk of bias in at least one domain. </p> <p>We used the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness, and publication bias) to assess the quality of the body of evidence at one of four levels. </p> <p> <ul id="CD012700-list-0017"> <li> <p>High quality: Further research is very unlikely to change our confidence in the estimate of effect. </p> </li> <li> <p>Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. </p> </li> <li> <p>Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> </li> <li> <p>Very low quality: Research shows substantial uncertainty about the estimate.</p> </li> </ul> </p> <p>We assigned GRADE quality ratings separately for the seven major outcomes. Because of the comprehensive nature of the outcome variable of health‐related quality of life, we gave it primacy over all other variables in the "Summary of findings" table and in the "Plain language summary." </p> </section> </section> <section id="CD012700-sec-0052"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned two subgroup analyses on two major outcomes (HRQL and pain intensity) for the aerobics versus control comparison. </p> <p> <ul id="CD012700-list-0018"> <li> <p>To explore the relative effects of age: Subgroups for age were younger (≤ 45 years of age) and older (&gt; 45 years of age). Forty‐five is proposed as the cut‐off because of changes in hormone levels and lifestyle (physical activity participation) that occur with aging (<a href="https://archie.cochrane.org/sections/documents/view?version=z1506170122538841020248853599531%26format=REVMAN#REF-Shephard-1998" target="_blank">Shephard 1998</a>). </p> </li> <li> <p>To explore subgroups for exercise volume (frequency × duration × intensity) based upon American College of Sports Medicine (ACSM) criteria (meets ACSM criteria/does not meet ACSM criteria) according to <a href="https://archie.cochrane.org/sections/documents/view?version=z1506170122538841020248853599531%26format=REVMAN#REF-ACSM-2013-9th-Guidelines" target="_blank">ACSM 2013 9th Guidelines</a>. </p> </li> </ul> </p> </section> <section id="CD012700-sec-0053"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to conduct a sensitivity analysis to assess how results of the meta‐analysis might be affected by selection, attrition (&gt; 20%), and detection biases for post‐treatment pain intensity and HRQL outcomes in the main comparison. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012700-sec-0054" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012700-sec-0054"></div> <section id="CD012700-sec-0055"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD012700-sec-0139" title="">Characteristics of included studies</a>; <a href="./references#CD012700-sec-0140" title="">Characteristics of excluded studies</a>; and <a href="./references#CD012700-sec-0141" title="">Characteristics of studies awaiting classification</a>. </p> <section id="CD012700-sec-0056"> <h4 class="title">Results of the search</h4> <p>The search resulted in a total of 3684 records, which included 3646 journal records and 38 trial registry records. After we had removed 942 duplicates, 2742 records remained. We excluded 2529 records on citation and abstract screening. We assessed 213 full‐text articles and 20 protocols/trial registry records for eligibility and excluded 77 full‐text articles and seven protocols/trial registry records. We included 16 full‐text publications (13 primary studies, three companion papers) and three RCT protocols examining aerobic exercise training. On the most recent update to the search, we found five additional full‐text articles (three of which had trial registry records) that are awaiting full assessment. See <a href="#CD012700-fig-0001">Figure 1</a> for details. </p> <div class="figure" id="CD012700-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD012700-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD012700-sec-0057"> <h4 class="title">Included studies</h4> <p>We considered for this review 16 full‐text reports and three registry records describing 13 unique aerobic exercise training studies and meeting our selection criteria. We used the three registry records (hereafter, RCT protocols) to assess the quality of studies (<a href="./references#CD012700-bbs2-0002" title="FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity in adults with fibromyalgia: results at follow‐up. Journal of Clinical Rheumatology2011;17(2):64‐8. FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Research Therapy2010;12(2):R55. ">Fontaine 2010</a>; <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>; <a href="./references#CD012700-bbs2-0006" title="MannerkorpiK , NordemanL , CiderA , JonssonG . Does moderate‐to‐high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial. Arthritis Research &amp; Therapy2010;12(5):R189. ">Mannerkorpi 2010</a>). We included the following 13 distinct RCTs for analysis: <a href="./references#CD012700-bbs2-0001" title="FontaineKR , HaasS . Effects of lifestyle physical activity on health status, pain, and function in adults with fibromyalgia syndrome. Journal of Musculoskeletal Pain2007;15(1):3‐9. ">Fontaine 2007</a>; <a href="./references#CD012700-bbs2-0002" title="FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity in adults with fibromyalgia: results at follow‐up. Journal of Clinical Rheumatology2011;17(2):64‐8. FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Research Therapy2010;12(2):R55. ">Fontaine 2010</a>; <a href="./references#CD012700-bbs2-0003" title="GowansSE , deHueckA , VossS , SilajA , AbbeySE . Six‐month and one‐year follow up of 23 weeks of aerobic exercise for individuals with fibromyalgia. Arthritis Care &amp; Research2004;51(6):890‐8. GowansSE , deHueckA , VossS , SilajA , AbbeySE , ReynoldsWJ . Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Care &amp; Research2001;45(6):519‐29. ">Gowans 2001</a>; <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>; <a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a>; <a href="./references#CD012700-bbs2-0006" title="MannerkorpiK , NordemanL , CiderA , JonssonG . Does moderate‐to‐high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial. Arthritis Research &amp; Therapy2010;12(5):R189. ">Mannerkorpi 2010</a>; <a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a>; <a href="./references#CD012700-bbs2-0008" title="NicholsDS , GlennTM . Effects of aerobic exercise on pain perception, affect, and level of disability in individuals with fibromyalgia. Physical Therapy1994;74:327‐32. ">Nichols 1994</a>; <a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a>; <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>; <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>; <a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a>; and <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>. Although we found 16 separate article publications, we included only 13 studies. One publication (<a href="./references#CD012700-bbs2-0245" title="FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity in adults with fibromyalgia: results at follow‐up. Journal of Clinical Rheumatology2011;17(2):64‐8. ">Fontaine 2011</a>) reported additional variables from the <a href="./references#CD012700-bbs2-0002" title="FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity in adults with fibromyalgia: results at follow‐up. Journal of Clinical Rheumatology2011;17(2):64‐8. FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Research Therapy2010;12(2):R55. ">Fontaine 2010</a> primary study; therefore, we included the two and counted them as one study for analysis (hereafter identified as <a href="./references#CD012700-bbs2-0002" title="FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity in adults with fibromyalgia: results at follow‐up. Journal of Clinical Rheumatology2011;17(2):64‐8. FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Research Therapy2010;12(2):R55. ">Fontaine 2010</a>). Similarly, <a href="./references#CD012700-bbs2-0074" title="GowansSE , deHueckA , AbbeySE . Measuring exercise‐induced mood changes in fibromyalgia: a comparison of several measures. Arthritis &amp; Rheumatism2002;47:603‐9. ">Gowans 2002</a> reported additional variables from the primary article for <a href="./references#CD012700-bbs2-0003" title="GowansSE , deHueckA , VossS , SilajA , AbbeySE . Six‐month and one‐year follow up of 23 weeks of aerobic exercise for individuals with fibromyalgia. Arthritis Care &amp; Research2004;51(6):890‐8. GowansSE , deHueckA , VossS , SilajA , AbbeySE , ReynoldsWJ . Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Care &amp; Research2001;45(6):519‐29. ">Gowans 2001</a>, and we counted these as one study for analysis (hereafter identified as <a href="./references#CD012700-bbs2-0003" title="GowansSE , deHueckA , VossS , SilajA , AbbeySE . Six‐month and one‐year follow up of 23 weeks of aerobic exercise for individuals with fibromyalgia. Arthritis Care &amp; Research2004;51(6):890‐8. GowansSE , deHueckA , VossS , SilajA , AbbeySE , ReynoldsWJ . Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Care &amp; Research2001;45(6):519‐29. ">Gowans 2001</a>). One publication by Mengshoel published in 1993 reported additional variables from the <a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a> primary study; therefore, we included the two and counted them as one study for analysis (hereafter identified as <a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a>). The average length of treatment was 15 weeks (minimum of six and maximum of 24 weeks); follow‐up data post intervention were available for seven trials (<a href="./references#CD012700-bbs2-0002" title="FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity in adults with fibromyalgia: results at follow‐up. Journal of Clinical Rheumatology2011;17(2):64‐8. FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Research Therapy2010;12(2):R55. ">Fontaine 2010</a>; <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>; <a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a>; <a href="./references#CD012700-bbs2-0006" title="MannerkorpiK , NordemanL , CiderA , JonssonG . Does moderate‐to‐high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial. Arthritis Research &amp; Therapy2010;12(5):R189. ">Mannerkorpi 2010</a>; <a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a>; <a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a>; <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>) and ranged from 24 to 208 weeks. All studies used a randomized clinical trial with a parallel group study design. In the recent update to the search, we identified five additional full‐text articles (with three registry records) that are awaiting assessment (<a href="./references#CD012700-bbs2-0211" title="BjersingJL , DehlinM , ErlandssonM , BokarewaMI , MannerkorpiK . Changes in pain and insulin‐like growth factor 1 in fibromyalgia during exercise: the involvement of cerebrospinal inflammatory factors and neuropeptides. Arthritis Research &amp; Therapy2012;14(4):R162. ">Bjersing 2012</a>; <a href="./references#CD012700-bbs2-0212" title="DuruturkN , TuzunEH , CulhaogluB . Is balance exercise training as effective as aerobic exercise training in fibromyalgia syndrome?. Rheumatology International2015;35(5):845‐54. ">Duruturk 2015</a>; <a href="./references#CD012700-bbs2-0213" title="Espí‐LópezGV , InglésM , Ruescas‐NiculauM‐A , Moreno‐SeguraN . Effect of low‐impact aerobic exercise combined with music therapy on patients with fibromyalgia. A pilot study. Complementary Therapies in Medicine2016;28:1‐7. ">Espí‐López 2016</a>; <a href="./references#CD012700-bbs2-0214" title="MendoncaME , SimisM , GreccoLC , BattistellaLR , BaptistaAF , FregniF . Transcranial direct current simulation combined with aerobic exercise to optimize analgesic responses in fibromyalgia: a randomized placebo‐controlled clinical trial. Frontiers in Human Neurosciences2016;10:68. ">Mendonca 2016</a>; <a href="./references#CD012700-bbs2-0215" title="SanudoB , CarrascoL , DeHoyoM , FigueroaA , SaxtonJM . Vagal modulation and symptomatology following a 6‐month aerobic exercise program for women with fibromyalgia. Clinical and Experimental Rheumatology2015;33(1 Suppl 88):41‐5. ">Sanudo 2015</a>). </p> <p>Studies were published between 1992 and 2011 and were conducted across eight countries, including Canada (3), United States (3), Brazil (1), Spain (1), Norway (2), Sweden (1), United Kingdom (1), and Turkey (1). All studies were written in English. We contacted six study authors (<a href="./references#CD012700-bbs2-0001" title="FontaineKR , HaasS . Effects of lifestyle physical activity on health status, pain, and function in adults with fibromyalgia syndrome. Journal of Musculoskeletal Pain2007;15(1):3‐9. ">Fontaine 2007</a>; <a href="./references#CD012700-bbs2-0002" title="FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity in adults with fibromyalgia: results at follow‐up. Journal of Clinical Rheumatology2011;17(2):64‐8. FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Research Therapy2010;12(2):R55. ">Fontaine 2010</a>; <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>; <a href="./references#CD012700-bbs2-0006" title="MannerkorpiK , NordemanL , CiderA , JonssonG . Does moderate‐to‐high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial. Arthritis Research &amp; Therapy2010;12(5):R189. ">Mannerkorpi 2010</a>; <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>; <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>) using open‐ended questions to request information needed to assess risk of bias, the exercise intervention, and/or the treatment effect. We received responses from five study authors and have presented in <a href="#CD012700-tbl-0004">Table 3</a> outcome measures extracted for all included studies. </p> <div class="table" id="CD012700-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Outcome measures used in included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Name of Instrument or index/subscale</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Health‐related quality of life</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FIQ Total (0‐100)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain intensity/interference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Current pain (VAS), FIQ pain (VAS), SF‐36 bodily pain (interference)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fatigue</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VAS (0‐100), FIQ fatigue (0‐100), SF‐36 vitality (0‐100), Fatigue Severity Scale (9‐63), Multidimensional Fatigue Inventory (4‐20) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Stiffness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FIQ stiffness</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physical function</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SF‐36 physical functioning (0‐100), FIQ physical function (0‐100), Sickness Impact Profile (0‐68), Health Assessment Questionnaire (HAQ) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maximal cardiorespiratory function</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oxygen uptake (VO<sub>2</sub>max), maximum work capacity (w) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Submaximal cardiorespiratory function</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6‐minute walk test (distance in meters), Astrand submaximal cycle ergometer test (heart rate at a steady state workload) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not a standardized instrument or index/narrative information</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>FIQ: Fibromyalgia Impact Questionnaire; HAQ: Health Assessment Questionnaire; SF‐36: Short Form 36; VAS: visual analogue scale; VO<sub>2</sub>max: maximal oxygen uptake </p> </div> </div> <p>Six studies reported findings on multiple treatment arms (<a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>; <a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a>; <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>; <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>; <a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a>; <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>); we included in the analysis arms comparing an aerobic exercise training group versus another aerobic exercise training group or versus a non‐exercise intervention. Information on which arms were included in the analyses can be found in the <a href="./references#CD012700-sec-0139" title="">Characteristics of included studies</a> section. </p> <section id="CD012700-sec-0058"> <h5 class="title">Participants</h5> <p>This review included 839 participants, of whom 750 were female. Nine studies included female participants only, three included participants of both genders, and one study (<a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a>) did not specify the gender of participants. The average duration of disease or symptoms since diagnosis ranged from 5 to 11.5 years; three studies did not report this information (<a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a>; <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>; <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>). Average age of participants was 41 years (minimum to maximum, 32 to 56 years); one study (<a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a>) did not report participants' age. </p> <p>Fibromyalgia diagnosis was based on ACR 1990 (<a href="./references#CD012700-bbs2-0297" title="WolfeF , SmytheHA , YunusMB , BennettRM , BombardierC , GoldenbergDL , et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis &amp; Rheumatism1990;33(2):160‐72. ">Wolfe 1990</a>) criteria in all studies but one (<a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>), in which participants had to fulfill the diagnostic criteria of <a href="./references#CD012700-bbs2-0286" title="SmytheHA . Non‐articular rheumatism and psychogenic musculoskeletal syndromes. In: McCartyDJ editor(s). Arthritis and Allied Conditions. Philadelphia: Lea and Febiger, 1979:881‐91. ">Smythe 1979</a> and <a href="./references#CD012700-bbs2-0303" title="YunusM , MasiAT , CalabroJJ , MillerKA , FeigenbaumSL . Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Seminars in Arthritis and Rheumatism1981;11:151‐71. ">Yunus 1981</a>. Retrospective investigation confirmed that 58 of the 60 participants in this study also fulfilled ACR 1990 criteria (<a href="./references#CD012700-bbs2-0297" title="WolfeF , SmytheHA , YunusMB , BennettRM , BombardierC , GoldenbergDL , et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis &amp; Rheumatism1990;33(2):160‐72. ">Wolfe 1990</a>). </p> <p>Inclusion criteria for these trials included age (eg, 18 to 65, 30 to 55); a diagnosis of fibromyalgia; interest in exercising or willingness to comply with the exercise protocol; sedentary for six months before the trial; permission to exercise from family doctor; acceptance of randomization results; signed informed consent for study participation; stable on medications for at least three months before the start of the study; patient at the institution where the study took place or resident of the city where the study was conducted; discontinuation of medications for fibromyalgia four weeks before the start of the study; at least four years of schooling; involvement in medico‐legal cases (patients were not excluded); ability to manage a bicycle test at 50 watts or more; interest in exercising outdoors; and normal laboratory test results. </p> <p>Exclusion criteria for trials consisted of presence of an acute or chronic medical condition or disease (eg, cancer; cardiovascular or respiratory disease; metabolic, musculoskeletal, and neurological conditions) interfering with moderate‐intensity aerobic exercise; inflammatory diseases (eg, systemic lupus erythematous, rheumatoid arthritis); other pain disorders; intention to seek professional help for depression or anxiety during the study period or intent to change medications that might affect mood; need for an assistive device to ambulate; enrollment in or intention to begin an aerobic exercise program or ongoing planned physical activity including exercise or participation in any regular aerobic exercise program within the six months before the study or meeting the US Surgeon 1996 recommendation for physical activity for the previous six months (not engaging in moderate physical activity for the previous six months for 30 minutes on five days per week or vigorous physical activity three times per week for 10 minutes each time during the previous month); unstable pharmacological treatment in the first month before study entry; and not speaking Swedish. </p> </section> <section id="CD012700-sec-0059"> <h5 class="title">Interventions</h5> <p>We have provided a detailed description of trial interventions, including FITT‐VP parameters, in the <a href="./references#CD012700-sec-0139" title="">Characteristics of included studies</a> section and in <a href="#CD012700-tbl-0005">Table 4</a>. <a href="./references#CD012700-bbs2-0001" title="FontaineKR , HaasS . Effects of lifestyle physical activity on health status, pain, and function in adults with fibromyalgia syndrome. Journal of Musculoskeletal Pain2007;15(1):3‐9. ">Fontaine 2007</a>; <a href="./references#CD012700-bbs2-0002" title="FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity in adults with fibromyalgia: results at follow‐up. Journal of Clinical Rheumatology2011;17(2):64‐8. FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Research Therapy2010;12(2):R55. ">Fontaine 2010</a>; <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>; and <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a> met ACSM guidelines for healthy adults. <a href="./references#CD012700-bbs2-0003" title="GowansSE , deHueckA , VossS , SilajA , AbbeySE . Six‐month and one‐year follow up of 23 weeks of aerobic exercise for individuals with fibromyalgia. Arthritis Care &amp; Research2004;51(6):890‐8. GowansSE , deHueckA , VossS , SilajA , AbbeySE , ReynoldsWJ . Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Care &amp; Research2001;45(6):519‐29. ">Gowans 2001</a> met ACSM criteria for individuals who are sedentary/have no habitual activity/are extremely deconditioned. We have provided a summary of congruence with ACSM guidelines in <a href="#CD012700-tbl-0006">Table 5</a>. </p> <div class="table" id="CD012700-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">FITT parameters</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Author, year, intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b> Frequency, times per week – length in weeks</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Intensity/ACSM intensity classification</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Time/Duration/Session, minutes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Type/Mode</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Aerobic vs control</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0003" title="GowansSE , deHueckA , VossS , SilajA , AbbeySE . Six‐month and one‐year follow up of 23 weeks of aerobic exercise for individuals with fibromyalgia. Arthritis Care &amp; Research2004;51(6):890‐8. GowansSE , deHueckA , VossS , SilajA , AbbeySE , ReynoldsWJ . Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Care &amp; Research2001;45(6):519‐29. ">Gowans 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60%‐75% age‐adjusted HRmax<br/> ACSM: low to moderate </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30'</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised water walking/running progressing to land walking/running</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40%‐50% HRR at week 1 to 60%‐70% HRR by week 16<br/> ACSM: moderate at week 1 to vigorous by week 16 </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>˜ 60'</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised indoor or outdoor walking</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60%‐75% predicted HRmax<br/> ACSM: light to moderate </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Starting duration 10 to 15' progressing to 20 to 40'</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised walking, aquacise (deep and shallow water), or low‐impact aerobics</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>120‐150 beats per minute</p> <p>ACSM: moderate to vigorous</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60'</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised low‐impact aerobic dance program</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0008" title="NicholsDS , GlennTM . Effects of aerobic exercise on pain perception, affect, and level of disability in individuals with fibromyalgia. Physical Therapy1994;74:327‐32. ">Nichols 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60%‐70% predicted HRmax/age</p> <p>ACSM: light to moderate</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised fast‐paced walking on an indoor track</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60%‐65% HRmax (steady state aerobics) and 75%‐80% HRmax (interval training)</p> <p>ACSM: light to moderate and moderate to vigorous</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45‐60’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised aerobics including continuous walking with arm movements and jogging; interval training including aerobic dance and jogging </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a> Short bout </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 to 5 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40%‐50% HRR at week 1, 60%‐70% HRR by week 10</p> <p>ACSM: moderate at week 1, vigorous by week 10</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2/d, 5' at week 1 to 15'<br/> at week 9 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Home program of low‐impact aerobics to videotaped instructor and music, rhythmical movements of lower body muscles. Supervision at 0, 4, 8, and 12 weeks </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a> </p> <p>Long bout</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 to 5 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40%‐50% HRR at week 1, 60%‐70% HRR by week 10</p> <p>ACSM: moderate at week 1; vigorous by week 10</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10' at week 1 to 30'<br/> at week 9 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Home program of low‐impact aerobics to videotaped instructor and music, rhythmical movements of lower body muscles. Supervision at 0, 4, 8, and 12 weeks </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a> Aerobic exercise </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not specified</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cycle ergometry. Supervision unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tempo gradually increased up to, and decreased down from, 4 periods of 60%‐70% HRmax</p> <p>ACSM: light to moderate</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised movement to music and games</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Aerobic vs aerobic2</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0006" title="MannerkorpiK , NordemanL , CiderA , JonssonG . Does moderate‐to‐high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial. Arthritis Research &amp; Therapy2010;12(5):R189. ">Mannerkorpi 2010</a> AE: Nordic walking </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10’ at RPE 9‐11 2' intervals of RPE 13‐15, alternated with 2' at RPE 10 to 11</p> <p>ACSM: 10’ light, 2’ intervals moderate to vigorous alternated with 2’ light.</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised walking in parks and forests with flat areas and small hills</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0006" title="MannerkorpiK , NordemanL , CiderA , JonssonG . Does moderate‐to‐high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial. Arthritis Research &amp; Therapy2010;12(5):R189. ">Mannerkorpi 2010</a> </p> <p>AE2: low‐intensity walking</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 time/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RPE 9 to 11<br/> ACSM: light </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised walking in parks and forests with flat areas and small hills</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a>. </p> <p>AE: exercise class</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 time/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not specified</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised graded circuit exercises consisting of step‐ups, sitting to standing, skipping, jogging on the spot, alternate side bends, circling arms with increasing weights, plus encouragement to continue and increase exercises at home </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a> </p> <p>AE2: single class</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 session</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not specified</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Demonstration of aerobic exercises, stretching and relaxation technique, plus written advice on aerobic exercises plus stretching and relaxation </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>: AE: short bout </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 to 5/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40%‐50% HRR at week 1, 60%‐70% HRR by week 10<br/> ACSM: moderate at week 1, vigorous by weeks 10‐16 </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2/d 5' up to 15'</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Home program of low‐impact aerobics to videotaped instructor and music, rhythmical movements of lower body muscles. Supervision at 0, 4, 8, and 12 weeks </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a> </p> <p>AE2: long bout</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 to 5/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40%‐50% HRR at week 1, 60%‐70% HRR by week 10</p> <p>ACSM: moderate at week 1, vigorous by weeks 10‐16</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10' up to 30'</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Home program of low‐impact aerobics to videotaped instructor and music, rhythmical movements of lower body muscles. Supervision at 0, 4, 8, and 12 weeks </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Aerobic vs other (education or stress management training)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0001" title="FontaineKR , HaasS . Effects of lifestyle physical activity on health status, pain, and function in adults with fibromyalgia syndrome. Journal of Musculoskeletal Pain2007;15(1):3‐9. ">Fontaine 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group session every 2 weeks AE: 5‐7 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moderate intensity</p> <p>ACSM: moderate<br/> Review authors used appropriate references to help translate "moderate" into action </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10’ and increase daily 5’/wk to at least 30’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Brisk walking and other modes of aerobic activity (+ group session/supervision)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0002" title="FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity in adults with fibromyalgia: results at follow‐up. Journal of Clinical Rheumatology2011;17(2):64‐8. FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Research Therapy2010;12(2):R55. ">Fontaine 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5‐7 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moderate (breathing heavily but able to keep a conversation) + 15’ of above usual level </p> <p>ACSM: moderate</p> <p>Review authors used appropriate references to help translate "moderate" into action</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Walking (the most common form of LPA) and other forms (eg, garden/mowing the lawn); household activity (eg, vacuuming); and sports activity (eg, cycling, swimming, field hockey) (+ group sessions/supervision) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60%‐75% predicted HRmax</p> <p>ACSM: light to moderate</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Starting duration 10 to 15' progressing to 20 to 40'</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised walking, aquacise (deep and shallow water), or low‐impact aerobics</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not specified</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cycle ergometry. Supervision unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tempo gradually increased up to, and decreased down from, 4 periods at 60%‐70% HRmax ACSM: light to moderate </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised movement to music and games</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ACSM: American College of Sports Medicine; AE: aerobic exercise; FITT: frequency, intensity, time, and type of training; HRmax: maximum heart rate; HRR: heart rate reserve; RPE: rating of perceived exertion </p> </div> </div> <div class="table" id="CD012700-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Congruence with ACSM aerobic criteria for healthy adults</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Met ACSM criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Did not meet ACSM criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Not enough information to judge</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0001" title="FontaineKR , HaasS . Effects of lifestyle physical activity on health status, pain, and function in adults with fibromyalgia syndrome. Journal of Musculoskeletal Pain2007;15(1):3‐9. ">Fontaine 2007</a>; <a href="./references#CD012700-bbs2-0002" title="FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity in adults with fibromyalgia: results at follow‐up. Journal of Clinical Rheumatology2011;17(2):64‐8. FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Research Therapy2010;12(2):R55. ">Fontaine 2010</a>; <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>; <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a> met ACSM guidelines for healthy adults. <a href="./references#CD012700-bbs2-0003" title="GowansSE , deHueckA , VossS , SilajA , AbbeySE . Six‐month and one‐year follow up of 23 weeks of aerobic exercise for individuals with fibromyalgia. Arthritis Care &amp; Research2004;51(6):890‐8. GowansSE , deHueckA , VossS , SilajA , AbbeySE , ReynoldsWJ . Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Care &amp; Research2001;45(6):519‐29. ">Gowans 2001</a> met ACSM criteria for individuals who are sedentary/have no habitual activity/are extremely deconditioned </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a>: based on frequency and duration (only 3/wk, light to moderate); <a href="./references#CD012700-bbs2-0006" title="MannerkorpiK , NordemanL , CiderA , JonssonG . Does moderate‐to‐high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial. Arthritis Research &amp; Therapy2010;12(5):R189. ">Mannerkorpi 2010</a>: based on frequency and duration (only twice or once a week with 20' session duration); <a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a>: based on frequency of 2 times/wk; <a href="./references#CD012700-bbs2-0008" title="NicholsDS , GlennTM . Effects of aerobic exercise on pain perception, affect, and level of disability in individuals with fibromyalgia. Physical Therapy1994;74:327‐32. ">Nichols 1994</a>: based on frequency and duration (only twice a week); <a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a>: based on frequency (only once a week); <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>: based on frequency (only twice a week) for aerobics; <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>: intensity too low, duration too short (only 18‐20’ at HR 60%‐70%) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a> </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ACSM: American College of Sports Medicine; HR: heart rate</p> </div> </div> <p> <ul id="CD012700-list-0019"> <li> <p>Aerobic versus control conditions (treatment as usual, wait list control, daily activities including physical activity as usual): Exercise frequency was three times per week in most studies. In <a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a> and <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>, exercise frequency was two times per week for 20 and 24 weeks, respectively. Duration varied from six weeks (<a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a>) to 24 weeks (<a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>). Investigators expressed intensity five different ways: percentage age‐adjusted heart rate (<a href="./references#CD012700-bbs2-0003" title="GowansSE , deHueckA , VossS , SilajA , AbbeySE . Six‐month and one‐year follow up of 23 weeks of aerobic exercise for individuals with fibromyalgia. Arthritis Care &amp; Research2004;51(6):890‐8. GowansSE , deHueckA , VossS , SilajA , AbbeySE , ReynoldsWJ . Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Care &amp; Research2001;45(6):519‐29. ">Gowans 2001</a>), target heart rate (<a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a>), percentage maximum heart rate (HRmax; <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>), predicted maximum heart rate (<a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a>; <a href="./references#CD012700-bbs2-0008" title="NicholsDS , GlennTM . Effects of aerobic exercise on pain perception, affect, and level of disability in individuals with fibromyalgia. Physical Therapy1994;74:327‐32. ">Nichols 1994</a>), and percentage heart rate reserve (HRR; <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>; <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>). One study (<a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a>) did not specify duration, and another study (<a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>) provided a description involving tempo. Average intervention time was 35 minutes (minimum‐maximum: 20 to 60). The predominant mode of activity was walking (indoor or outdoor), in some cases accompanied by upper body movements or with progression to running; other modes included aerobic exercise on a stationary bicycle, low‐impact aerobics to music, rhythmical movements of lower body muscles, aquacise, and music and games. All interventions were supervised regularly or at specified times (<a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>). We were unable to determine if the intervention was supervised in one study (<a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a>). </p> </li> <li> <p>Aerobic versus aerobic: Investigators performed three sets of comparisons: Nordic walking versus low‐intensity walking (<a href="./references#CD012700-bbs2-0006" title="MannerkorpiK , NordemanL , CiderA , JonssonG . Does moderate‐to‐high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial. Arthritis Research &amp; Therapy2010;12(5):R189. ">Mannerkorpi 2010</a>); once‐per‐week exercise versus single exercise session and home program (<a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a>); and one long versus two short bouts of aerobic exercise (<a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>). Exercise frequency varied from one time per week to three times per week. One study (<a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a>) did not specify intensity; another (<a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>) expressed intensity in HRR; and another study (<a href="./references#CD012700-bbs2-0006" title="MannerkorpiK , NordemanL , CiderA , JonssonG . Does moderate‐to‐high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial. Arthritis Research &amp; Therapy2010;12(5):R189. ">Mannerkorpi 2010</a>) provided a rating of perceived exertion (RPE). Among the studies that reported intensity, intensity started light and increased to moderate or vigorous. Average duration of the intervention was 30 minutes. The mode involved supervised (Nordic or low‐intensity) walking in parks and forests with flat areas and small hills, low‐impact aerobics to music, rhythmical movements of lower body muscles, an unspecified home program, cardiovascular fitness classes plus stretching and relaxation, and written advice on aerobic exercises plus stretching and relaxation. Interventions were supervised in five of the six comparisons, and were self‐supervised in another (<a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a>). </p> </li> <li> <p>Aerobic versus other: We found three distinct sets of comparisons: aerobic exercise versus education (<a href="./references#CD012700-bbs2-0001" title="FontaineKR , HaasS . Effects of lifestyle physical activity on health status, pain, and function in adults with fibromyalgia syndrome. Journal of Musculoskeletal Pain2007;15(1):3‐9. ">Fontaine 2007</a>; <a href="./references#CD012700-bbs2-0002" title="FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity in adults with fibromyalgia: results at follow‐up. Journal of Clinical Rheumatology2011;17(2):64‐8. FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Research Therapy2010;12(2):R55. ">Fontaine 2010</a>; <a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a>); aerobic exercise versus stress management training (<a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>); and aerobic exercise versus medication (eg, paroxetine; <a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a>). Two trials reported frequency of exercise as five to seven times per week, and the other three reported exercise three times per week. Intensity was set at "moderate" (breathing heavily but able to keep a conversation), was reported as 60% to 75% predicted heart rate or with a tempo gradually increased up to, and decreased down from, four periods of high‐intensity training at 60% to 70% HRmax, and was not specified in one study (<a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a>). Average duration was 30 minutes. The aerobic mode involved walking (the most common form of leisure time physical activity) and other forms of movement; and sports activity (eg, cycling, swimming, field hockey), aquacise, low‐impact aerobics, and movement to music and games. </p> </li> </ul> </p> </section> </section> <section id="CD012700-sec-0060"> <h4 class="title">Excluded studies</h4> <p>We excluded 2529 records on citation and abstract screening, as they did not meet the inclusion criteria for this review (see <a href="#CD012700-fig-0001">Figure 1</a>). We examined 213 full‐text articles and 20 RCT protocols, and we excluded 77 full‐text articles and seven RCT protocols. We excluded full‐text articles because they did not meet the selection criteria related to diagnosis of fibromyalgia (n = 9); intervention (n = 16); designated outcomes not measured (n = 2); or randomization (n = 50). The remaining 136 full‐text articles represented RCTs examining effects of physical activity interventions for fibromyalgia. We screened 115 additional articles to rule them out because the physical activity intervention did not have an aerobics‐only intervention; or the study was reviewed or was designated to be reviewed in another Cochrane Review in this series. </p> </section> </section> <section id="CD012700-sec-0061"> <h3 class="title">Risk of bias in included studies</h3> <p>We have provided results of the "Risk of bias" assessment for the 13 included studies in the <a href="./references#CD012700-sec-0139" title="">Characteristics of included studies</a> section and in <a href="#CD012700-fig-0002">Figure 2</a> and <a href="#CD012700-fig-0003">Figure 3</a>. "Risk of bias" assessments were based on primary article data supplemented by study author responses. </p> <div class="figure" id="CD012700-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies." data-id="CD012700-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD012700-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgments about each risk of bias item for each included study." data-id="CD012700-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgments about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD012700-sec-0062"> <h4 class="title">Allocation</h4> <p>Seven of the 13 studies used an acceptable method of random sequence generation (computer‐generated sequence, coin toss, drawing of cards or lots), and we rated them as low risk (<a href="./references#CD012700-bbs2-0002" title="FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity in adults with fibromyalgia: results at follow‐up. Journal of Clinical Rheumatology2011;17(2):64‐8. FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Research Therapy2010;12(2):R55. ">Fontaine 2010</a>; <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>; <a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a>; <a href="./references#CD012700-bbs2-0006" title="MannerkorpiK , NordemanL , CiderA , JonssonG . Does moderate‐to‐high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial. Arthritis Research &amp; Therapy2010;12(5):R189. ">Mannerkorpi 2010</a>; <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>; <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>; <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>). Six studies used allocation methods that were unclear (<a href="./references#CD012700-bbs2-0001" title="FontaineKR , HaasS . Effects of lifestyle physical activity on health status, pain, and function in adults with fibromyalgia syndrome. Journal of Musculoskeletal Pain2007;15(1):3‐9. ">Fontaine 2007</a>; <a href="./references#CD012700-bbs2-0003" title="GowansSE , deHueckA , VossS , SilajA , AbbeySE . Six‐month and one‐year follow up of 23 weeks of aerobic exercise for individuals with fibromyalgia. Arthritis Care &amp; Research2004;51(6):890‐8. GowansSE , deHueckA , VossS , SilajA , AbbeySE , ReynoldsWJ . Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Care &amp; Research2001;45(6):519‐29. ">Gowans 2001</a>; <a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a>; <a href="./references#CD012700-bbs2-0008" title="NicholsDS , GlennTM . Effects of aerobic exercise on pain perception, affect, and level of disability in individuals with fibromyalgia. Physical Therapy1994;74:327‐32. ">Nichols 1994</a>; <a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a>; <a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a>). </p> <p>We rated four studies as low risk because they utilized acceptable methods to conceal the allocation sequence, such as central allocation by telephone, Web‐based or pharmacy‐controlled randomization, or sequentially numbered opaque sealed envelopes (<a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>; <a href="./references#CD012700-bbs2-0006" title="MannerkorpiK , NordemanL , CiderA , JonssonG . Does moderate‐to‐high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial. Arthritis Research &amp; Therapy2010;12(5):R189. ">Mannerkorpi 2010</a>; <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>; <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>). We rated as presenting unclear risk nine studies that did not present sufficient information to allow definitive judgment (<a href="./references#CD012700-bbs2-0001" title="FontaineKR , HaasS . Effects of lifestyle physical activity on health status, pain, and function in adults with fibromyalgia syndrome. Journal of Musculoskeletal Pain2007;15(1):3‐9. ">Fontaine 2007</a>; <a href="./references#CD012700-bbs2-0002" title="FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity in adults with fibromyalgia: results at follow‐up. Journal of Clinical Rheumatology2011;17(2):64‐8. FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Research Therapy2010;12(2):R55. ">Fontaine 2010</a>; <a href="./references#CD012700-bbs2-0003" title="GowansSE , deHueckA , VossS , SilajA , AbbeySE . Six‐month and one‐year follow up of 23 weeks of aerobic exercise for individuals with fibromyalgia. Arthritis Care &amp; Research2004;51(6):890‐8. GowansSE , deHueckA , VossS , SilajA , AbbeySE , ReynoldsWJ . Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Care &amp; Research2001;45(6):519‐29. ">Gowans 2001</a>; <a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a>; <a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a>; <a href="./references#CD012700-bbs2-0008" title="NicholsDS , GlennTM . Effects of aerobic exercise on pain perception, affect, and level of disability in individuals with fibromyalgia. Physical Therapy1994;74:327‐32. ">Nichols 1994</a>; <a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a>; <a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a>; <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>). </p> </section> <section id="CD012700-sec-0063"> <h4 class="title">Blinding</h4> <p>In exercise studies, blinding of participants and care providers from treatment allocation is very rare. </p> <section id="CD012700-sec-0064"> <h5 class="title">Performance bias</h5> <p>Among the included studies, we rated blinding of participants and personnel (performance bias) as low risk for two studies (<a href="./references#CD012700-bbs2-0003" title="GowansSE , deHueckA , VossS , SilajA , AbbeySE . Six‐month and one‐year follow up of 23 weeks of aerobic exercise for individuals with fibromyalgia. Arthritis Care &amp; Research2004;51(6):890‐8. GowansSE , deHueckA , VossS , SilajA , AbbeySE , ReynoldsWJ . Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Care &amp; Research2001;45(6):519‐29. ">Gowans 2001</a>; <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>), unclear risk for eight studies (<a href="./references#CD012700-bbs2-0001" title="FontaineKR , HaasS . Effects of lifestyle physical activity on health status, pain, and function in adults with fibromyalgia syndrome. Journal of Musculoskeletal Pain2007;15(1):3‐9. ">Fontaine 2007</a>; <a href="./references#CD012700-bbs2-0002" title="FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity in adults with fibromyalgia: results at follow‐up. Journal of Clinical Rheumatology2011;17(2):64‐8. FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Research Therapy2010;12(2):R55. ">Fontaine 2010</a>; <a href="./references#CD012700-bbs2-0006" title="MannerkorpiK , NordemanL , CiderA , JonssonG . Does moderate‐to‐high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial. Arthritis Research &amp; Therapy2010;12(5):R189. ">Mannerkorpi 2010</a>; <a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a>; <a href="./references#CD012700-bbs2-0008" title="NicholsDS , GlennTM . Effects of aerobic exercise on pain perception, affect, and level of disability in individuals with fibromyalgia. Physical Therapy1994;74:327‐32. ">Nichols 1994</a>; <a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a>; <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>; <a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a>), and high risk for three studies (<a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a>; <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>; <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>). </p> </section> <section id="CD012700-sec-0065"> <h5 class="title">Detection bias</h5> <p>For detection bias, we separated assessment of blinded assessors for subjective and objective outcomes. Not all trials used a combination of both kinds of outcomes. While completing the "Risk of bias" tool, we were unable to insert "not applicable" or to leave the section blank (indicating that the outcome was not measured). We then chose "low risk" and inserted the comment "not applicable/this outcome was not measured."<br/> <br/> For self‐reported outcomes (subjective), we rated 11 studies as high risk (<a href="./references#CD012700-bbs2-0001" title="FontaineKR , HaasS . Effects of lifestyle physical activity on health status, pain, and function in adults with fibromyalgia syndrome. Journal of Musculoskeletal Pain2007;15(1):3‐9. ">Fontaine 2007</a>; <a href="./references#CD012700-bbs2-0002" title="FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity in adults with fibromyalgia: results at follow‐up. Journal of Clinical Rheumatology2011;17(2):64‐8. FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Research Therapy2010;12(2):R55. ">Fontaine 2010</a>; <a href="./references#CD012700-bbs2-0003" title="GowansSE , deHueckA , VossS , SilajA , AbbeySE . Six‐month and one‐year follow up of 23 weeks of aerobic exercise for individuals with fibromyalgia. Arthritis Care &amp; Research2004;51(6):890‐8. GowansSE , deHueckA , VossS , SilajA , AbbeySE , ReynoldsWJ . Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Care &amp; Research2001;45(6):519‐29. ">Gowans 2001</a>; <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>; <a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a>; <a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a>; <a href="./references#CD012700-bbs2-0008" title="NicholsDS , GlennTM . Effects of aerobic exercise on pain perception, affect, and level of disability in individuals with fibromyalgia. Physical Therapy1994;74:327‐32. ">Nichols 1994</a>; <a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a>; <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>; <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>; <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>); one study as low risk, as both interventions were considered equal (<a href="./references#CD012700-bbs2-0006" title="MannerkorpiK , NordemanL , CiderA , JonssonG . Does moderate‐to‐high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial. Arthritis Research &amp; Therapy2010;12(5):R189. ">Mannerkorpi 2010</a>); and one study using a placebo control as unclear risk (<a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a>), as we could not determine whether participants were aware of the intervention. For objective reported outcomes, nine studies blinded outcome assessors to participant group assignment, and we rated these studies as low risk (<a href="./references#CD012700-bbs2-0003" title="GowansSE , deHueckA , VossS , SilajA , AbbeySE . Six‐month and one‐year follow up of 23 weeks of aerobic exercise for individuals with fibromyalgia. Arthritis Care &amp; Research2004;51(6):890‐8. GowansSE , deHueckA , VossS , SilajA , AbbeySE , ReynoldsWJ . Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Care &amp; Research2001;45(6):519‐29. ">Gowans 2001</a>; <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>; <a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a>; <a href="./references#CD012700-bbs2-0006" title="MannerkorpiK , NordemanL , CiderA , JonssonG . Does moderate‐to‐high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial. Arthritis Research &amp; Therapy2010;12(5):R189. ">Mannerkorpi 2010</a>; <a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a>; <a href="./references#CD012700-bbs2-0008" title="NicholsDS , GlennTM . Effects of aerobic exercise on pain perception, affect, and level of disability in individuals with fibromyalgia. Physical Therapy1994;74:327‐32. ">Nichols 1994</a>; <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>; <a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a>; <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>). We rated four studies as unclear risk (<a href="./references#CD012700-bbs2-0001" title="FontaineKR , HaasS . Effects of lifestyle physical activity on health status, pain, and function in adults with fibromyalgia syndrome. Journal of Musculoskeletal Pain2007;15(1):3‐9. ">Fontaine 2007</a><a href="./references#CD012700-bbs2-0002" title="FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity in adults with fibromyalgia: results at follow‐up. Journal of Clinical Rheumatology2011;17(2):64‐8. FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Research Therapy2010;12(2):R55. ">Fontaine 2010</a>; <a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a>; <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>). </p> </section> </section> <section id="CD012700-sec-0066"> <h4 class="title">Incomplete outcome data</h4> <p>Twelve studies reported complete outcome data. <a href="./references#CD012700-bbs2-0003" title="GowansSE , deHueckA , VossS , SilajA , AbbeySE . Six‐month and one‐year follow up of 23 weeks of aerobic exercise for individuals with fibromyalgia. Arthritis Care &amp; Research2004;51(6):890‐8. GowansSE , deHueckA , VossS , SilajA , AbbeySE , ReynoldsWJ . Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Care &amp; Research2001;45(6):519‐29. ">Gowans 2001</a>; <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>; <a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a>; <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>; <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>; and <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a> analyzed data using ITT. <a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a> reported post‐test data and analyzed them using ITT; at follow‐up, investigators provided only complete data with no analysis. Missing outcome data were balanced in numbers across intervention groups, with similar reasons for missing data reported across groups in <a href="./references#CD012700-bbs2-0001" title="FontaineKR , HaasS . Effects of lifestyle physical activity on health status, pain, and function in adults with fibromyalgia syndrome. Journal of Musculoskeletal Pain2007;15(1):3‐9. ">Fontaine 2007</a>; <a href="./references#CD012700-bbs2-0006" title="MannerkorpiK , NordemanL , CiderA , JonssonG . Does moderate‐to‐high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial. Arthritis Research &amp; Therapy2010;12(5):R189. ">Mannerkorpi 2010</a>; and <a href="./references#CD012700-bbs2-0008" title="NicholsDS , GlennTM . Effects of aerobic exercise on pain perception, affect, and level of disability in individuals with fibromyalgia. Physical Therapy1994;74:327‐32. ">Nichols 1994</a>. Missing outcome data were balanced in numbers across intervention groups, and reasons for missing outcome data were unlikely to be related to true outcomes in <a href="./references#CD012700-bbs2-0002" title="FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity in adults with fibromyalgia: results at follow‐up. Journal of Clinical Rheumatology2011;17(2):64‐8. FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Research Therapy2010;12(2):R55. ">Fontaine 2010</a>. <a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a> reported no missing data at post‐test. <a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a> provided incomplete income data, and we rated this study as high risk. </p> </section> <section id="CD012700-sec-0067"> <h4 class="title">Selective reporting</h4> <p>A priori RCTs protocols were available for three of the reviewed studies (<a href="./references#CD012700-bbs2-0002" title="FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity in adults with fibromyalgia: results at follow‐up. Journal of Clinical Rheumatology2011;17(2):64‐8. FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Research Therapy2010;12(2):R55. ">Fontaine 2010</a>, ClinicalTrials.gov NCT00383084; <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>, ClinicalTrials.gov ID NCT00498264; <a href="./references#CD012700-bbs2-0006" title="MannerkorpiK , NordemanL , CiderA , JonssonG . Does moderate‐to‐high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial. Arthritis Research &amp; Therapy2010;12(5):R189. ">Mannerkorpi 2010</a>, ClinicalTrials.gov ID NCT00643006). We rated 10 of the 13 studies as having low risk of selective reporting bias. These included two studies with an a priori RCT protocol (<a href="./references#CD012700-bbs2-0002" title="FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity in adults with fibromyalgia: results at follow‐up. Journal of Clinical Rheumatology2011;17(2):64‐8. FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Research Therapy2010;12(2):R55. ">Fontaine 2010</a>; <a href="./references#CD012700-bbs2-0006" title="MannerkorpiK , NordemanL , CiderA , JonssonG . Does moderate‐to‐high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial. Arthritis Research &amp; Therapy2010;12(5):R189. ">Mannerkorpi 2010</a>). In eight published reports, although RCT protocols were not available, it was clear that published reports included all expected outcomes (<a href="./references#CD012700-bbs2-0003" title="GowansSE , deHueckA , VossS , SilajA , AbbeySE . Six‐month and one‐year follow up of 23 weeks of aerobic exercise for individuals with fibromyalgia. Arthritis Care &amp; Research2004;51(6):890‐8. GowansSE , deHueckA , VossS , SilajA , AbbeySE , ReynoldsWJ . Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Care &amp; Research2001;45(6):519‐29. ">Gowans 2001</a>; <a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a>; <a href="./references#CD012700-bbs2-0008" title="NicholsDS , GlennTM . Effects of aerobic exercise on pain perception, affect, and level of disability in individuals with fibromyalgia. Physical Therapy1994;74:327‐32. ">Nichols 1994</a>; <a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a>; <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>; <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>; <a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a>; <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>). We rated one study as having high risk of selective reporting. <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a> did not provide in the article outcome data for some key variables such as tender points, SF‐36 physical functioning, SF‐36 vitality, and SF‐36 mental health that would be expected. We rated two out of 13 studies as having unclear risk (<a href="./references#CD012700-bbs2-0001" title="FontaineKR , HaasS . Effects of lifestyle physical activity on health status, pain, and function in adults with fibromyalgia syndrome. Journal of Musculoskeletal Pain2007;15(1):3‐9. ">Fontaine 2007</a>; <a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a>). Overall, we rated risk of selective reporting bias as low (77%; <a href="#CD012700-fig-0002">Figure 2</a>). </p> </section> <section id="CD012700-sec-0068"> <h4 class="title">Other potential sources of bias</h4> <p>Overall, we rated risk due to other sources of bias as low (70%; <a href="#CD012700-fig-0002">Figure 2</a>). We rated four studies as having unclear risk because information was insufficient for assessment of whether an important risk of bias existed (<a href="./references#CD012700-bbs2-0001" title="FontaineKR , HaasS . Effects of lifestyle physical activity on health status, pain, and function in adults with fibromyalgia syndrome. Journal of Musculoskeletal Pain2007;15(1):3‐9. ">Fontaine 2007</a>; <a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a>; <a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a>; <a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a>). </p> <p>Poor adherence is another potential source of bias in exercise studies. None of the included studies reported detailed results of systematic data collection and analysis of participant adherence to exercise performance in a way that would allow the review authors to understand the volume of exercise training actually performed by participants. </p> </section> </section> <section id="CD012700-sec-0069"> <h3 class="title" id="CD012700-sec-0069">Effects of interventions</h3> <p>See: <a href="./full#CD012700-tbl-0001"><b>Summary of findings for the main comparison</b> Aerobic exercise training compared with control for fibromyalgia</a> </p> <p>See <a href="./full#CD012700-tbl-0001">summary of findings Table for the main comparison</a> for the main comparison ‐ aerobic exercise training compared with control conditions (treatment as usual, wait list control, daily activities including physical activity as usual). We have grouped results related to effects of interventions from the meta‐analysis to correspond to comparisons and objectives of the review. See below. </p> <section id="CD012700-sec-0070"> <h4 class="title">Aerobics versus control at the end of the intervention</h4> <section id="CD012700-sec-0071"> <h5 class="title">Major outcomes</h5> <p>Five studies provided data for health‐related quality of life (<a href="./references#CD012700-bbs2-0003" title="GowansSE , deHueckA , VossS , SilajA , AbbeySE . Six‐month and one‐year follow up of 23 weeks of aerobic exercise for individuals with fibromyalgia. Arthritis Care &amp; Research2004;51(6):890‐8. GowansSE , deHueckA , VossS , SilajA , AbbeySE , ReynoldsWJ . Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Care &amp; Research2001;45(6):519‐29. ">Gowans 2001</a>; <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>; <a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a>; <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>; <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>), six studies for pain intensity (<a href="./references#CD012700-bbs2-0003" title="GowansSE , deHueckA , VossS , SilajA , AbbeySE . Six‐month and one‐year follow up of 23 weeks of aerobic exercise for individuals with fibromyalgia. Arthritis Care &amp; Research2004;51(6):890‐8. GowansSE , deHueckA , VossS , SilajA , AbbeySE , ReynoldsWJ . Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Care &amp; Research2001;45(6):519‐29. ">Gowans 2001</a>; <a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a>; <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>; <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>; <a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a>; <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>), four for fatigue (<a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>; <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>; <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>; <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>) and physical function (<a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>; <a href="./references#CD012700-bbs2-0008" title="NicholsDS , GlennTM . Effects of aerobic exercise on pain perception, affect, and level of disability in individuals with fibromyalgia. Physical Therapy1994;74:327‐32. ">Nichols 1994</a>; <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>; <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>), and one for the major outcome of stiffness (<a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>). For this comparison, one study (<a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>) included two aerobic exercise arms; the arms were aggregated for analyses and were compared with control conditions. </p> <section id="CD012700-sec-0072"> <h6 class="title">HRQL (self‐reported, FIQ Total, lower scores mean better health, negative numbers mean improvement) </h6> <p>Researchers in five studies (<a href="./references#CD012700-bbs2-0003" title="GowansSE , deHueckA , VossS , SilajA , AbbeySE . Six‐month and one‐year follow up of 23 weeks of aerobic exercise for individuals with fibromyalgia. Arthritis Care &amp; Research2004;51(6):890‐8. GowansSE , deHueckA , VossS , SilajA , AbbeySE , ReynoldsWJ . Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Care &amp; Research2001;45(6):519‐29. ">Gowans 2001</a>; <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>; <a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a>; <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>; <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>) provided evidence of effect post intervention for aerobic exercise training compared with control (N = 372; mean difference (MD) ‐7.89, 95% confidence interval (CI) ‐13.23 to ‐2.55; <a href="./references#CD012700-fig-0004" title="">Analysis 1.1</a>). Absolute change was 8% (3% to 13%) and relative improvement with exercise was 15% (95% CI 5% to 24%); the number needed to treat for an additional beneficial outcome (NNTB) was 6 (4 to 16). </p> </section> <section id="CD012700-sec-0073"> <h6 class="title">Pain intensity (self‐reported, 0 to 100 VAS scale, lower scores mean less pain, negative numbers mean improvement) </h6> <p>Data from six studies (<a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>; <a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a>; <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>; <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>; <a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a>; <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>) revealed a difference between aerobic exercise training and control favoring aerobic training post intervention (N = 351; MD ‐11.06, 95% CI ‐18.34 to ‐3.77; <a href="./references#CD012700-fig-0006" title="">Analysis 1.3</a>). Absolute change was 11% (4% to 18%) and relative change was 18% (95% CI 7% to 30%); the NNTB was 4 (2 to 15). </p> </section> <section id="CD012700-sec-0074"> <h6 class="title">Fatigue (self‐reported, 0 to 100 scale, lower scores mean less fatigue, negative numbers mean improvement) </h6> <p>Data on fatigue were available for five studies (<a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>; <a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a>; <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>; <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>; <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>). Data on fatigue provided by <a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a> were available only in ordinal format and were not included in the meta‐analysis; <a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a> found no difference in fatigue between aerobic exercise and control when performing non‐parametric analysis. The meta‐analysis presented evidence of no statistically significant effect for aerobic exercise training compared with control post intervention (N = 286; MD ‐6.06, 95% CI ‐12.41 to 0.30; <a href="./references#CD012700-fig-0009" title="">Analysis 1.6</a>). Absolute difference was 6% improvement (12% improvement to 0.3% worse). Relative change was 8% (95% CI 16% improvement to 0.4%worse); the NNTB was not applicable. </p> </section> <section id="CD012700-sec-0075"> <h6 class="title">Stiffness (self‐reported, 0 to 100 FIQ scale, lower scores mean less stiffness, negative numbers mean improvement) </h6> <p>Only one study provided data on stiffness (<a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>), showing evidence of an effect of aerobic exercise training (two arms) compared with control post intervention (N = 143; MD ‐7.96, 95% CI ‐14.95 to ‐0.97; <a href="./references#CD012700-fig-0010" title="">Analysis 1.7</a>). Absolute difference shows 8% (1% to 15%) improvement. Relative change was 11% (95% CI 1% to 21%); the NNTB was 6 (3 to 218). </p> </section> <section id="CD012700-sec-0076"> <h6 class="title">Physical function (self‐reported, 0 to 100 FIQ impairment scale, lower scores means fewer limitations, negative numbers mean improvement) </h6> <p>Four trials assessed physical function as an outcome (<a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>; <a href="./references#CD012700-bbs2-0008" title="NicholsDS , GlennTM . Effects of aerobic exercise on pain perception, affect, and level of disability in individuals with fibromyalgia. Physical Therapy1994;74:327‐32. ">Nichols 1994</a>; <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>; <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>). Assessment of statistical heterogeneity among trials indicated I<sup>2</sup> = 69% (ie, from 50% to 90% as may represent "substantial" heterogeneity). After we performed a sensitivity analysis and removed <a href="./references#CD012700-bbs2-0008" title="NicholsDS , GlennTM . Effects of aerobic exercise on pain perception, affect, and level of disability in individuals with fibromyalgia. Physical Therapy1994;74:327‐32. ">Nichols 1994</a>, I<sup>2</sup> was decreased to 0%. Evidence showed an effect of aerobic exercise training compared with control post intervention (N = 246; MD ‐10.16, 95% CI ‐15.39 to ‐4.94; <a href="./references#CD012700-fig-0011" title="">Analysis 1.8</a>). Absolute change was 10% (15% to 5%) improvement. Relative change was 21.9% (95% CI ‐33.2% to 10.7%); the NNTB was 5 (3 to 13). </p> </section> <section id="CD012700-sec-0077"> <h6 class="title">Adverse events</h6> <p>Most studies did not measure adverse events, and other studies reported them incompletely; thus we are uncertain of the estimate. </p> <p>The following statements show some of the adverse events that occurred after aerobic exercise training. </p> <p> <ul id="CD012700-list-0020"> <li> <p>"...unable to exercise after an injury" (<a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>; page 1840), but it is unclear whether the injury was related to participation in the intervention. </p> </li> </ul> <ul id="CD012700-list-0021"> <li> <p>"One participant assigned to the short bout exercise withdrew after developing a metatarsal stress fracture" (<a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>; page 347). </p> </li> </ul> </p> <p>One study author surmised that aerobic exercise is safe for individuals with fibromyalgia, as follows: "the present study findings confirm earlier studies that have shown aerobic exercise to reduce tender point tenderness, increase work capacity without adverse side effects..." (<a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>; page 83 to 84). </p> <p><b>All‐cause withdrawal</b> rates for aerobic exercise training groups (n1/N1) versus control groups (n2/N2) were 12/27 versus 8/24 (<a href="./references#CD012700-bbs2-0003" title="GowansSE , deHueckA , VossS , SilajA , AbbeySE . Six‐month and one‐year follow up of 23 weeks of aerobic exercise for individuals with fibromyalgia. Arthritis Care &amp; Research2004;51(6):890‐8. GowansSE , deHueckA , VossS , SilajA , AbbeySE , ReynoldsWJ . Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Care &amp; Research2001;45(6):519‐29. ">Gowans 2001</a>); 5/30 versus 5/30 (<a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>); 4/46 versus 5/39 (<a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a>); 7/18 versus 3/17 (<a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a>); 2/12 versus 3/12 (<a href="./references#CD012700-bbs2-0008" title="NicholsDS , GlennTM . Effects of aerobic exercise on pain perception, affect, and level of disability in individuals with fibromyalgia. Physical Therapy1994;74:327‐32. ">Nichols 1994</a>); 4/22 versus 1/21 (<a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>); 21/56 versus 5/18 (<a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>); 15/51 versus 5/18 (<a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>); 0/20 and 0/20 (<a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a>) (not included in the analysis); and 4/20 versus 3/20 (<a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>). We found no significant difference in all‐cause withdrawal between aerobic exercise and control groups (risk ratio (RR) 1.25, 95% CI 0.89 to 1.77; <a href="./references#CD012700-fig-0012" title="">Analysis 1.9</a>). Reasons for participant withdrawals are footnoted in the meta‐analysis (<a href="./references#CD012700-fig-0012" title="">Analysis 1.9</a>). </p> </section> </section> <section id="CD012700-sec-0078"> <h5 class="title">Minor outcomes</h5> <p>Four studies (<a href="./references#CD012700-bbs2-0003" title="GowansSE , deHueckA , VossS , SilajA , AbbeySE . Six‐month and one‐year follow up of 23 weeks of aerobic exercise for individuals with fibromyalgia. Arthritis Care &amp; Research2004;51(6):890‐8. GowansSE , deHueckA , VossS , SilajA , AbbeySE , ReynoldsWJ . Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Care &amp; Research2001;45(6):519‐29. ">Gowans 2001</a>; <a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a>; <a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a>; <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>) evaluated effects of aerobic training on the minor outcome of submaximal cardiorespiratory function. Two studies (<a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>; <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>) evaluated maximal cardiorespiratory function. </p> <section id="CD012700-sec-0079"> <h6 class="title">CR max (oxygen uptake)</h6> <p>Two arms of the same study presented data on this outcome (<a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>). Results showed no differences between groups in cardiorespiratory function post intervention (N = 143; MD 1.60, 95% CI ‐0.06 to 3.26; <a href="./references#CD012700-fig-0013" title="">Analysis 1.10</a>). </p> </section> <section id="CD012700-sec-0080"> <h6 class="title">CR submax (six‐minute walk test (m))</h6> <p>We found a statistically significant difference in submaximal cardiorespiratory function favoring the aerobic exercise training intervention post intervention (N = 169; MD 55.58 metres, 95% CI 27.20 to 83.96; <a href="./references#CD012700-fig-0014" title="">Analysis 1.11</a>).. </p> <p>We did not include <a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a> in the meta‐analysis; unlike the other three studies that measured CR submax, <a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a> used an Astrand steady state cycle ergometry test to obtain heart rate (HR) at steady state and did not provide standard deviation (SD) values. <a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a> found no difference in CR submax between aerobic exercise and control groups using non‐parametric analysis. </p> </section> <section id="CD012700-sec-0081"> <h6 class="title">Improvement in pain greater than 30%</h6> <p>No studies reported data on this outcome.</p> </section> <section id="CD012700-sec-0082"> <h6 class="title">Clincal significance</h6> <p>Two major outcomes met the threshold for clinically relevant differences (15%) in this comparison as follows: pain intensity (15%) and physical function (22%). </p> </section> </section> </section> <section id="CD012700-sec-0083"> <h4 class="title">Aerobics versus control, subgroup analyses</h4> <p>We planned to carry out a subgroup analysis of the relative effects of age (≤ 45 years of age and &gt; 45 years of age); we did not do this because of the proximity of mean age to the set cut‐off of 45 years. This proximity would have prevented us from seeing meaningful differences. </p> <p>Subgroup analysis investigating effects of the intervention for studies meeting ACSM criteria for HRQL versus studies not meeting ACSM criteria for HRQL and pain intensity (<a href="./references#CD012700-fig-0004" title="">Analysis 1.1</a>; <a href="./references#CD012700-fig-0006" title="">Analysis 1.3</a>) showed no statistically significant differences (P &gt; 0.05). We report these analyses as follows. </p> <p> <ul id="CD012700-list-0022"> <li> <p>HRQL: studies that met ACSM (MD ‐8.66, 95% CI ‐17.77 to 0.44); those that did not meet ACSM (MD ‐6.77, 95% CI ‐12.97 to ‐0.57); test for subgroup differences: Chi² = 0.11, df = 1 (P = 0.74). </p> </li> </ul> <ul id="CD012700-list-0023"> <li> <p>Pain intensity: studies that met ACSM (MD ‐5.89, 95% CI ‐18.79 to 6.95); those that did not meet ACSM (MD ‐14.90, 95% ‐21.36 to ‐8.44); test for subgroup differences: Chi² = 1.51, df = 1 (P = 0.22). </p> </li> </ul> </p> </section> <section id="CD012700-sec-0084"> <h4 class="title">Aerobics versus control, sensitivity analyses</h4> <p>We explored effects of selection biases for HRQL and pain intensity outcomes and attrition biases for pain intensity. We did not find attrition rates greater than 20% for HRQL; therefore, we did not conduct this sensitivity analysis as planned.<br/> <br/> Results of sensitivity analysis for HRQL (selection bias) showed no major impact on the direction and magnitude of estimates when we removed studies with high or unclear risk from the meta‐analyses. We have presented results in <a href="#CD012700-tbl-0007">Table 6</a> and <a href="./references#CD012700-fig-0005" title="">Analysis 1.2</a>. Results of sensitivity analysis for pain intensity (selection bias) changed the effect size to a non‐significant result; this can potentially be interpreted as the influence of primary studies with high or unclear risks of bias on the direction and magnitude of estimates. We have presented these results in <a href="#CD012700-tbl-0007">Table 6</a> and in <a href="./references#CD012700-fig-0007" title="">Analysis 1.4</a> and <a href="./references#CD012700-fig-0008" title="">Analysis 1.5</a>. Pain intensity attrition bias sensitivity analysis effect estimates remained the same. However, these analyses must be interpreted with caution, as the number of studies included is small, and the analyses are exploratory in nature. It is possible that a risk may exist, but presently we do not know how much it might affects study results. </p> <div class="table" id="CD012700-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Sensitivity analyses: aerobics versus control</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All studies</b> </p> <p><b>MD (95% CI), number of studies (participants), I<sup>2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Low risk of selection bias</b> </p> <p><b>MD (95% CI), number of studies (participants), I<sup>2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Low risk of attrition bias</b> </p> <p><b>MD (95% CI), number of studies (participants), I<sup>2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Detection bias</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HRQL</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐7.89 (‐13.23 to ‐2.55), 5 studies (372), I<sup>2</sup>= 58% </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐10.47 (‐20.79 to ‐0.15), 3 studies (246), I<sup>2</sup> = 77% </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 20% was not present ‐ this sensitivity analysis was not conducted</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitivity analysis not conducted</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐11.06 (‐18.34 to ‐3.77), 6 studies (351), I<sup>2</sup>= 59% </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐8.38 (‐17.88 to 1.12), 3 studies (246), I<sup>2</sup> = 59% </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐11.71 (‐19.93 to ‐3.50), 5 studies (326), I<sup>2</sup> = 66% </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitivity analysis not conducted</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval; HRQL: health‐related quality of life; MD: mean difference</p> </div> </div> <p>We did not conduct sensitivity analysis for HRQL and pain intensity for detection bias as all of these outcomes were evaluated with self‐report instruments; therefore we deemed risk of bias to be high. </p> </section> <section id="CD012700-sec-0085"> <h4 class="title">Aerobics versus control, long‐term effects</h4> <p>Four studies examined long‐term effects: <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a> (follow‐up at four years after the end of the 14‐week intervention), <a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a> (follow‐up at 24 weeks, 12 weeks after the end of the 16‐week intervention), <a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a> (follow‐up at 26 weeks, 20 weeks after the end of the six‐week intervention), and <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a> (follow‐up at 28 weeks, 12 weeks after the end of the 16‐week intervention). </p> <section id="CD012700-sec-0086"> <h5 class="title">Major outcomes</h5> <section id="CD012700-sec-0087"> <h6 class="title">HRQL (self‐reported, 0 to 100 FIQ Total scale, lower scores mean better health, negative numbers mean improvement) </h6> <p>Two studies examined the long‐term effects of aerobic exercise on HRQL: <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a> found a statistically significant effect favoring aerobic exercise (N = 60; MD ‐19.16, 95% CI ‐29.7 to ‐8.62; <a href="./references#CD012700-fig-0015" title="">Analysis 2.1</a>), whereas <a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a> found no statistically significant difference (MD ‐4.00, 95% CI ‐11.86 to 3.86). </p> </section> <section id="CD012700-sec-0088"> <h6 class="title">Pain intensity (self‐reported, 0 to 100 mm VAS scale, lower scores mean less pain, negative numbers mean improvement) </h6> <p>Three studies examined long‐term effects of aerobic exercise on pain intensity (<a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>; <a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a>; <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>) and found a statistically significant effect for the aerobic intervention at post‐test follow‐up (N = 134; MD ‐10.56, 95% CI ‐20.00 to ‐1.12; <a href="./references#CD012700-fig-0016" title="">Analysis 2.2</a>). </p> </section> <section id="CD012700-sec-0089"> <h6 class="title">Fatigue (self‐reported, 0 to 100 mm VAS scale, lower scores mean less fatigue, negative numbers mean improvement) </h6> <p>Two studies examined the long‐term effects of aerobic exercise on fatigue (<a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>; <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>). <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a> found a statistically significant effect favoring aerobic exercise (N = 60; MD ‐14.00, 95% CI ‐24.34 to ‐3.81; <a href="./references#CD012700-fig-0017" title="">Analysis 2.3</a>), whereas <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a> found no significant differences (N = 40; MD 5.00, 95% CI ‐12.69 to 22.69). </p> </section> <section id="CD012700-sec-0090"> <h6 class="title">Physical function (self‐reported, 0 to 100 FIQ impairment scale, lower scores mean fewer limitations, negative numbers mean improvement) </h6> <p>One study examined the long‐term effects of aerobic exercise on physical function (<a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>) and found a statistically significant effect favoring aerobic exercise (N = 60; MD ‐11.33, 95% CI ‐22.11 to ‐0.55; <a href="./references#CD012700-fig-0018" title="">Analysis 2.4</a>). </p> </section> <section id="CD012700-sec-0091"> <h6 class="title">All‐cause withdrawal</h6> <p>Three studies provided sufficient data for evaluation of differences in all‐cause withdrawal: <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>; <a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a>; and <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>. We excluded <a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a> from the analysis because the sample size of the control group at follow‐up was not provided. By follow‐up, 22 of 70 had withdrawn from the aerobics groups compared with 25 of 70 in the control groups. Researchers found no significant differences in the proportion of participants who had withdrawn at follow‐up (N = 140; RR 0.75, 95% CI 0.47 to 1.22; <a href="./references#CD012700-fig-0019" title="">Analysis 2.5</a>). </p> </section> <section id="CD012700-sec-0092"> <h6 class="title">Stiffness and adverse events</h6> <p>No studies reported data on these outcomes.</p> </section> </section> <section id="CD012700-sec-0093"> <h5 class="title">Minor outcomes</h5> <section id="CD012700-sec-0094"> <h6 class="title">CR max (work capacity (w))</h6> <p>One study examined the long‐term effects of aerobic exercise on CR max (<a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>) and found no evidence of an effect at four years (208 weeks) between aerobic and control groups (<a href="./references#CD012700-fig-0020" title="">Analysis 2.6</a>). </p> </section> <section id="CD012700-sec-0095"> <h6 class="title">CR submax (six‐minute walk test (m))</h6> <p>One study examined the long‐term effects of aerobic exercise on CR submax (<a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a>) and found no evidence of an effect at two years (24 weeks) between aerobic and control groups (<a href="./references#CD012700-fig-0021" title="">Analysis 2.7</a>). </p> </section> <section id="CD012700-sec-0096"> <h6 class="title">Improvement in pain greater than 30%</h6> <p>No studies reported data on this outcome.</p> </section> </section> </section> <section id="CD012700-sec-0097"> <h4 class="title">Aerobics versus aerobics at the end of the intervention</h4> <p>We did not pool studies, as these interventions (ie, population and mode) were not considered comparable across trials. Three studies provided data for this comparison: <a href="./references#CD012700-bbs2-0006" title="MannerkorpiK , NordemanL , CiderA , JonssonG . Does moderate‐to‐high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial. Arthritis Research &amp; Therapy2010;12(5):R189. ">Mannerkorpi 2010</a> compared Nordic walking versus low‐intensity aerobic training; <a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a> compared supervised versus unsupervised aerobic exercise; and <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a> compared two short bouts versus one long bout of aerobic exercise per day. Results from these studies show the effect sizes found for each of the reported outcomes. Unless otherwise indicated, researchers measured HRQL, pain, fatigue, stiffness, and physical function on a 0 to 100 scale; lower scores are best, and negative numbers mean improvement. </p> <p><a href="./references#CD012700-bbs2-0006" title="MannerkorpiK , NordemanL , CiderA , JonssonG . Does moderate‐to‐high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial. Arthritis Research &amp; Therapy2010;12(5):R189. ">Mannerkorpi 2010</a>, which compared 15‐week Nordic walking (n = 28) versus low‐intensity aerobic training (n = 27), found evidence of no effect on HRQL (FIQ Total, scale 0 to 100; N = 55; MD ‐7.30, 95% CI ‐18.90 to 4.30; <a href="./references#CD012700-fig-0022" title="">Analysis 3.1</a>), pain intensity (100‐mm VAS; N = 57; MD ‐4.70, 95% CI ‐17.42 to 8.02; <a href="./references#CD012700-fig-0023" title="">Analysis 3.2</a>), fatigue (Multidimensional Fatigue Inventory, scale 4 to 20; N = 55; MD ‐0.33, 95% CI ‐0.87 to 0.20; <a href="./references#CD012700-fig-0024" title="">Analysis 3.3</a>), physical function (FIQ impairment scale, scale 0 to 100; MD ‐6.00, 95% CI ‐18.77 to 6.77; <a href="./references#CD012700-fig-0026" title="">Analysis 3.5</a> ), all‐cause withdrawals (RR 1.21, 95% CI 0.36 to 4.13; <a href="./references#CD012700-fig-0027" title="">Analysis 3.6</a>), and CR submax (six‐minute walk test in meters; N = 55; MD 28.80, 95% CI ‐3.89 to 61.49). Regarding adverse effects, <a href="./references#CD012700-bbs2-0006" title="MannerkorpiK , NordemanL , CiderA , JonssonG . Does moderate‐to‐high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial. Arthritis Research &amp; Therapy2010;12(5):R189. ">Mannerkorpi 2010</a> observed that "a temporary increase of pain was reported by several patients at exercise sessions, not only participants in the Nordic walking group but also participants in the low intensity walking group"; however, one participant in the Nordic walking group had increased pain and dropped out, and "only one patient interrupted the exercise program due to adverse effects of exercise. She had chronic trochanteritis, which deteriorated after a few exercise sessions" (page 8 of 10). </p> <p><a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a> compared participants undertaking supervised aerobic exercise (N = 37) versus participants attending a single exercise class with instructions to continue with a home program (N = 37). At 12 weeks, <a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a> found evidence of no effect on pain intensity (100‐mm VAS; N = 74; MD ‐3.00, 95% CI ‐15.38 to 9.38; <a href="./references#CD012700-fig-0023" title="">Analysis 3.2</a>). <a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a> did not clearly specify drop‐outs from the study; therefore, we were not able to pool the data. <a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a> reported no adverse events but measured physical function with a modified HAQ and presented data in medians and 25th and 75th percentiles. The HAQ is a 20‐item instrument with total scores ranging from 0 to 3 (with high scores denoting poorer function). Because no other trial in this review used the HAQ, we were not able to impute standard deviations for this trial. Using non‐parametric tests, <a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a> found no significant differences in HAQ scores between the two groups. </p> <p><a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>, which compared 16‐week programs of one long bout per day (N = 51) versus two short bouts per day (N = 56) of low‐impact aerobics intensity, found no statistically significant between‐group differences in HRQL (FIQ Total, scale 0 to 100; N = 107; MD ‐1.00, 95% CI ‐7.75 to 5.75; <a href="./references#CD012700-fig-0022" title="">Analysis 3.1</a>), pain intensity (100‐mm VAS; N = 107; MD ‐5.00, 95% CI ‐14.00 to 4.00; <a href="./references#CD012700-fig-0023" title="">Analysis 3.2</a>), fatigue (FIQ fatigue, scale 0 to 100; N = 107; MD 0.10, 95% CI ‐0.28 to 0.48; <a href="./references#CD012700-fig-0024" title="">Analysis 3.3</a>), stiffness (FIQ stiffness, scale 0 to 100; N = 107; MD ‐2.00, 95% CI ‐10.53 to 6.53; <a href="./references#CD012700-fig-0025" title="">Analysis 3.4</a>), physical function (FIQ impairment scale, scale 0 to 100; N = 107; MD 5.00, 95% CI ‐4.02 to 14.02; <a href="./references#CD012700-fig-0026" title="">Analysis 3.5</a>), all‐cause withdrawals (N = 107; RR 0.78, 95% CI 0.46 to 1.35; <a href="./references#CD012700-fig-0027" title="">Analysis 3.6</a>), or CR max (VO<sub>2</sub>max, mL/kg; N = 107; MD 0.70, 95% CI ‐1.23 to 2.63; <a href="./references#CD012700-fig-0028" title="">Analysis 3.7</a>). Regarding adverse events, Schachter noted: "One participant assigned to the short bout exercise withdrew after developing a metatarsal stress fracture" (page 347). </p> <p>No studies comparing two aerobic interventions provided data on Improvement in pain greater than 30%. </p> </section> <section id="CD012700-sec-0098"> <h4 class="title">Aerobics versus other non‐exercise interventions at the end of the intervention</h4> <p>We did not pool studies, as we did not consider interventions and comparators comparable across trials. Five studies (six publications) provided data for this comparison (<a href="./references#CD012700-bbs2-0001" title="FontaineKR , HaasS . Effects of lifestyle physical activity on health status, pain, and function in adults with fibromyalgia syndrome. Journal of Musculoskeletal Pain2007;15(1):3‐9. ">Fontaine 2007</a>; <a href="./references#CD012700-bbs2-0002" title="FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity in adults with fibromyalgia: results at follow‐up. Journal of Clinical Rheumatology2011;17(2):64‐8. FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Research Therapy2010;12(2):R55. ">Fontaine 2010</a>; <a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a>; <a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a>; <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>). <a href="./references#CD012700-bbs2-0001" title="FontaineKR , HaasS . Effects of lifestyle physical activity on health status, pain, and function in adults with fibromyalgia syndrome. Journal of Musculoskeletal Pain2007;15(1):3‐9. ">Fontaine 2007</a>; <a href="./references#CD012700-bbs2-0002" title="FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity in adults with fibromyalgia: results at follow‐up. Journal of Clinical Rheumatology2011;17(2):64‐8. FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Research Therapy2010;12(2):R55. ">Fontaine 2010</a>; and <a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a> compared aerobic exercise versus education, <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a> compared aerobic exercise versus stress management training, and <a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a> compared aerobic exercise versus medication (ie, paroxetine). Our analyses show effect size on major and minor outcome variables for each of the included studies. Unless otherwise indicated, investigators measured HRQL, pain, and fatigue on a 0 to 100 scale, lower scores are best, and negative numbers mean improvement. </p> <p><a href="./references#CD012700-bbs2-0001" title="FontaineKR , HaasS . Effects of lifestyle physical activity on health status, pain, and function in adults with fibromyalgia syndrome. Journal of Musculoskeletal Pain2007;15(1):3‐9. ">Fontaine 2007</a>, which compared a 12‐week program of aerobic exercise (called "leisure time physical activity"; n = 22) versus education (n = 26), found evidence of no effect on HRQL (FIQ Total, scale 0 to 100; N = 33; MD ‐8.90, 95% CI ‐24.07 to 6.2; <a href="./references#CD012700-fig-0030" title="">Analysis 4.1</a>), fatigue (Fatigue Severity Scale; N = 32; SMD ‐0.14, 95% CI ‐0.84 to 0.56; <a href="./references#CD012700-fig-0032" title="">Analysis 4.3</a>), all‐cause withdrawal (N = 48; RR 1.03, 95% CI ‐0.45 to 2.40), and CR submax (six‐minute walk test, meters; N = 33; MD ‐4.30, 95% CI ‐99.14 to 90.54; <a href="./references#CD012700-fig-0035" title="">Analysis 4.6</a>). This study found statistically significant results for pain intensity (100‐mm VAS; N = 32; MD ‐15.00, 95% CI ‐29.95 to ‐0.05; <a href="./references#CD012700-fig-0031" title="">Analysis 4.2</a>) and reported no adverse events (ie, injuries, exacerbations, or other) for either group. </p> <p><a href="./references#CD012700-bbs2-0002" title="FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity in adults with fibromyalgia: results at follow‐up. Journal of Clinical Rheumatology2011;17(2):64‐8. FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Research Therapy2010;12(2):R55. ">Fontaine 2010</a>, which compared a 12‐week aerobics program (leisure time physical activity) (n = 43) versus education (n = 33), found statistically significant differences post intervention in HRQL (FIQ Total, scale 0 to 100; N = 73; MD ‐10.30, 95% CI ‐19.30 to ‐1.30; <a href="./references#CD012700-fig-0030" title="">Analysis 4.1</a>), pain intensity (100‐mm VAS; N = 73; MD ‐16.10, 95% CI ‐27.33 to ‐4.87; <a href="./references#CD012700-fig-0031" title="">Analysis 4.2</a>), and CR submax (six‐minute walk test, meters; N = 73; MD 42.80, 95% CI 3.40 to 82.20; <a href="./references#CD012700-fig-0034" title="">Analysis 4.5</a>); this study did not report between‐group differences post intervention in fatigue (Fatigue Severity Scale; N = 73; SMD 0.00, 95% CI ‐0.46 to 0.46; <a href="./references#CD012700-fig-0032" title="">Analysis 4.3</a>) or all‐cause withdrawal (N = 73; RR 0.99, 95% CI ‐0.33 to 3.00; <a href="./references#CD012700-fig-0033" title="">Analysis 4.4</a>). Neither group reported adverse events (ie, injuries, exacerbations, or other). </p> <p><a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a> compared a 12‐week aerobic intervention (n = 42) versus education (n = 41) and found evidence of no effects on HRQL (FIQ Total, scale 0 to 80; MD ‐4.40, 95% CI ‐10.75 to 1.95), all‐cause withdrawal (RR ‐0.56, 95% CI ‐0.18 to 1.76), or CR submax (six‐minute walk test, meters; MD 13.20, 95% CI ‐24.57 to 50.97). With regard to adverse events, study authors surmise, "No complications or adverse effects were observed during the study period among patients who completed the treatment protocols" (page 3 of 8). </p> <p><a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a> compared a 14‐week aerobics program (n = 16) versus stress management training (n = 17) and noted no between‐group differences in pain intensity (100‐mm VAS; N = 40; MD ‐2.00, 95% CI ‐14.41 to 10.41; <a href="./references#CD012700-fig-0031" title="">Analysis 4.2</a>), fatigue (100‐mm VAS; N = 40; SMD ‐0.46, 95% CI ‐1.08 to 0.17; <a href="./references#CD012700-fig-0032" title="">Analysis 4.3</a>), or all‐cause withdrawal (N = 40; RR ‐0.80, 95% CI ‐0.25 to 2.55; <a href="./references#CD012700-fig-0033" title="">Analysis 4.4</a>) and reported no adverse events (ie, injuries, exacerbations, or other) for either group. Data on CR max post intervention show a statistically significant difference in favor of aerobic exercise training versus stress management therapy (measured by work capacity, watts; N = 40; MD 0.10, 95% CI 0.00 to 0.20; <a href="./references#CD012700-fig-0034" title="">Analysis 4.5</a>). </p> <p><a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a> compared six weeks of aerobic exercise (ie, cycling; n = 20) versus medication (ie, paroxetine; n = 20) and found no evidence of effects on pain intensity (N = 40; MD 5.00, 95% CI ‐2.14 to 12.14; <a href="./references#CD012700-fig-0031" title="">Analysis 4.2</a>). Investigators reported no adverse events (ie, injuries, exacerbations, or other) for either group. </p> <section id="CD012700-sec-0099"> <h5 class="title">Stiffness, physical function, and improvement in pain greater than 30%</h5> <p>No studies reported data on these outcomes.</p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012700-sec-0100" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012700-sec-0100"></div> <p>This review is one of a series of reviews examining effects of physical activity interventions for individuals with fibromyalgia; this review focused on aerobic exercise training. </p> <section id="CD012700-sec-0101"> <h3 class="title" id="CD012700-sec-0101">Summary of main results</h3> <p>Thirteen unique studies involving 839 people met our inclusion criteria. Nine studies compared aerobic exercise versus control, three compared one aerobic intervention versus another aerobic intervention, and five compared aerobic exercise versus a non‐exercise intervention. </p> <p> <ul id="CD012700-list-0024"> <li> <p>Aerobics versus control studies: IThe eight trials that compared aerobic exercise training versus control included a total of 456 participants. Investigators reported statistically significant improvement at the end of the intervention (with two outcomes reaching clinical significance) and provided evidence of low to moderate quality favoring aerobic exercise training for health‐related quality of life (HRQL), pain intensity, stiffness, and physical function. Results showed no statistically significant differences in the number of participants who withdrew from exercise groups and control groups, and fatigue and other adverse events were difficult to evaluate because they were not reported in a systematic or standardized manner. A small quantiity of data revealed that those who participated in aerobic interventions had less pain and better physical function at long‐term follow‐up when compared with those in control groups; however, long‐term follow‐up revealed no differences in HRQL. </p> </li> <li> <p>Aerobics versus aerobics studies: Three studies involving 248 people compared two forms of aerobic exercise. Owing to differences between interventions and comparators, we did not pool the data. One study compared Nordic walking versus low‐intensity walking, another compared aerobic exercise done in two short bouts versus one long bout per day, and a final study compared effects of a once‐per‐week exercise class versus a single exercise session and home program. Results showed no significant differences in major or minor outcomes between any of the interventions provided in these studies. </p> </li> <li> <p>Aerobics versus other non‐exercise intervention studies: Four studies compared aerobic exercise versus self‐management training and education interventions, and one study compared aerobic exercise versus medication (paroxetine). Owing to differences between interventions and comparators, we did not pool the data. Results showed statistically significant differences favoring the aerobics program for HRQL (one of three trials) and pain intensity (two of four studies). Researchers noted no differences in fatigue nor in all‐cause withdrawals. No studies provided data on stiffness and physical function. Information on the number and quality of adverse events was scarce. </p> </li> </ul> </p> </section> <section id="CD012700-sec-0102"> <h3 class="title" id="CD012700-sec-0102">Overall completeness and applicability of evidence</h3> <p>Although additional studies with greater numbers of participants would increase our confidence in these results, and despite the issues mentioned above, it appears that aerobic exercise training can be effective in improving our major fibromyalgia outcomes of health‐related quality of life, pain intensity, stiffness, and physical function. Evidence on long‐term effects (24 to 208 weeks post intervention) shows that benefits for pain and function persisted, but benefits for HRQL or fatigue did not. Withdrawals were similar, and stiffness and adverse events were not measured. It is important to note that aerobic exercise training does not seem to be linked with greater withdrawal from programs. Indeed, results lead us to believe that this is an acceptable intervention for individuals with fibromyalgia. Aerobic exercise is a type of exercise that can be performed without the need for elaborate equipment or facilities; it is therefore an accessible form of exercise for individuals with fibromyalgia. Our limited evidence appears to support aerobic exercise training as part of the management of fibromyalgia. Although the body of literature has grown over the past decade, studies remain insufficient for subgroup analyses or evaluation of dose‐response relationships. </p> <p>We evaluated exercise interventions against well‐accepted guidelines for improving cardiorespiratory fitness and health that outline frequency, intensity, time, type, and volume, as well as progression of aerobic exercise training (<a href="./references#CD012700-bbs2-0246" title="GarberCE , BlissmerB , DeschenesMR , FranklinBA , LamonteMJ , LeeIM , et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Medicine &amp; Science in Sports Exercise2011;43(7):1334‐59. ">Garber 2011</a>). Only four of 13 studies included interventions that were congruent with American College of Sports Medicine (ACSM) guidelines (<a href="#CD012700-tbl-0006">Table 5</a>). Interventions that fell short of the guidelines included exercise intensities and frequencies below recommendations and total accumulated durations less than the minimum 150 minutes per week for programs of moderate intensity. Few studies in the subgroup analyses (<a href="./references#CD012700-fig-0004" title="">Analysis 1.1</a>; <a href="./references#CD012700-fig-0006" title="">Analysis 1.3</a>) indicate that the effect of the intervention in studies not meeting ACSM guidelines is similar to effects on HRQL and pain intensity. Further, it does appear that aerobic exercise training programs providing lower training volumes than those recommended by ACSM can improve fibromyalgia symptoms. Nonetheless, ACSM guidelines may serve as a useful guide for individuals with fibromyalgia and for health care providers, as they provide ideas for starting, progressing, and maintaining aerobic exercise training programs associated with cardiorespiratory fitness and other health‐related benefits (eg, lower all‐cause mortality, lower risk of cardiovascular disease mortality and morbidity) (<a href="./references#CD012700-bbs2-0217" title="American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription Ninth Edition. 9th Edition. Baltimore, MD: Lippincott Williams &amp; Wilkins, 2013. ">ACSM 2013</a>; <a href="./references#CD012700-bbs2-0246" title="GarberCE , BlissmerB , DeschenesMR , FranklinBA , LamonteMJ , LeeIM , et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Medicine &amp; Science in Sports Exercise2011;43(7):1334‐59. ">Garber 2011</a>). </p> <p>Included studies were published in Canada, United States, Brazil, Spain, Norway, Sweden, United Kingdom, and Turkey. These may represent only some of the total published papers on aerobic exercise and fibromyalgia. Most interventions reflected supervised group training, hence we do not know what home programs or individualized supervision would do to our quality of evidence levels. Most of our studies included only female participants. Additional studies that focus on interventions for males will indicate whether aerobic exercise training interventions have similar effects for men and women. Therefore, our findings are not easily generalized beyond a middle‐aged, largely Caucasian, female population. </p> <p>Within the context of current practice, many programs targeting individuals with fibromyalgia are already implementing aerobic exercise training, such as walking or moving to music. Expensive or challenging equipment is not required for aerobic exercise training to be incorporated into practice, yet evidence shows a paucity of research examining these types of interventions. </p> </section> <section id="CD012700-sec-0103"> <h3 class="title" id="CD012700-sec-0103">Quality of the evidence</h3> <p>We extracted the evidence presented in this review from trials published in academic journals, from trial registries, and from information requested of trial authors. Using the GRADE system in rating our evidence for major outcomes, we found evidence of low to moderate quality for benefits in HRQL, pain intensity, fatigue, stiffness, and physical function with aerobic exercise training versus control at the end of treatment. We downgraded this evidence because of potential limitations related to imprecision (ie, total cumulative sample size lower than 400, wide confidence intervals), data based on results of one study, and limitations related to risk of bias. Sample sizes of aerobic exercise intervention groups among the 13 studies ranged from 10 to 56 participants. Although most of the individual studies were underpowered, aerobic exercise training versus control group meta‐analyses were sufficient to reveal differences for most variables. Reporting of adverse events was limited owing to inconsistency and lack of information among these studies, although it remains unclear whether injuries occurred, as the reporting is not explicit. Our analysis identified moderate‐quality evidence showing that withdrawal rates did not differ between aerobic exercise training and controls. </p> <p>We rated the quality of evidence as low for long‐term benefits of aerobic exercise for pain intensity and all‐cause withdrawal owing to risk of bias (lack of allocation concealment, blinding) and imprecision (wide confidence intervals, small number of participants), and we further downgraded the level to very low for HRQL, fatigue, and physical function owing to considerable heterogeneity in study results, Investigators did not measure stiffness and adverse events (see <a href="#CD012700-tbl-0008">Table 7</a>). </p> <div class="table" id="CD012700-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Quality of evidence ‐ GRADE assessment: long‐term effects of AE versus control comparison</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Quality assessment</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Number of participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Importance</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study design</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk of bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Inconsistency</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Indirectness</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Imprecision</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Other comments</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>AE only</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>HRQL</b> (follow‐up 12 weeks after end of intervention; assessed with 0‐100 scale, lower is best) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CRITICAL</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Pain intensity</b> (follow‐up 12 weeks after end of intervention to 4 years; assessed with 0‐100 scale, lower is best) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CRITICAL</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Fatigue</b> (follow‐up from 12 weeks after end of intervention to 4 years; assessed with 0‐100 scale, lower is best) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IMPORTANT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Stiffness</b>: not measured </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Physical function</b> (follow‐up at 12 weeks after end of intervention; assessed with 0‐100 scale, lower is best) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>One study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IMPORTANT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>All‐cause withdrawal</b> (follow‐up from 12 weeks after end of intervention to 4 years) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22/92 (23.9%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25/84 (29.8%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IMPORTANT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Adverse events</b>: not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>Issues with allocation, detection, performance, selective reporting, and other biases </p> <p><sup>b</sup>Considerable heterogeneity in results (I<sup>2</sup> = 80%) </p> <p><sup>c</sup>Number of participants lower than 400 rule of thumb, wide confidence interval </p> <p><sup>d</sup>Issues related to detection bias, performance bias, and selective reporting </p> <p>AE: aerobic exercise; HRQL: health‐related quality of life</p> </div> </div> <p>In comparisons of an aerobic intervention versus another, we found evidence of low to very low quality for benefits in HRQL, pain intensity, fatigue, stiffness, physical function, and all‐cause withdrawal. We downgraded the quality of evidence owing to issues with risk of bias (detection, performance, and other risks of bias), imprecision (wide confidence intervals and small numbers of participants), and heterogeneity of interventions (see <a href="#CD012700-tbl-0009">Table 8</a>). </p> <div class="table" id="CD012700-tbl-0009"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Quality of evidence ‐ GRADE assessment: AE intervention versus another AE intervention</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Quality assessment</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Number of participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Importance</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study design</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk of bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Inconsistency</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Indirectness</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Imprecision</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Other considerations</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>AE intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>AE control</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>HRQL</b>, 0‐100, lower is best </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Studies not pooled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CRITICAL</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Pain intensity</b>, 0‐100, lower is best </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Studies not pooled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CRITICAL</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Fatigue,</b> 0‐100, lower is best </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Studies not pooled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IMPORTANT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Stiffness,</b> 0‐100, lower is best </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>One study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IMPORTANT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Physical function</b>, 0‐100, lower is best </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IMPORTANT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>All‐cause withdrawals</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20/85 (23.5%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25/89 (28.1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IMPORTANT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Adverse events</b>: not reported </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>Issues of detection and performance bias </p> <p><sup>b</sup>Issues related to selection, detection, performance, and other risk of bias </p> <p><sup>c</sup>Wide confidence intervals, number of participants less than 400 rule of thumb </p> <p><sup>d</sup>Interventions not similar across studies </p> <p>AE: aerobic exercise; HRQL: health‐related quality of life</p> </div> </div> <p>In comparisons of an aerobic intervention versus a non‐exercise (other) intervention, the quality of the evidence ranged from low to very low. We downgraded the quality of the evidence because of issues related to risk of bias, very low numbers of trial participants and wide confidence intervals, and inconsistency across comparators (see <a href="#CD012700-tbl-0010">Table 9</a>). </p> <div class="table" id="CD012700-tbl-0010"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Quality of evidence ‐ GRADE assessment AE intervention versus other (non‐exercise intervention)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Quality assessment</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Number of participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Importance</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study design</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk of bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Inconsistency</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Indirectness</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Imprecision</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Other considerations</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>AE</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Other</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>HRQL,</b> 0‐100, lower is best (AE and lifestyle vs education or SMP) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CRITICAL</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Pain intensity</b>, 0‐100, lower is best (AE only vs education or SMP and AE only vs medication) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CRITICAL</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Fatigue,</b> 0‐100, lower is best (AE and lifestyle vs education or SMP) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IMPORTANT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Withdrawals</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21/130 (16.2%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25/125 (20.0%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IMPORTANT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Stiffness and physical function</b>: not measured </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Adverse events</b>: reported for 1 study: <a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a>: "No complications or adverse effects were observed during the study period among patients who completed the treatment protocols" (page 3 of 8) </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>AE: aerobic; HRQL: health‐related quality of life; SMP: self‐management program</p> <p><sup>a</sup>Issues related to risk of bias </p> <p><sup>b</sup>Low number of participants (less than 400 rule of thumb) and wide confidence intervals </p> <p><sup>c</sup>Comparator not similar across studies </p> <p>AE: aerobic exercise; HRQL: health‐related quality of life; SMP: self‐management program</p> </div> </div> <p>However, the robustness of study results remains questionable until we are certain whether participants in these trials were aware of their allocated group (ie, whether they were aware of the intervention to which they were assigned). Until we are certain of this, study results presented may tend to be overestimated. This is particularly true for self‐reported outcomes such as HRQL, pain intensity, fatigue, stiffness, and physical function. Therefore, evidence must be interpreted with caution. </p> </section> <section id="CD012700-sec-0104"> <h3 class="title" id="CD012700-sec-0104">Potential biases in the review process</h3> <p>Despite efforts to reduce the impact of publication bias on this review, the possibility remains that some studies (with positive or negative findings) may not have been identified by the search. </p> <p>Contacting study authors for additional information enhanced the accuracy of the information reported in most cases, but this may have introduced a "response bias" into the risk of bias assessment. </p> <p>We had to impute some values for missing data (such as standard deviations).</p> <p>The small number of trials included in some analyses further reduced the robustness of these findings. </p> <p>Other bias may have been introduced by limitations such as incomplete description of exercise protocols and inadequate documentation of adherence to exercise prescriptions. </p> <p>In our review process, we attempted to control for biases in the following ways.</p> <p> <ul id="CD012700-list-0025"> <li> <p>We applied no language restrictions.</p> </li> <li> <p>We updated searches periodically and utilized multiple databases.</p> </li> <li> <p>We complemented our searches with handsearching.</p> </li> <li> <p>We contacted primary authors for clarification and additional information when indicated, although we did not always receive a response. We asked our questions in an open‐ended fashion, so as to avoid leading questions or answers. </p> </li> <li> <p>By searching clinical trial registries (eg, clinicaltrials.gov), we enhanced the opportunity to identify unpublished trials and selective reporting of outcomes. Publication bias may lead to overestimation of a treatment effect by up to 12%. </p> </li> <li> <p>Our multidisciplinary team represented a range of expertise (ie, in library science, systematic reviews and methods, critical appraisal, clinical rheumatology, exercise physiology, physiotherapy, kinesiology, and knowledge translation). </p> </li> <li> <p>We used a standardized procedure to determine selection and inclusion of studies in the review, and review authors were trained in data extraction. </p> </li> <li> <p>Two members of our multidisciplinary team also presented the perspective of consumers (ie, one team member had fibromyalgia, and another team member had another rheumatic disease). </p> </li> <li> <p>We used intention‐to‐treat data preferentially.</p> </li> </ul> </p> </section> <section id="CD012700-sec-0105"> <h3 class="title" id="CD012700-sec-0105">Agreements and disagreements with other studies or reviews</h3> <p>Over the past 10 years, several reviews have assessed physical activity interventions for fibromyalgia. In light of their relevance to aerobic exercise, we have chosen to comment on five recent publications: <a href="./references#CD012700-bbs2-0231" title="BrosseauL , WellsGA , TugwellP , EganM , WilsonKG , DuboulozCJ , et al. Ottawa panel evidence‐based clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia: part 1. Physical Therapy2008;88(7):857‐71. ">Brosseau 2008</a> (a clinical practice guideline), <a href="./references#CD012700-bbs2-0247" title="Garcia‐HermosoA , SaavedraJM , EscalanteY . Effects of exercise on functional aerobic capacity in adults with fibromyalgia syndrome: a systematic review of randomized controlled trials. Journal of Back and Musculoskeletal Rehabilitation2014;28(4):609‐19. ">Garcia‐Hermoso 2014</a> (a systematic review), <a href="./references#CD012700-bbs2-0249" title="HauserW , KloseP , LanghorstJ , MoradiB , SteinbachM , SchiltenwolfM , et al. Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta‐analysis of randomised controlled trials. Arthritis Research &amp; Therapy2010;12(3):R79. ">Hauser 2010</a> (a systematic review), <a href="./references#CD012700-bbs2-0289" title="ThomasEN , BlotmanF . Aerobic exercise in fibromyalgia: a practical review. Rheumatology International2010;30(9):1143‐50. ">Thomas 2010</a> (a practical review), and <a href="./references#CD012700-bbs2-0273" title="NueschE , HauserW , BernardyK , BarthJ , JuniP . Comparative efficacy of pharmacological and non‐pharmacological interventions in fibromyalgia syndrome: network meta‐analysis. Annals of the Rheumatic Disease2013;72(6):955‐62. ">Nuesch 2013</a> (a network meta‐analysis). </p> <p><a href="./references#CD012700-bbs2-0231" title="BrosseauL , WellsGA , TugwellP , EganM , WilsonKG , DuboulozCJ , et al. Ottawa panel evidence‐based clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia: part 1. Physical Therapy2008;88(7):857‐71. ">Brosseau 2008</a> provided clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia and presented evidence on 13 randomized controlled trials (RCTs; we included only four in this review) and three controlled clinical trials evaluating aerobic exercise for fibromyalgia. <a href="./references#CD012700-bbs2-0231" title="BrosseauL , WellsGA , TugwellP , EganM , WilsonKG , DuboulozCJ , et al. Ottawa panel evidence‐based clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia: part 1. Physical Therapy2008;88(7):857‐71. ">Brosseau 2008</a> reviewed trials of aquatics‐based aerobic exercise as well as interventions including mixed types of exercise such as components of muscle strengthening. We excluded these aquatic and mixed interventions from our present review. <a href="./references#CD012700-bbs2-0231" title="BrosseauL , WellsGA , TugwellP , EganM , WilsonKG , DuboulozCJ , et al. Ottawa panel evidence‐based clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia: part 1. Physical Therapy2008;88(7):857‐71. ">Brosseau 2008</a> assessed methodological quality using the Jadad scale and identified six of 16 trials as having high quality and remaining trials as showing low quality. In contrast, we used the Cochrane "Risk of bias" tool to assess methodological quality. In our review, we identified five studies with high risk of performance bias or reporting bias, and we noted low or unclear risks of bias in remaining categories of all studies. <a href="./references#CD012700-bbs2-0231" title="BrosseauL , WellsGA , TugwellP , EganM , WilsonKG , DuboulozCJ , et al. Ottawa panel evidence‐based clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia: part 1. Physical Therapy2008;88(7):857‐71. ">Brosseau 2008</a> identified inconclusive effects of aerobic exercise training alone on symptoms of fibromyalgia including pain and depression. Conversely, <a href="./references#CD012700-bbs2-0231" title="BrosseauL , WellsGA , TugwellP , EganM , WilsonKG , DuboulozCJ , et al. Ottawa panel evidence‐based clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia: part 1. Physical Therapy2008;88(7):857‐71. ">Brosseau 2008</a> identified aerobic exercise training as improving endurance, which in turn greatly improves physical function, even when only low to moderate exercise intensity is achieved. <a href="./references#CD012700-bbs2-0231" title="BrosseauL , WellsGA , TugwellP , EganM , WilsonKG , DuboulozCJ , et al. Ottawa panel evidence‐based clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia: part 1. Physical Therapy2008;88(7):857‐71. ">Brosseau 2008</a> identified challenges in interpreting results due to a diversity of outcome measures and instruments across primary studies. These challenges combined with the diversity of exercise types included in the <a href="./references#CD012700-bbs2-0231" title="BrosseauL , WellsGA , TugwellP , EganM , WilsonKG , DuboulozCJ , et al. Ottawa panel evidence‐based clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia: part 1. Physical Therapy2008;88(7):857‐71. ">Brosseau 2008</a> review prevented pooled analysis. Conversely, in our review, we were able to conduct pooled analyses identifying benefits of aerobic exercise training for health‐related quality of life, pain intensity, fatigue, stiffness, physical function, and submaximal cardiorespiratory function. Overall, both reviews support aerobic exercise training for the management of fibromyalgia. </p> <p><a href="./references#CD012700-bbs2-0249" title="HauserW , KloseP , LanghorstJ , MoradiB , SteinbachM , SchiltenwolfM , et al. Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta‐analysis of randomised controlled trials. Arthritis Research &amp; Therapy2010;12(3):R79. ">Hauser 2010</a> was a systematic review and meta‐analysis that evaluated the efficacy of aerobic exercise in fibromyalgia. Review authors identified 28 RCTs comparing aerobic exercise versus a control, and seven RCTs comparing different types of aerobic exercise. In contrast to our review, these review authors included studies combining aerobics with other physical activities such as muscle strengthening and aquatic‐specific exercise training programs. We included in our review eight studies identified by <a href="./references#CD012700-bbs2-0249" title="HauserW , KloseP , LanghorstJ , MoradiB , SteinbachM , SchiltenwolfM , et al. Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta‐analysis of randomised controlled trials. Arthritis Research &amp; Therapy2010;12(3):R79. ">Hauser 2010</a>. Attrition rates identified by <a href="./references#CD012700-bbs2-0249" title="HauserW , KloseP , LanghorstJ , MoradiB , SteinbachM , SchiltenwolfM , et al. Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta‐analysis of randomised controlled trials. Arthritis Research &amp; Therapy2010;12(3):R79. ">Hauser 2010</a> for combined aerobic and control groups were higher, at 67%, versus our 27.3% overall withdrawal rate. Further, <a href="./references#CD012700-bbs2-0249" title="HauserW , KloseP , LanghorstJ , MoradiB , SteinbachM , SchiltenwolfM , et al. Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta‐analysis of randomised controlled trials. Arthritis Research &amp; Therapy2010;12(3):R79. ">Hauser 2010</a> identified that aerobic exercise training groups had lower rates of intervention program completion when compared with control intervention groups (78% vs 83%). Both reviews identified statistically significant reductions in pain intensity post aerobic exercise training, with effect sizes of standardized mean difference (SMD) ‐0.29 (95% confidence interval (CI) ‐0.46 to ‐0.13), specifically among land‐based aerobic exercise groups (<a href="./references#CD012700-bbs2-0249" title="HauserW , KloseP , LanghorstJ , MoradiB , SteinbachM , SchiltenwolfM , et al. Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta‐analysis of randomised controlled trials. Arthritis Research &amp; Therapy2010;12(3):R79. ">Hauser 2010</a>), whereas we have reported a mean difference (MD) of ‐10.39 on a 100‐point scale (SMD ‐0.48, small effect calculated for comparison). Both reviews identified significant reductions in fatigue and health‐related quality of life. <a href="./references#CD012700-bbs2-0249" title="HauserW , KloseP , LanghorstJ , MoradiB , SteinbachM , SchiltenwolfM , et al. Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta‐analysis of randomised controlled trials. Arthritis Research &amp; Therapy2010;12(3):R79. ">Hauser 2010</a> found that aerobic exercise training programs improved physical fitness, with improvements similar to those noted in our review for submaximal cardiorespiratory function. <a href="./references#CD012700-bbs2-0249" title="HauserW , KloseP , LanghorstJ , MoradiB , SteinbachM , SchiltenwolfM , et al. Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta‐analysis of randomised controlled trials. Arthritis Research &amp; Therapy2010;12(3):R79. ">Hauser 2010</a> identified a need for standardized outcome measures and standardized reporting of adverse events in future research. This important finding is congruent with our results, showing inconsistent and unspecified reporting of adverse events of exercise for this population. </p> <p><a href="./references#CD012700-bbs2-0289" title="ThomasEN , BlotmanF . Aerobic exercise in fibromyalgia: a practical review. Rheumatology International2010;30(9):1143‐50. ">Thomas 2010</a> was a practical review that evaluated aerobic exercise for fibromyalgia. This review included 19 primary articles evaluating land‐ or aquatic‐based exercise and comparing aerobic‐only exercise training versus non‐aerobic exercise training. <a href="./references#CD012700-bbs2-0289" title="ThomasEN , BlotmanF . Aerobic exercise in fibromyalgia: a practical review. Rheumatology International2010;30(9):1143‐50. ">Thomas 2010</a> identified nine RCTs of land‐based exercise groups compared with non‐exercise groups. We included five of these primary articles in our review. We excluded from our review the additional four primary articles identified in <a href="./references#CD012700-bbs2-0289" title="ThomasEN , BlotmanF . Aerobic exercise in fibromyalgia: a practical review. Rheumatology International2010;30(9):1143‐50. ">Thomas 2010</a> because they include strength training in addition to aerobic exercise in the training program. In contrast to our review, <a href="./references#CD012700-bbs2-0289" title="ThomasEN , BlotmanF . Aerobic exercise in fibromyalgia: a practical review. Rheumatology International2010;30(9):1143‐50. ">Thomas 2010</a> did not pool results from studies to identify overall benefits and risks of aerobic exercise, but review authors identified mixed outcomes , with some studies reporting significant improvements in pain, physical function, and aerobic capacity, and others reporting no differences. <a href="./references#CD012700-bbs2-0289" title="ThomasEN , BlotmanF . Aerobic exercise in fibromyalgia: a practical review. Rheumatology International2010;30(9):1143‐50. ">Thomas 2010</a> identified statistically significant improvements in pain with aerobic‐ and land‐based exercise among one of three primary articles, and lack of improvement in fatigue in another article. By contrast, we identified statistically significant effects on pain and fatigue in our review, although these improvements may not be clinically significant. Three of four primary articles in the <a href="./references#CD012700-bbs2-0289" title="ThomasEN , BlotmanF . Aerobic exercise in fibromyalgia: a practical review. Rheumatology International2010;30(9):1143‐50. ">Thomas 2010</a> review found that physical function significantly improved, similar to statistically significant improvements in physical function identified in our review. Three of four primary articles identified by <a href="./references#CD012700-bbs2-0289" title="ThomasEN , BlotmanF . Aerobic exercise in fibromyalgia: a practical review. Rheumatology International2010;30(9):1143‐50. ">Thomas 2010</a> evaluated significant improvements in maximal cardiorespiratory function (CR max) or submaximal cardiorespiratory function (CR submax) with aerobic‐ and land‐based exercise. In our review, we identified significant improvements in CR submax. <a href="./references#CD012700-bbs2-0289" title="ThomasEN , BlotmanF . Aerobic exercise in fibromyalgia: a practical review. Rheumatology International2010;30(9):1143‐50. ">Thomas 2010</a> identified a need for standard outcome measure reporting, adequately sized research investigations, and reporting of adherence in future studies. Similarly, we determined that future investigations should report adverse events associated with aerobic exercise. </p> <p><a href="./references#CD012700-bbs2-0247" title="Garcia‐HermosoA , SaavedraJM , EscalanteY . Effects of exercise on functional aerobic capacity in adults with fibromyalgia syndrome: a systematic review of randomized controlled trials. Journal of Back and Musculoskeletal Rehabilitation2014;28(4):609‐19. ">Garcia‐Hermoso 2014</a> was a systematic review of 13 primary studies published to August 2013 evaluating the effectiveness and structure of exercise programs designed to improve functional capacity in patients with fibromyalgia. This review included four primary studies of aerobic exercise, two of which we included in the current review. We excluded from the current review two additional studies identified by <a href="./references#CD012700-bbs2-0247" title="Garcia‐HermosoA , SaavedraJM , EscalanteY . Effects of exercise on functional aerobic capacity in adults with fibromyalgia syndrome: a systematic review of randomized controlled trials. Journal of Back and Musculoskeletal Rehabilitation2014;28(4):609‐19. ">Garcia‐Hermoso 2014</a> review authors ‐ one because trial used a single group design, and the second because we judged the belly dance intervention to represent mixed exercise (aerobic and resistance training, rather than strictly aerobic training). Both reviews evaluated randomized controlled interventions of aerobic exercise training compared with a control. In contrast to our review, <a href="./references#CD012700-bbs2-0247" title="Garcia‐HermosoA , SaavedraJM , EscalanteY . Effects of exercise on functional aerobic capacity in adults with fibromyalgia syndrome: a systematic review of randomized controlled trials. Journal of Back and Musculoskeletal Rehabilitation2014;28(4):609‐19. ">Garcia‐Hermoso 2014</a> assessed the quality of methods by applying Physiotherapy Evidence Database (PEDro) criteria, rather than the Cochrane "Risk of bias" tool, as was used in our investigation. Our review identified greater diversity of aerobic training program details, with training program length ranging from 6 to 24 weeks, frequency from one to five times per week, duration from 5 to 60 minutes per session, and intensity from light to vigorous, compared with program length of 12 to 24 weeks, frequency of 0.5 to 2 times per week, duration of 45 to 60 minutes per session, and HRmax intensity of 75% to 80% (one study), as identified by <a href="./references#CD012700-bbs2-0247" title="Garcia‐HermosoA , SaavedraJM , EscalanteY . Effects of exercise on functional aerobic capacity in adults with fibromyalgia syndrome: a systematic review of randomized controlled trials. Journal of Back and Musculoskeletal Rehabilitation2014;28(4):609‐19. ">Garcia‐Hermoso 2014</a>. Our findings regarding CR submax are generally consistent with those of <a href="./references#CD012700-bbs2-0247" title="Garcia‐HermosoA , SaavedraJM , EscalanteY . Effects of exercise on functional aerobic capacity in adults with fibromyalgia syndrome: a systematic review of randomized controlled trials. Journal of Back and Musculoskeletal Rehabilitation2014;28(4):609‐19. ">Garcia‐Hermoso 2014</a>. Authors of the <a href="./references#CD012700-bbs2-0247" title="Garcia‐HermosoA , SaavedraJM , EscalanteY . Effects of exercise on functional aerobic capacity in adults with fibromyalgia syndrome: a systematic review of randomized controlled trials. Journal of Back and Musculoskeletal Rehabilitation2014;28(4):609‐19. ">Garcia‐Hermoso 2014</a> review identified a large effect size for benefits of aerobic exercise training in improving CR submax (SMD 0.85, 95% CI 0.57 to 1.12), but we identified an effect estimate of MD 62.81 m on the six‐minute walk test, with 95% CI of 26.19 to 99.44 (moderate; SMD 0.58, 95% CI 0.27 to 0.89, calculated for comparison). Similar to our review, <a href="./references#CD012700-bbs2-0247" title="Garcia‐HermosoA , SaavedraJM , EscalanteY . Effects of exercise on functional aerobic capacity in adults with fibromyalgia syndrome: a systematic review of randomized controlled trials. Journal of Back and Musculoskeletal Rehabilitation2014;28(4):609‐19. ">Garcia‐Hermoso 2014</a> noted that adverse events are not well reported by most investigators. </p> <p><a href="./references#CD012700-bbs2-0273" title="NueschE , HauserW , BernardyK , BarthJ , JuniP . Comparative efficacy of pharmacological and non‐pharmacological interventions in fibromyalgia syndrome: network meta‐analysis. Annals of the Rheumatic Disease2013;72(6):955‐62. ">Nuesch 2013</a> conducted a network meta‐analysis (NMA) evaluating pharmacological and non‐pharmacological interventions for adults with fibromyalgia. NMA is a method used to assess the comparative effectiveness of experimental treatments among similar populations that have not been compared directly in a randomized clinical trial. Unlike the meta‐analysis conducted for this review, which summarized the results of trials that evaluated similar interventions, NMA compares results from two or more studies that have one treatment in common. Nuesch included 33 trials of aerobic exercise as one of the non‐pharmacological interventions evaluated. Both reviews found that aerobic exercise training improved pain intensity, although analysis limited to groups of 50 or more patients within the <a href="./references#CD012700-bbs2-0273" title="NueschE , HauserW , BernardyK , BarthJ , JuniP . Comparative efficacy of pharmacological and non‐pharmacological interventions in fibromyalgia syndrome: network meta‐analysis. Annals of the Rheumatic Disease2013;72(6):955‐62. ">Nuesch 2013</a> review reduced the degree of identified improvements. Both reviews found that aerobic exercise was associated with improvements in health‐related quality of life. In contrast to the <a href="./references#CD012700-bbs2-0273" title="NueschE , HauserW , BernardyK , BarthJ , JuniP . Comparative efficacy of pharmacological and non‐pharmacological interventions in fibromyalgia syndrome: network meta‐analysis. Annals of the Rheumatic Disease2013;72(6):955‐62. ">Nuesch 2013</a> review, we identified significant reductions in fatigue with aerobic exercise for fibromyalgia. Neither our review nor <a href="./references#CD012700-bbs2-0273" title="NueschE , HauserW , BernardyK , BarthJ , JuniP . Comparative efficacy of pharmacological and non‐pharmacological interventions in fibromyalgia syndrome: network meta‐analysis. Annals of the Rheumatic Disease2013;72(6):955‐62. ">Nuesch 2013</a> could identify clinically relevant differences of pain intensity or fatigue outcome measures. Consistent with our findings, <a href="./references#CD012700-bbs2-0273" title="NueschE , HauserW , BernardyK , BarthJ , JuniP . Comparative efficacy of pharmacological and non‐pharmacological interventions in fibromyalgia syndrome: network meta‐analysis. Annals of the Rheumatic Disease2013;72(6):955‐62. ">Nuesch 2013</a> identified a need for large‐scale studies of high methodological quality to compare interventions of aerobic exercise for this population. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012700-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD012700-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/full#CD012700-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies." data-id="CD012700-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/full#CD012700-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgments about each risk of bias item for each included study." data-id="CD012700-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgments about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/full#CD012700-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 AE versus control (end of intervention), Outcome 1 HRQL, FIQ Total, 0‐100, lower is best." data-id="CD012700-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 AE versus control (end of intervention), Outcome 1 HRQL, FIQ Total, 0‐100, lower is best. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 AE versus control (end of intervention), Outcome 2 HRQL, sensitivity.selection bias." data-id="CD012700-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 AE versus control (end of intervention), Outcome 2 HRQL, sensitivity.selection bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 AE versus control (end of intervention), Outcome 3 Pain, intensity, 0‐100, lower is best." data-id="CD012700-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 AE versus control (end of intervention), Outcome 3 Pain, intensity, 0‐100, lower is best. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 AE versus control (end of intervention), Outcome 4 Pain, sensitivity.selection bias." data-id="CD012700-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 AE versus control (end of intervention), Outcome 4 Pain, sensitivity.selection bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 AE versus control (end of intervention), Outcome 5 Pain, sensitivity, attrition bias." data-id="CD012700-fig-0008" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 AE versus control (end of intervention), Outcome 5 Pain, sensitivity, attrition bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 AE versus control (end of intervention), Outcome 6 Fatigue, 0‐100 mm, lower is best." data-id="CD012700-fig-0009" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 AE versus control (end of intervention), Outcome 6 Fatigue, 0‐100 mm, lower is best. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 AE versus control (end of intervention), Outcome 7 Stiffness, 0‐100 mm, lower is best." data-id="CD012700-fig-0010" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 AE versus control (end of intervention), Outcome 7 Stiffness, 0‐100 mm, lower is best. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 AE versus control (end of intervention), Outcome 8 Physical Ftn, 0‐100 mm, lower is best." data-id="CD012700-fig-0011" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 AE versus control (end of intervention), Outcome 8 Physical Ftn, 0‐100 mm, lower is best. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 AE versus control (end of intervention), Outcome 9 Withdrawals." data-id="CD012700-fig-0012" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 AE versus control (end of intervention), Outcome 9 Withdrawals.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 AE versus control (end of intervention), Outcome 10 CR max, VO2max, mL/kg/min." data-id="CD012700-fig-0013" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 AE versus control (end of intervention), Outcome 10 CR max, VO<sub>2</sub>max, mL/kg/min. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 AE versus control (end of intervention), Outcome 11 CR submax, 6MWT (distance ‐ meters, higher is best)." data-id="CD012700-fig-0014" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 AE versus control (end of intervention), Outcome 11 CR submax, 6MWT (distance ‐ meters, higher is best). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 AE versus control (long term), Outcome 1 HRQL, 0‐100, lower is best." data-id="CD012700-fig-0015" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 AE versus control (long term), Outcome 1 HRQL, 0‐100, lower is best.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 AE versus control (long term), Outcome 2 Pain intensity, 0‐100, lower is best." data-id="CD012700-fig-0016" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 AE versus control (long term), Outcome 2 Pain intensity, 0‐100, lower is best. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 AE versus control (long term), Outcome 3 Fatigue, 0‐100, lower is best." data-id="CD012700-fig-0017" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 AE versus control (long term), Outcome 3 Fatigue, 0‐100, lower is best.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 AE versus control (long term), Outcome 4 Physical Ftn, 0‐100, lower is best." data-id="CD012700-fig-0018" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 AE versus control (long term), Outcome 4 Physical Ftn, 0‐100, lower is best. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 AE versus control (long term), Outcome 5 Withdrawals." data-id="CD012700-fig-0019" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 AE versus control (long term), Outcome 5 Withdrawals.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 AE versus control (long term), Outcome 6 CR max, work capacity (W)." data-id="CD012700-fig-0020" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 AE versus control (long term), Outcome 6 CR max, work capacity (W).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 AE versus control (long term), Outcome 7 CR submax, 6MWT (meters, higher is best)." data-id="CD012700-fig-0021" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 AE versus control (long term), Outcome 7 CR submax, 6MWT (meters, higher is best). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 AE versus AE (end of intervention), Outcome 1 HRQL, 0‐100, lower is best." data-id="CD012700-fig-0022" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 AE versus AE (end of intervention), Outcome 1 HRQL, 0‐100, lower is best.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 AE versus AE (end of intervention), Outcome 2 Pain intensity, 0‐100, lower is best." data-id="CD012700-fig-0023" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 AE versus AE (end of intervention), Outcome 2 Pain intensity, 0‐100, lower is best. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 AE versus AE (end of intervention), Outcome 3 Fatigue, 0‐100, lower is best." data-id="CD012700-fig-0024" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 AE versus AE (end of intervention), Outcome 3 Fatigue, 0‐100, lower is best. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 AE versus AE (end of intervention), Outcome 4 Stiffness, 0‐100, lower is best." data-id="CD012700-fig-0025" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 AE versus AE (end of intervention), Outcome 4 Stiffness, 0‐100, lower is best. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 AE versus AE (end of intervention), Outcome 5 Physical Ftn, 0‐100, lower is best." data-id="CD012700-fig-0026" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 AE versus AE (end of intervention), Outcome 5 Physical Ftn, 0‐100, lower is best. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 AE versus AE (end of intervention), Outcome 6 Withdrawals." data-id="CD012700-fig-0027" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 AE versus AE (end of intervention), Outcome 6 Withdrawals.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 AE versus AE (end of intervention), Outcome 7 CR max, VO2max, mL/kg/min." data-id="CD012700-fig-0028" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 AE versus AE (end of intervention), Outcome 7 CR max, VO<sub>2</sub>max, mL/kg/min. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 AE versus AE (end of intervention), Outcome 8 CR submax, 6MWT (distance ‐ meters, higher is best)." data-id="CD012700-fig-0029" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 AE versus AE (end of intervention), Outcome 8 CR submax, 6MWT (distance ‐ meters, higher is best). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 AE versus other (end of intervention), Outcome 1 HRQL, 0‐100, lower is best." data-id="CD012700-fig-0030" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 AE versus other (end of intervention), Outcome 1 HRQL, 0‐100, lower is best. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 AE versus other (end of intervention), Outcome 2 Pain intensity, 0‐100, lower is best." data-id="CD012700-fig-0031" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 AE versus other (end of intervention), Outcome 2 Pain intensity, 0‐100, lower is best. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 AE versus other (end of intervention), Outcome 3 Fatigue, 0‐100, lower is best." data-id="CD012700-fig-0032" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 AE versus other (end of intervention), Outcome 3 Fatigue, 0‐100, lower is best. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 AE versus other (end of intervention), Outcome 4 Withdrawals." data-id="CD012700-fig-0033" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 AE versus other (end of intervention), Outcome 4 Withdrawals.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 AE versus other (end of intervention), Outcome 5 CR max, work capacity (w)." data-id="CD012700-fig-0034" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 AE versus other (end of intervention), Outcome 5 CR max, work capacity (w). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012700-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/urn:x-wiley:14651858:media:CD012700:CD012700-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_t/tCD012700-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 AE versus other (end of intervention), Outcome 6 CR submax, 6 MWT(distance ‐ meters, higher is best)." data-id="CD012700-fig-0035" src="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 AE versus other (end of intervention), Outcome 6 CR submax, 6 MWT(distance ‐ meters, higher is best). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012700/media/CDSR/CD012700/image_n/nCD012700-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012700-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Aerobic exercise training compared with control for fibromyalgia</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Aerobic exercise training compared with control for fibromyalgia</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> individuals with fibromyalgia<br/> <b>Settings:</b> group and supervised<br/> <b>Intervention:</b> aerobic exercise training<br/> <b>Comparison:</b> control comparison (treatment as usual, wait list control, continuation of daily activities including physical activity) </p> <p><b>Outcome:</b> measured at the end of the intervention </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Aerobic exercise training</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Health‐related quality of life</b> <br/> FIQ Total. Scale from 0 to 100 (0 is best)<br/> Follow‐up: 12‐24 weeks<sup>a</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean health‐related quality of life ranged across control groups from<br/> <b>54 to 63.7 units</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean health‐related quality of life in the intervention groups was<br/> <b>7.89 lower</b> <br/> (13.23 to 2.55 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>372</p> <p>(5 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute change</p> <p>8% (3% to 13%) better</p> <p>Relative change<sup>c</sup> 15% (5% to 24%) better </p> <p>NNTB 6 (4 to 16)<sup>d</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain intensity</b> <br/> Visual analogue scale </p> <p>Scale from 0 to 100 mm (0 is best)<br/> Follow‐up: 6‐24 weeks<sup>e</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean pain intensity ranged across control groups from<br/> <b>56 to 80.5 mm</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean pain intensity in the intervention groups was<br/> <b>11.06 lower</b> <br/> (18.34 to 3.77 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>351<br/> (6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>b,f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute change</p> <p>11% (4% to 18%) better</p> <p>Relative change<sup>c</sup> 18% (7% to 30%) better </p> <p>NNTB 4 (2 to 15)<sup>d</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Fatigue</b> <br/> Visual analogue scale </p> <p>Scale from 0 to 100 mm (0 is best)<br/> Follow‐up: 14‐24 weeks<sup>g</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean fatigue ranged across control groups from<br/> <b>62.3 to 72 mm</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean fatigue in the intervention groups was</p> <p><b>6.06 lower</b> </p> <p>(‐12.41 lower to 0.30 higher)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>246<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>b,h</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute difference</p> <p>6% improvement (12% improvement to 0.3% worse)</p> <p>Relative change<sup>c</sup> 8% improvement (16% improved to </p> <p>0.4% worse)</p> <p>NNTB n/a</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Stiffness</b> <br/> FIQ Scale from 0 to 100 mm (lower scores mean less stiffness) </p> <p>Follow‐up: 16 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean stiffness in control groups was<br/> <b>69 mm</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean stiffness in the intervention groups was<br/> <b>7.96 lower</b> <br/> (14.95 to 0.97 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>143<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>b,i</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute difference</p> <p>8% (1% to 15%) improvement</p> <p>Relative change<sup>c</sup> 11% improvement (1% to 21% improved) </p> <p>NNTB 6 (3 to 218)<sup>d</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Physical function</b> <br/> FIQ and SF‐36 converted, 0 to 100 scale (0 is best)<br/> Follow‐up: 8‐24 weeks<sup>j</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean physical function ranged across control groups from<br/> <b>6 to 22 units</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean physical function in the intervention groups was <b>10.16 lower</b> </p> <p>(15.39 to 4.94 lower)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>246<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>b,h</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute change</p> <p>10% (95% CI 15 to 5) improvement</p> <p>Relative change<sup>c</sup> 21.9% (95% CI 33.2 to 10.7) </p> <p>improvement</p> <p>NNTB 5 (3 to 13)<sup>d</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Withdrawals</b> <br/> All‐cause attrition<br/> Follow‐up: 6‐24 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>17 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>20 per 100</b> <br/> (14 to 25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.25</b> </p> <p>(0.89 to 1.77)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>456<br/> (8 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute change: 5% more withdrawals with exercise (3% fewer to 12% more)</p> <p>Relative change 25% more (11% fewer to 77% more)</p> <p>NNTH n/a</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> <p>Descriptive information</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>"the present study findings confirm earlier studies that have shown aerobic exercise to reduce tender point tenderness, increase work capacity without adverse side effects..." (<a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>; pages 83‐84). The following statements show some minor adverse events following aerobic exercise training: "...unable to exercise after an injury" (<a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>; pages 1840), but it is unclear whether the injury was related to intervention participation: "One participant assigned to the short bout exercise withdrew after developing a metatarsal stress fracture" (<a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>; page 347) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> CI: confidence interval; NNTB: number needed to treat for an additional beneficial outcome; NNTH: number needed to treat for an additional harmful outcome; RR: risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Study author (intervention length in weeks): <a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a> (12), <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a> and <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a> (16), <a href="./references#CD012700-bbs2-0003" title="GowansSE , deHueckA , VossS , SilajA , AbbeySE . Six‐month and one‐year follow up of 23 weeks of aerobic exercise for individuals with fibromyalgia. Arthritis Care &amp; Research2004;51(6):890‐8. GowansSE , deHueckA , VossS , SilajA , AbbeySE , ReynoldsWJ . Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Care &amp; Research2001;45(6):519‐29. ">Gowans 2001</a> (23), <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a> (24)<br/> <sup>b</sup>Downgraded because of lack of blinding (performance and detection bias)<br/> <sup>c</sup>Relative change calculation as per Cochrane Musculoskeletal Review Group procedures: mean difference (MD)/pooled control group baseline means<br/> <sup>d</sup>Number needed to treat for an additional beneficial outcome (NNTB): NNTB for continuous outcomes calculated using the Wells calculator (from the CMSG Editorial office; http://musculoskeletal.cochrane.org/) for statistically significant outcomes only. Mean and standard deviation (SD) for the control group at baseline taken from <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a> (health‐related quality of life 55 (1.3), pain 61 (1.97), stifness 7 (1.9), and physical function 38 (1.86)<br/> <sup>e</sup>Study author (intervention length in weeks): <a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a> (6), <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a> (14), <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a> and <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a> (16), <a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a> (20), <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a> (24)<br/> <sup>f</sup>Downgraded for imprecision, wide confidence intervals, issues related to selective reporting (ie, <a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a> and/or <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>)<br/> <sup>g</sup>Study author (intervention length in weeks): <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a> (14), <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a> and <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a> (16), <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a> (24)<br/> <sup>h</sup>Downgraded for imprecision<br/> <sup>i</sup>One study </p> <p><sup>j</sup>Study author (intervention length in weeks): <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a> (14), <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a> and <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a> (16), <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a> (24) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Aerobic exercise training compared with control for fibromyalgia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012700/full#CD012700-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012700-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Glossary of terms</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Term</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Definition</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Agonist‐antagonist muscle contraction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Agonist muscles and antagonist muscles refer to muscles that cause or inhibit movement. Agonist muscles cause movement to occur through their own contraction, and antagonist muscles oppose a specific movement, for example, biceps (agonist) and triceps (antagonist) muscles </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Amitriptyline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A widely use tricyclic antidepressant medication; it is used to treat several mental illnesses/disorders such as major depression, anxiety, psychosis, bipolar disorder, etc. Other uses include prevention of neuropathic pain such as fibromyalgia </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Biomarker</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>In medicine, "biomarker" is a term that is often used to refer to measurable characteristics that reflect the severity or presence of some disease state. It is often an indicator of a particular disease state or some other psychological state of an organism </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiorespiratory fitness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The ability of the circulatory and respiratory systems to supply oxygen to muscles during sustained physical activity </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cognitive‐behavioral therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A form of therapy in which the goal is to diminish symptoms by correcting distorted thinking based on negative self‐perceptions and expectations </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Concomitant</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Existing or concurring with something else</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Detraining</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Losing physical and health effects gained during exercise training by stopping exercise</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Exercise</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physical activity that is planned, structured, and repetitive, and [that] has as a final or intermediate objective of improvement or maintenance of physical fitness (<a href="./references#CD012700-bbs2-0246" title="GarberCE , BlissmerB , DeschenesMR , FranklinBA , LamonteMJ , LeeIM , et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Medicine &amp; Science in Sports Exercise2011;43(7):1334‐59. ">Garber 2011</a>) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Exercise training</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Program that is designed to meet individual health and physical fitness goals; a single exercise session should include warm‐up, stretching, conditioning, and cool‐down components. The rate of progression depends on the individual's health status and exercise tolerance </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Genetic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Considered a field of biology, genetics is the study of genes within living organisms; pertaining or according to genetics </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heart rate reserve (HRR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Difference between resting heart rate (HRrest) and maximum heart rate (HRmax). Heart rate reserve is used to determine exercise heart rates </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hormones</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Any of various internally secreted compounds, such as insulin or thyroxine, formed in endocrine glands that affect the functions of specifically receptive organs or tissues when transported to them by body fluids </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Inflammatory</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathology of or caused by inflammation; biological response of body tissues to harmful stimuli such as irritants, damaged cells, or pathogens </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maximal aerobic performance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maximum rate of oxygen consumption as measured during incremental exercise</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maximum heart rate (HRmax)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The highest number of beats per minute your heart can reach during maximum physical exertion. This rate is individual and depends on hereditary factors and age </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Microtrauma</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trauma to muscle cells</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Milnacipran</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A serotonin‐norepinephrine reuptake inhibitor</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Min × d<sup>−1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Minutes per day</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Monoamine oxidase inhibitors</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>An oxidoreductase inhibitor of a single amino group neurotransmitter</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Muscle strength</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A physical test of the amount of force a muscle can generate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neurotransmitters</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Any of several chemical substances, such as epinephrine or acetylcholine, that transmit nerve impulses across a synapse to a postsynaptic element, such as another nerve, muscle, or gland </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Non‐pharmacological</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment that does not include medication</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>OMERACT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>OMERACT (Outcome Measures in Rheumatology) is an independent initiative of international health professionals interested in outcome measures in rheumatology. Over the past 20 years, OMERACT has served a critical role in the development and validation of clinical and radiographic outcome measures in rheumatoid arthritis, osteoarthritis, psoriatic arthritis, fibromyalgia, and other rheumatic diseases (www.omeract.org). OMERACT is linked to the Cochrane Collaboration Musculoskeletal Review Group, where outcomes endorsed by OMERACT are recommended for use in Cochrane Systematic Reviews </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathophysiology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The physiology of abnormal or diseased organisms or their parts</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Perceived exertion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Amount of effort that is perceived by someone, usually rated on a scale of 6 to 20 or 1 to 10 </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physical activity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Any bodily movement produced by skeletal muscles that results in energy expenditure above resting (basal) levels. Physical activity broadly encompasses exercise, sports, and physical activities done as part of daily living, occupation, leisure, and active transportation (<a href="./references#CD012700-bbs2-0246" title="GarberCE , BlissmerB , DeschenesMR , FranklinBA , LamonteMJ , LeeIM , et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Medicine &amp; Science in Sports Exercise2011;43(7):1334‐59. ">Garber 2011</a>) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physical fitness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ability to carry out daily tasks with vigor and alertness, without undue fatigue and with ample energy to enjoy (leisure) pursuits and to meet unforeseen emergencies. Physical fitness is operationalized as "[a set of] measurable health and skill‐related attributes" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physical function</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The capacity of an individual to carry out physical activities of daily living. Physical function reflects motor function and control, physical fitness, and habitual physical activity and is an independent predictor of functional independence, disability, and morbidity </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physiology</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Branch of biology dealing with the functions and activities of living organisms and their parts, including all physical and chemical processes </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Predicted maximum heart rate (HRmax‐p)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HRmax‐p is a score equivalent to maximum heart rate (HRmax). HRmax‐p may provide a way to define training intensities as percentages of maximum heart rate and to follow maximum heart rate changes due to training without an exhaustive maximal stress test </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pregabalin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>An antiepileptic medication</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prevalence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rate of occurrence of a condition, usually expressed on a per‐year basis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Skewness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not every distribution of data is symmetrical ‐ sets of data that are not symmetrical are said to be "asymmetrical." The measure of how asymmetrical a distribution can be is called "skewness" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sleep disturbance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A score derived from a questionnaire that measures sleep quantity and quality. The Medical Outcomes Survey Sleep Scale measures 6 dimensions of sleep (initiation, staying asleep, quantity, adequacy, drowsiness, shortness of breath, snoring) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Somatic comorbidities</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Conditions of the body related to a disease</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Symptoms</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Patients' perceptions of an "abnormal" physical, emotional, or cognitive state</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tenderness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain evoked by tactile pressure</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Glossary of terms</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012700/full#CD012700-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012700-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Classification of exercise intensity (Garber, 2011)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intensity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>%VO<sub>2</sub> reserve/% HR reserve</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>% HRmax</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Perceived exertion scale (RPE) 6 to 20</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very light</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RPE &lt; 9</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Light</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37 to 45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>57 to 63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RPE 9 (very light) to 11 (fairly light)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46 to 63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64 to 76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RPE 12 (fairly light) to 13 (somewhat hard)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vigorous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64 to 90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77 to 95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RRE 14 (somewhat hard to 17 (very hard)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Near maximal to maximal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≥ 96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RPE ≥ 18 (very hard)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>HR: heart rate; RPE: rating of perceived exertion; VO<sub>2</sub>: oxygen consumption </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Classification of exercise intensity (Garber, 2011)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012700/full#CD012700-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012700-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Outcome measures used in included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Name of Instrument or index/subscale</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Health‐related quality of life</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FIQ Total (0‐100)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain intensity/interference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Current pain (VAS), FIQ pain (VAS), SF‐36 bodily pain (interference)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fatigue</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VAS (0‐100), FIQ fatigue (0‐100), SF‐36 vitality (0‐100), Fatigue Severity Scale (9‐63), Multidimensional Fatigue Inventory (4‐20) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Stiffness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FIQ stiffness</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physical function</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SF‐36 physical functioning (0‐100), FIQ physical function (0‐100), Sickness Impact Profile (0‐68), Health Assessment Questionnaire (HAQ) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maximal cardiorespiratory function</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oxygen uptake (VO<sub>2</sub>max), maximum work capacity (w) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Submaximal cardiorespiratory function</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6‐minute walk test (distance in meters), Astrand submaximal cycle ergometer test (heart rate at a steady state workload) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not a standardized instrument or index/narrative information</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>FIQ: Fibromyalgia Impact Questionnaire; HAQ: Health Assessment Questionnaire; SF‐36: Short Form 36; VAS: visual analogue scale; VO<sub>2</sub>max: maximal oxygen uptake </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Outcome measures used in included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012700/full#CD012700-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012700-tbl-0005"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">FITT parameters</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Author, year, intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b> Frequency, times per week – length in weeks</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Intensity/ACSM intensity classification</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Time/Duration/Session, minutes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Type/Mode</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Aerobic vs control</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0003" title="GowansSE , deHueckA , VossS , SilajA , AbbeySE . Six‐month and one‐year follow up of 23 weeks of aerobic exercise for individuals with fibromyalgia. Arthritis Care &amp; Research2004;51(6):890‐8. GowansSE , deHueckA , VossS , SilajA , AbbeySE , ReynoldsWJ . Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Care &amp; Research2001;45(6):519‐29. ">Gowans 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60%‐75% age‐adjusted HRmax<br/> ACSM: low to moderate </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30'</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised water walking/running progressing to land walking/running</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40%‐50% HRR at week 1 to 60%‐70% HRR by week 16<br/> ACSM: moderate at week 1 to vigorous by week 16 </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>˜ 60'</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised indoor or outdoor walking</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60%‐75% predicted HRmax<br/> ACSM: light to moderate </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Starting duration 10 to 15' progressing to 20 to 40'</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised walking, aquacise (deep and shallow water), or low‐impact aerobics</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>120‐150 beats per minute</p> <p>ACSM: moderate to vigorous</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60'</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised low‐impact aerobic dance program</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0008" title="NicholsDS , GlennTM . Effects of aerobic exercise on pain perception, affect, and level of disability in individuals with fibromyalgia. Physical Therapy1994;74:327‐32. ">Nichols 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60%‐70% predicted HRmax/age</p> <p>ACSM: light to moderate</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised fast‐paced walking on an indoor track</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60%‐65% HRmax (steady state aerobics) and 75%‐80% HRmax (interval training)</p> <p>ACSM: light to moderate and moderate to vigorous</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45‐60’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised aerobics including continuous walking with arm movements and jogging; interval training including aerobic dance and jogging </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a> Short bout </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 to 5 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40%‐50% HRR at week 1, 60%‐70% HRR by week 10</p> <p>ACSM: moderate at week 1, vigorous by week 10</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2/d, 5' at week 1 to 15'<br/> at week 9 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Home program of low‐impact aerobics to videotaped instructor and music, rhythmical movements of lower body muscles. Supervision at 0, 4, 8, and 12 weeks </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a> </p> <p>Long bout</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 to 5 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40%‐50% HRR at week 1, 60%‐70% HRR by week 10</p> <p>ACSM: moderate at week 1; vigorous by week 10</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10' at week 1 to 30'<br/> at week 9 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Home program of low‐impact aerobics to videotaped instructor and music, rhythmical movements of lower body muscles. Supervision at 0, 4, 8, and 12 weeks </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a> Aerobic exercise </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not specified</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cycle ergometry. Supervision unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tempo gradually increased up to, and decreased down from, 4 periods of 60%‐70% HRmax</p> <p>ACSM: light to moderate</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised movement to music and games</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Aerobic vs aerobic2</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0006" title="MannerkorpiK , NordemanL , CiderA , JonssonG . Does moderate‐to‐high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial. Arthritis Research &amp; Therapy2010;12(5):R189. ">Mannerkorpi 2010</a> AE: Nordic walking </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10’ at RPE 9‐11 2' intervals of RPE 13‐15, alternated with 2' at RPE 10 to 11</p> <p>ACSM: 10’ light, 2’ intervals moderate to vigorous alternated with 2’ light.</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised walking in parks and forests with flat areas and small hills</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0006" title="MannerkorpiK , NordemanL , CiderA , JonssonG . Does moderate‐to‐high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial. Arthritis Research &amp; Therapy2010;12(5):R189. ">Mannerkorpi 2010</a> </p> <p>AE2: low‐intensity walking</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 time/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RPE 9 to 11<br/> ACSM: light </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised walking in parks and forests with flat areas and small hills</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a>. </p> <p>AE: exercise class</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 time/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not specified</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised graded circuit exercises consisting of step‐ups, sitting to standing, skipping, jogging on the spot, alternate side bends, circling arms with increasing weights, plus encouragement to continue and increase exercises at home </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a> </p> <p>AE2: single class</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 session</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not specified</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Demonstration of aerobic exercises, stretching and relaxation technique, plus written advice on aerobic exercises plus stretching and relaxation </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a>: AE: short bout </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 to 5/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40%‐50% HRR at week 1, 60%‐70% HRR by week 10<br/> ACSM: moderate at week 1, vigorous by weeks 10‐16 </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2/d 5' up to 15'</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Home program of low‐impact aerobics to videotaped instructor and music, rhythmical movements of lower body muscles. Supervision at 0, 4, 8, and 12 weeks </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a> </p> <p>AE2: long bout</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 to 5/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40%‐50% HRR at week 1, 60%‐70% HRR by week 10</p> <p>ACSM: moderate at week 1, vigorous by weeks 10‐16</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10' up to 30'</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Home program of low‐impact aerobics to videotaped instructor and music, rhythmical movements of lower body muscles. Supervision at 0, 4, 8, and 12 weeks </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Aerobic vs other (education or stress management training)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0001" title="FontaineKR , HaasS . Effects of lifestyle physical activity on health status, pain, and function in adults with fibromyalgia syndrome. Journal of Musculoskeletal Pain2007;15(1):3‐9. ">Fontaine 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group session every 2 weeks AE: 5‐7 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moderate intensity</p> <p>ACSM: moderate<br/> Review authors used appropriate references to help translate "moderate" into action </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10’ and increase daily 5’/wk to at least 30’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Brisk walking and other modes of aerobic activity (+ group session/supervision)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0002" title="FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity in adults with fibromyalgia: results at follow‐up. Journal of Clinical Rheumatology2011;17(2):64‐8. FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Research Therapy2010;12(2):R55. ">Fontaine 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5‐7 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moderate (breathing heavily but able to keep a conversation) + 15’ of above usual level </p> <p>ACSM: moderate</p> <p>Review authors used appropriate references to help translate "moderate" into action</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Walking (the most common form of LPA) and other forms (eg, garden/mowing the lawn); household activity (eg, vacuuming); and sports activity (eg, cycling, swimming, field hockey) (+ group sessions/supervision) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60%‐75% predicted HRmax</p> <p>ACSM: light to moderate</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Starting duration 10 to 15' progressing to 20 to 40'</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised walking, aquacise (deep and shallow water), or low‐impact aerobics</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not specified</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cycle ergometry. Supervision unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 times/wk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tempo gradually increased up to, and decreased down from, 4 periods at 60%‐70% HRmax ACSM: light to moderate </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supervised movement to music and games</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p>ACSM: American College of Sports Medicine; AE: aerobic exercise; FITT: frequency, intensity, time, and type of training; HRmax: maximum heart rate; HRR: heart rate reserve; RPE: rating of perceived exertion </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">FITT parameters</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012700/full#CD012700-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012700-tbl-0006"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Congruence with ACSM aerobic criteria for healthy adults</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Met ACSM criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Did not meet ACSM criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Not enough information to judge</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0001" title="FontaineKR , HaasS . Effects of lifestyle physical activity on health status, pain, and function in adults with fibromyalgia syndrome. Journal of Musculoskeletal Pain2007;15(1):3‐9. ">Fontaine 2007</a>; <a href="./references#CD012700-bbs2-0002" title="FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity in adults with fibromyalgia: results at follow‐up. Journal of Clinical Rheumatology2011;17(2):64‐8. FontaineKR , ConnL , ClauwDJ . Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Research Therapy2010;12(2):R55. ">Fontaine 2010</a>; <a href="./references#CD012700-bbs2-0004" title="KayoAH , PeccinMS , SanchesCM , TrevisaniVF . Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatology International2011;32(8):2285‐92. ">Kayo 2011</a>; <a href="./references#CD012700-bbs2-0011" title="SchachterCL , BuschAJ , PelosoP , SheppardMS . The effects of short vs long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Physical Therapy2003;83(4):340‐58. ">Schachter 2003</a> met ACSM guidelines for healthy adults. <a href="./references#CD012700-bbs2-0003" title="GowansSE , deHueckA , VossS , SilajA , AbbeySE . Six‐month and one‐year follow up of 23 weeks of aerobic exercise for individuals with fibromyalgia. Arthritis Care &amp; Research2004;51(6):890‐8. GowansSE , deHueckA , VossS , SilajA , AbbeySE , ReynoldsWJ . Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Care &amp; Research2001;45(6):519‐29. ">Gowans 2001</a> met ACSM criteria for individuals who are sedentary/have no habitual activity/are extremely deconditioned </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a>: based on frequency and duration (only 3/wk, light to moderate); <a href="./references#CD012700-bbs2-0006" title="MannerkorpiK , NordemanL , CiderA , JonssonG . Does moderate‐to‐high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial. Arthritis Research &amp; Therapy2010;12(5):R189. ">Mannerkorpi 2010</a>: based on frequency and duration (only twice or once a week with 20' session duration); <a href="./references#CD012700-bbs2-0007" title="MengshoelAM , ForreO . Physical fitness training in patients with fibromyalgia. Musculoskeletal Pain1993;1(4):267‐72. MengshoelAM , KomnaesHB , ForreO . The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clinical &amp; Experimental Rheumatology1992;10(4):345‐9. ">Mengshoel 1992</a>: based on frequency of 2 times/wk; <a href="./references#CD012700-bbs2-0008" title="NicholsDS , GlennTM . Effects of aerobic exercise on pain perception, affect, and level of disability in individuals with fibromyalgia. Physical Therapy1994;74:327‐32. ">Nichols 1994</a>: based on frequency and duration (only twice a week); <a href="./references#CD012700-bbs2-0009" title="RamsayC , MorelandJ , HoM , JoyceS , WalkerS , PullarT . An observer‐blinded comparison of supervised and unsupervised aerobic exercise regimens in fibromyalgia. Rheumatology (Oxford)2000;39(5):501‐5. ">Ramsay 2000</a>: based on frequency (only once a week); <a href="./references#CD012700-bbs2-0010" title="SanudoB , GalianoD , CarrascoL , BlagojevicM , deHoyoM , SaxtonJ . Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation2010;91(12):1838‐43. ">Sanudo 2010</a>: based on frequency (only twice a week) for aerobics; <a href="./references#CD012700-bbs2-0013" title="FinsetA , WigersSH , GotestamKG . Depressed mood impedes pain treatment response in patients with fibromyalgia. Journal of Rheumatology2004;31(5):976‐80. WigersSH , StilesTC , VogelPA . Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scandinavian Journal of Rheumatology1996;25(2):77‐86. ">Wigers 1996</a>: intensity too low, duration too short (only 18‐20’ at HR 60%‐70%) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012700-bbs2-0012" title="SencanS , AkS , KaranA , MuslumanogluL , OzcanE , BerkerE . A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. Journal of Back &amp; Musculoskeletal Rehabilitation2004;17(2):57‐61. ">Sencan 2004</a> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>ACSM: American College of Sports Medicine; HR: heart rate</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Congruence with ACSM aerobic criteria for healthy adults</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012700/full#CD012700-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012700-tbl-0007"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Sensitivity analyses: aerobics versus control</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All studies</b> </p> <p><b>MD (95% CI), number of studies (participants), I<sup>2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Low risk of selection bias</b> </p> <p><b>MD (95% CI), number of studies (participants), I<sup>2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Low risk of attrition bias</b> </p> <p><b>MD (95% CI), number of studies (participants), I<sup>2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Detection bias</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HRQL</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐7.89 (‐13.23 to ‐2.55), 5 studies (372), I<sup>2</sup>= 58% </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐10.47 (‐20.79 to ‐0.15), 3 studies (246), I<sup>2</sup> = 77% </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 20% was not present ‐ this sensitivity analysis was not conducted</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitivity analysis not conducted</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐11.06 (‐18.34 to ‐3.77), 6 studies (351), I<sup>2</sup>= 59% </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐8.38 (‐17.88 to 1.12), 3 studies (246), I<sup>2</sup> = 59% </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐11.71 (‐19.93 to ‐3.50), 5 studies (326), I<sup>2</sup> = 66% </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitivity analysis not conducted</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>CI: confidence interval; HRQL: health‐related quality of life; MD: mean difference</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Sensitivity analyses: aerobics versus control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012700/full#CD012700-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012700-tbl-0008"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Quality of evidence ‐ GRADE assessment: long‐term effects of AE versus control comparison</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Quality assessment</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Number of participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Importance</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study design</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk of bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Inconsistency</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Indirectness</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Imprecision</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Other comments</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>AE only</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>HRQL</b> (follow‐up 12 weeks after end of intervention; assessed with 0‐100 scale, lower is best) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CRITICAL</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Pain intensity</b> (follow‐up 12 weeks after end of intervention to 4 years; assessed with 0‐100 scale, lower is best) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CRITICAL</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Fatigue</b> (follow‐up from 12 weeks after end of intervention to 4 years; assessed with 0‐100 scale, lower is best) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IMPORTANT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Stiffness</b>: not measured </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Physical function</b> (follow‐up at 12 weeks after end of intervention; assessed with 0‐100 scale, lower is best) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>One study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IMPORTANT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>All‐cause withdrawal</b> (follow‐up from 12 weeks after end of intervention to 4 years) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22/92 (23.9%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25/84 (29.8%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IMPORTANT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Adverse events</b>: not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> <tfoot> <tr> <td colspan="11"> <div class="table-footnote"> <p><sup>a</sup>Issues with allocation, detection, performance, selective reporting, and other biases </p> <p><sup>b</sup>Considerable heterogeneity in results (I<sup>2</sup> = 80%) </p> <p><sup>c</sup>Number of participants lower than 400 rule of thumb, wide confidence interval </p> <p><sup>d</sup>Issues related to detection bias, performance bias, and selective reporting </p> <p>AE: aerobic exercise; HRQL: health‐related quality of life</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Quality of evidence ‐ GRADE assessment: long‐term effects of AE versus control comparison</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012700/full#CD012700-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012700-tbl-0009"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Quality of evidence ‐ GRADE assessment: AE intervention versus another AE intervention</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Quality assessment</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Number of participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Importance</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study design</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk of bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Inconsistency</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Indirectness</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Imprecision</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Other considerations</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>AE intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>AE control</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>HRQL</b>, 0‐100, lower is best </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Studies not pooled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CRITICAL</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Pain intensity</b>, 0‐100, lower is best </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Studies not pooled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CRITICAL</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Fatigue,</b> 0‐100, lower is best </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Studies not pooled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IMPORTANT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Stiffness,</b> 0‐100, lower is best </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>One study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IMPORTANT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Physical function</b>, 0‐100, lower is best </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IMPORTANT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>All‐cause withdrawals</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20/85 (23.5%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25/89 (28.1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IMPORTANT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Adverse events</b>: not reported </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="11"> <div class="table-footnote"> <p><sup>a</sup>Issues of detection and performance bias </p> <p><sup>b</sup>Issues related to selection, detection, performance, and other risk of bias </p> <p><sup>c</sup>Wide confidence intervals, number of participants less than 400 rule of thumb </p> <p><sup>d</sup>Interventions not similar across studies </p> <p>AE: aerobic exercise; HRQL: health‐related quality of life</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Quality of evidence ‐ GRADE assessment: AE intervention versus another AE intervention</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012700/full#CD012700-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012700-tbl-0010"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Quality of evidence ‐ GRADE assessment AE intervention versus other (non‐exercise intervention)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Quality assessment</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Number of participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Importance</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study design</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk of bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Inconsistency</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Indirectness</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Imprecision</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Other considerations</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>AE</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Other</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>HRQL,</b> 0‐100, lower is best (AE and lifestyle vs education or SMP) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CRITICAL</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Pain intensity</b>, 0‐100, lower is best (AE only vs education or SMP and AE only vs medication) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CRITICAL</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Fatigue,</b> 0‐100, lower is best (AE and lifestyle vs education or SMP) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IMPORTANT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Withdrawals</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomized trial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21/130 (16.2%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25/125 (20.0%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IMPORTANT</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Stiffness and physical function</b>: not measured </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="11" rowspan="1" valign=""> <p><b>Adverse events</b>: reported for 1 study: <a href="./references#CD012700-bbs2-0005" title="KingSJ , WesselJ , BhambhaniY , SholterD , MaksymowychW . The effects of exercise and education, individually or combined, in women with fibromyalgia. Journal of Rheumatology2002;29(12):2620‐7. ">King 2002</a>: "No complications or adverse effects were observed during the study period among patients who completed the treatment protocols" (page 3 of 8) </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="11"> <div class="table-footnote"> <p>AE: aerobic; HRQL: health‐related quality of life; SMP: self‐management program</p> <p><sup>a</sup>Issues related to risk of bias </p> <p><sup>b</sup>Low number of participants (less than 400 rule of thumb) and wide confidence intervals </p> <p><sup>c</sup>Comparator not similar across studies </p> <p>AE: aerobic exercise; HRQL: health‐related quality of life; SMP: self‐management program</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Quality of evidence ‐ GRADE assessment AE intervention versus other (non‐exercise intervention)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012700/full#CD012700-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012700-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">AE versus control (end of intervention)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 HRQL, FIQ Total, 0‐100, lower is best <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>372</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.89 [‐13.23, ‐2.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Met ACSM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.66 [‐17.77, 0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Did not meet ACSM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.77 [‐12.97, ‐0.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 HRQL, sensitivity.selection bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.47 [‐20.79, ‐0.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pain, intensity, 0‐100, lower is best <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐11.06 [‐18.34, ‐3.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Met ACSM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.89 [‐18.72, 6.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Did not meet ACSM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐14.90 [‐21.36, ‐8.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pain, sensitivity.selection bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.38 [‐17.88, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pain, sensitivity, attrition bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐11.71 [‐19.93, ‐3.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 New subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐11.71 [‐19.93, ‐3.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Fatigue, 0‐100 mm, lower is best <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>286</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.06 [‐12.41, 0.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Stiffness, 0‐100 mm, lower is best <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Physical Ftn, 0‐100 mm, lower is best <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.16 [‐15.39, ‐4.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Withdrawals <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>456</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.89, 1.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 CR max, VO<sub>2</sub>max, mL/kg/min <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>143</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.60 [‐0.06, 3.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 CR submax, 6MWT (distance ‐ meters, higher is best) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>55.58 [27.20, 83.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">AE versus control (end of intervention)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012700-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">AE versus control (long term)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 HRQL, 0‐100, lower is best <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐11.16 [‐25.99, 3.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Pain intensity, 0‐100, lower is best <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.56 [‐18.00, ‐1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Fatigue, 0‐100, lower is best <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.93 [‐24.34, 12.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Physical Ftn, 0‐100, lower is best <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐11.33 [‐22.11, ‐0.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Withdrawals <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.47, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 CR max, work capacity (W) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.06, 0.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 CR submax, 6MWT (meters, higher is best) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>41.5 [‐17.91, 100.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">AE versus control (long term)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012700-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">AE versus AE (end of intervention)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 HRQL, 0‐100, lower is best <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Pain intensity, 0‐100, lower is best <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Fatigue, 0‐100, lower is best <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Stiffness, 0‐100, lower is best <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Physical Ftn, 0‐100, lower is best <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Withdrawals <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 CR max, VO<sub>2</sub>max, mL/kg/min <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 CR submax, 6MWT (distance ‐ meters, higher is best) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">AE versus AE (end of intervention)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012700-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">AE versus other (end of intervention)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 HRQL, 0‐100, lower is best <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Pain intensity, 0‐100, lower is best <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 AE only vs education or SMP</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 AE only vs medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Fatigue, 0‐100, lower is best <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Withdrawals <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 CR max, work capacity (w) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 CR submax, 6 MWT(distance ‐ meters, higher is best) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">AE versus other (end of intervention)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012700/references#CD012700-tbl-0014">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012700&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD012700-note-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD012700-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012700-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="pl#CD012700-note-0002">Polski</a> </li> <li class="section-language"> <a class="" href="pt#CD012700-note-0018">Português</a> </li> <li class="section-language"> <a class="" href="ru#CD012700-note-0001">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012700\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012700\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012700\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012700"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012700\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012700\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012700\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012700\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012700\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012700"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012700\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012700\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012700\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012700"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012700\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012700\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012700\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012700"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uQyIsxpV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012700&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012700';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012700/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012700/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012700%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740726542516"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012700/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740726542520"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012700/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e962c3931f3c9',t:'MTc0MDcyNjU0My4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 